April 2020 – Third Perspective Capital

Month: April 2020

AI Trading NYSE Thu, 30 Apr

April 30, 2020April 30, 2020
by admin

Dear Reader,

Our featured stock today is NYSE:CCI. If you traded between 1998-12-31 – 2010-01-05 with our AI strategy, you would have made a 1445.93% return. On average a trade made 40.16% and was 73.0 days in the long position. There were a total of 36.0 postions taken over the period.

Here are the AI Trading NYSE Thu, 30 Apr buys:

Symbol	Model Accuracy	Price Target
NYSE:UPS	0.854356	96.1100
NYSE:PBA	0.831006	19.2966
NYSE:PBA	0.831006	20.3091
NYSE:ALLY	0.809313	12.9500
NYSE:CUK	0.808453	7.5000
NYSE:GE	0.804925	7.2300
NYSE:HMC	0.801072	20.8800
NYSE:VFC	0.795712	48.6800
NYSE:ABEV	0.795204	2.2000
NYSE:HST	0.790351	10.6200
NYSE:BA	0.787702	146.8700
NYSE:BA	0.787702	124.5200
NYSE:TDG	0.777568	284.4700
NYSE:MUFG	0.754533	3.6000
NYSE:NCLH	0.753223	11.3500
NYSE:NCLH	0.753223	8.4600
NYSE:LYG	0.751625	1.3100
NYSE:GPS	0.750447	5.6500
NYSE:BCS	0.749256	4.0100
NYSE:DAL	0.747692	23.8700
NYSE:AMOV	0.746713	10.9700
NYSE:SPR	0.738828	19.6100
NYSE:DB	0.733175	6.0900
NYSE:DELL	0.729167	37.1400
NYSE:LYV	0.727019	33.5700
NYSE:ITUB	0.705925	4.1000
NYSE:TME	0.673469	10.7300
NYSE:GOL	0.661629	4.5700
NYSE:GOL	0.661629	3.5200

Here are the AI Trading NYSE Thu, 30 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Symbol	From Date	To Date	Model Accuracy	Acc Profit/Loss	Avg Profit/Loss	Avg Days Invested	Total Positions
NYSE:UPS	2000-05-15	2020-01-30	85.0	115.15	23.03	134.0	5.0
NYSE:PBA	2012-05-14	2020-04-13	83.0	240.60	30.07	166.0	8.0
NYSE:ALLY	2016-06-09	2020-03-26	81.0	133.78	26.76	127.0	5.0
NYSE:CUK	2001-03-12	2020-03-26	81.0	779.49	37.12	135.0	21.0
NYSE:GE	2000-01-13	2020-03-26	80.0	542.65	28.56	93.0	19.0
NYSE:HMC	1998-07-24	2020-03-26	80.0	559.89	24.34	67.0	23.0
NYSE:VFC	1998-11-25	2020-03-26	80.0	685.57	36.08	193.0	19.0
NYSE:ABEV	2001-02-13	2020-03-26	80.0	1360.08	61.82	167.0	22.0
NYSE:HST	1999-01-15	2020-03-26	79.0	848.55	35.36	70.0	24.0
NYSE:BA	2000-01-19	2020-04-06	79.0	1045.21	61.48	236.0	17.0
NYSE:TDG	2008-01-04	2020-03-26	78.0	866.46	108.31	432.0	8.0
NYSE:MUFG	2001-10-03	2020-03-26	75.0	785.61	30.22	61.0	26.0
NYSE:NCLH	2014-02-12	2020-04-14	75.0	323.00	35.89	127.0	9.0
NYSE:LYG	2002-05-06	2020-03-25	75.0	1367.85	39.08	58.0	35.0
NYSE:GPS	1998-08-24	2019-09-16	75.0	1487.40	36.28	78.0	41.0
NYSE:BCS	1998-02-06	2020-03-26	75.0	1515.89	37.90	68.0	40.0
NYSE:DAL	2007-07-24	2020-03-26	75.0	1094.58	36.49	69.0	30.0
NYSE:AMOV	2001-06-07	2020-03-04	75.0	1173.46	46.94	123.0	25.0
NYSE:SPR	2007-07-25	2020-03-26	74.0	892.23	37.18	101.0	24.0
NYSE:DB	1998-05-26	2020-03-26	73.0	1608.75	32.83	65.0	49.0
NYSE:DELL	2019-05-30	2020-03-26	73.0	100.89	33.63	60.0	3.0
NYSE:LYV	2006-02-13	2020-03-27	73.0	1160.44	40.02	62.0	29.0
NYSE:ITUB	2002-04-12	2020-03-13	71.0	1670.03	37.11	73.0	45.0
NYSE:TME	2019-04-03	2020-02-11	67.0	69.70	34.85	80.0	2.0
NYSE:GOL	2004-09-24	2020-04-07	66.0	2696.04	46.48	55.0	58.0

Detail predictions over the past few days:
Buys:

Symbol	Date	Prediction	Adj Close	P/L %	Days
NYSE:UPS	2020-04-29	STRONGBUY	96.110
NYSE:UPS	2020-04-28	STRONGBUY	96.430
NYSE:UPS	2020-04-27	WEAKBUY	102.550
NYSE:UPS	2020-04-24	WEAKBUY	100.180
NYSE:UPS	2020-04-23	STRONGBUY	99.450
NYSE:UPS	2020-04-22	WEAKBUY	97.610
NYSE:UPS	2020-04-21	WEAKBUY	100.620
NYSE:UPS	2020-04-20	HOLD	101.200
NYSE:UPS	2020-04-17	HOLD	102.750
NYSE:UPS	2020-04-16	HOLD	102.220
NYSE:UPS	2020-04-15	HOLD	99.920
NYSE:UPS	2020-04-14	WEAKBUY	101.400
NYSE:UPS	2020-04-13	MEDIUMBUY	98.420
NYSE:UPS	2020-04-09	WEAKBUY	98.690
NYSE:UPS	2020-04-08	HOLD	98.790
NYSE:UPS	2020-04-07	WEAKBUY	92.910
NYSE:UPS	2020-04-06	WEAKBUY	95.680
NYSE:UPS	2020-04-03	WEAKBUY	90.000
NYSE:UPS	2020-04-02	WEAKBUY	93.040
NYSE:UPS	2020-04-01	MEDIUMBUY	90.390
NYSE:PBA	2020-04-29	WEAKBUY	24.040
NYSE:PBA	2020-04-28	WEAKBUY	21.620
NYSE:PBA	2020-04-27	WEAKBUY	20.460
NYSE:PBA	2020-04-24	WEAKBUY	20.210
NYSE:PBA	2020-04-23	WEAKBUY	19.920
NYSE:PBA	2020-04-22	STRONGBUY	19.297
NYSE:PBA	2020-04-21	STRONGBUY	18.622
NYSE:PBA	2020-04-20	WEAKBUY	19.336
NYSE:PBA	2020-04-17	WEAKBUY	20.230
NYSE:PBA	2020-04-16	WEAKBUY	18.830
NYSE:PBA	2020-04-15	WEAKBUY	19.058
NYSE:PBA	2020-04-14	WEAKSELL	20.001
NYSE:PBA	2020-04-13	WEAKSELL	19.793	-2.54	4
NYSE:PBA	2020-04-09	STRONGBUY	20.309
NYSE:PBA	2020-04-08	STRONGBUY	19.277
NYSE:PBA	2020-04-07	WEAKSELL	19.545
NYSE:PBA	2020-04-06	WEAKSELL	19.307	15.84	7
NYSE:PBA	2020-04-03	STRONGBUY	17.282
NYSE:PBA	2020-04-02	STRONGBUY	17.838
NYSE:PBA	2020-04-01	STRONGBUY	16.507
NYSE:ALLY	2020-04-29	WEAKBUY	18.020
NYSE:ALLY	2020-04-28	MEDIUMBUY	16.220
NYSE:ALLY	2020-04-27	MEDIUMBUY	15.200
NYSE:ALLY	2020-04-24	WEAKBUY	14.300
NYSE:ALLY	2020-04-23	MEDIUMBUY	14.300
NYSE:ALLY	2020-04-22	MEDIUMBUY	14.020
NYSE:ALLY	2020-04-21	MEDIUMBUY	14.180
NYSE:ALLY	2020-04-20	MEDIUMBUY	15.050
NYSE:ALLY	2020-04-17	MEDIUMBUY	15.370
NYSE:ALLY	2020-04-16	MEDIUMBUY	13.560
NYSE:ALLY	2020-04-15	MEDIUMBUY	14.160
NYSE:ALLY	2020-04-14	MEDIUMBUY	15.160
NYSE:ALLY	2020-04-13	MEDIUMBUY	15.750
NYSE:ALLY	2020-04-09	MEDIUMBUY	16.830
NYSE:ALLY	2020-04-08	MEDIUMBUY	15.220
NYSE:ALLY	2020-04-07	MEDIUMBUY	14.390
NYSE:ALLY	2020-04-06	MEDIUMBUY	13.840
NYSE:ALLY	2020-04-03	STRONGBUY	11.980
NYSE:ALLY	2020-04-02	STRONGBUY	12.950
NYSE:ALLY	2020-04-01	STRONGBUY	12.930
NYSE:CUK	2020-04-29	WEAKBUY	14.810
NYSE:CUK	2020-04-28	MEDIUMBUY	12.970
NYSE:CUK	2020-04-27	MEDIUMBUY	11.770
NYSE:CUK	2020-04-24	STRONGBUY	10.770
NYSE:CUK	2020-04-23	STRONGBUY	11.010
NYSE:CUK	2020-04-22	STRONGBUY	10.560
NYSE:CUK	2020-04-21	STRONGBUY	10.840
NYSE:CUK	2020-04-20	STRONGBUY	11.110
NYSE:CUK	2020-04-17	STRONGBUY	11.790
NYSE:CUK	2020-04-16	STRONGBUY	10.920
NYSE:CUK	2020-04-15	STRONGBUY	11.330
NYSE:CUK	2020-04-14	STRONGBUY	11.710
NYSE:CUK	2020-04-13	STRONGBUY	10.690
NYSE:CUK	2020-04-09	STRONGBUY	11.540
NYSE:CUK	2020-04-08	STRONGBUY	11.150
NYSE:CUK	2020-04-07	STRONGBUY	10.450
NYSE:CUK	2020-04-06	STRONGBUY	9.340
NYSE:CUK	2020-04-03	STRONGBUY	7.930
NYSE:CUK	2020-04-02	STRONGBUY	7.500
NYSE:CUK	2020-04-01	STRONGBUY	8.160
NYSE:GE	2020-04-29	STRONGBUY	6.580
NYSE:GE	2020-04-28	STRONGBUY	6.800
NYSE:GE	2020-04-27	STRONGBUY	6.430
NYSE:GE	2020-04-24	STRONGBUY	6.260
NYSE:GE	2020-04-23	STRONGBUY	6.520
NYSE:GE	2020-04-22	STRONGBUY	6.430
NYSE:GE	2020-04-21	STRONGBUY	6.480
NYSE:GE	2020-04-20	STRONGBUY	6.510
NYSE:GE	2020-04-17	STRONGBUY	6.840
NYSE:GE	2020-04-16	STRONGBUY	6.240
NYSE:GE	2020-04-15	STRONGBUY	6.500
NYSE:GE	2020-04-14	STRONGBUY	6.930
NYSE:GE	2020-04-13	STRONGBUY	7.020
NYSE:GE	2020-04-09	STRONGBUY	7.140
NYSE:GE	2020-04-08	STRONGBUY	7.300
NYSE:GE	2020-04-07	STRONGBUY	7.030
NYSE:GE	2020-04-06	STRONGBUY	7.230
NYSE:GE	2020-04-03	STRONGBUY	6.730
NYSE:GE	2020-04-02	HOLD	6.900
NYSE:GE	2020-04-01	HOLD	7.040
NYSE:HMC	2020-04-29	HOLD	23.890
NYSE:HMC	2020-04-28	HOLD	23.330
NYSE:HMC	2020-04-27	HOLD	23.570
NYSE:HMC	2020-04-24	HOLD	22.730
NYSE:HMC	2020-04-23	HOLD	22.480
NYSE:HMC	2020-04-22	HOLD	21.860
NYSE:HMC	2020-04-21	HOLD	21.780
NYSE:HMC	2020-04-20	HOLD	22.330
NYSE:HMC	2020-04-17	HOLD	22.630
NYSE:HMC	2020-04-16	STRONGBUY	21.010
NYSE:HMC	2020-04-15	HOLD	21.410
NYSE:HMC	2020-04-14	HOLD	22.040
NYSE:HMC	2020-04-13	HOLD	21.910
NYSE:HMC	2020-04-09	HOLD	22.330
NYSE:HMC	2020-04-08	HOLD	22.130
NYSE:HMC	2020-04-07	HOLD	21.700
NYSE:HMC	2020-04-06	HOLD	21.480
NYSE:HMC	2020-04-03	STRONGBUY	19.860
NYSE:HMC	2020-04-02	STRONGBUY	20.880
NYSE:HMC	2020-04-01	STRONGBUY	21.080
NYSE:VFC	2020-04-29	WEAKBUY	60.280
NYSE:VFC	2020-04-28	HOLD	59.500
NYSE:VFC	2020-04-27	STRONGBUY	57.710
NYSE:VFC	2020-04-24	STRONGBUY	54.570
NYSE:VFC	2020-04-23	STRONGBUY	54.350
NYSE:VFC	2020-04-22	STRONGBUY	54.270
NYSE:VFC	2020-04-21	STRONGBUY	53.340
NYSE:VFC	2020-04-20	STRONGBUY	55.830
NYSE:VFC	2020-04-17	STRONGBUY	57.500
NYSE:VFC	2020-04-16	STRONGBUY	54.850
NYSE:VFC	2020-04-15	STRONGBUY	55.850
NYSE:VFC	2020-04-14	HOLD	59.570
NYSE:VFC	2020-04-13	HOLD	57.500
NYSE:VFC	2020-04-09	HOLD	59.210
NYSE:VFC	2020-04-08	HOLD	57.990
NYSE:VFC	2020-04-07	HOLD	56.340
NYSE:VFC	2020-04-06	HOLD	54.670
NYSE:VFC	2020-04-03	STRONGBUY	48.880
NYSE:VFC	2020-04-02	STRONGBUY	49.120
NYSE:VFC	2020-04-01	STRONGBUY	48.680
NYSE:ABEV	2020-04-29	STRONGBUY	2.190
NYSE:ABEV	2020-04-28	STRONGBUY	2.130
NYSE:ABEV	2020-04-27	STRONGBUY	2.080
NYSE:ABEV	2020-04-24	STRONGBUY	2.000
NYSE:ABEV	2020-04-23	STRONGBUY	2.120
NYSE:ABEV	2020-04-22	STRONGBUY	2.170
NYSE:ABEV	2020-04-21	STRONGBUY	2.230
NYSE:ABEV	2020-04-20	STRONGBUY	2.240
NYSE:ABEV	2020-04-17	STRONGBUY	2.220
NYSE:ABEV	2020-04-16	STRONGBUY	2.200
NYSE:ABEV	2020-04-15	STRONGBUY	2.290
NYSE:ABEV	2020-04-14	MEDIUMBUY	2.360
NYSE:ABEV	2020-04-13	WEAKSELL	2.360
NYSE:ABEV	2020-04-09	WEAKSELL	2.400
NYSE:ABEV	2020-04-08	WEAKSELL	2.410
NYSE:ABEV	2020-04-07	WEAKSELL	2.370
NYSE:ABEV	2020-04-06	WEAKSELL	2.230
NYSE:ABEV	2020-04-03	WEAKSELL	2.180
NYSE:ABEV	2020-04-02	WEAKSELL	2.310
NYSE:ABEV	2020-04-01	WEAKSELL	2.250
NYSE:HST	2020-04-29	MEDIUMBUY	12.570
NYSE:HST	2020-04-28	MEDIUMBUY	11.690
NYSE:HST	2020-04-27	STRONGBUY	11.570
NYSE:HST	2020-04-24	STRONGBUY	11.100
NYSE:HST	2020-04-23	STRONGBUY	10.810
NYSE:HST	2020-04-22	STRONGBUY	10.620
NYSE:HST	2020-04-21	STRONGBUY	10.560
NYSE:HST	2020-04-20	MEDIUMBUY	10.800
NYSE:HST	2020-04-17	MEDIUMBUY	11.370
NYSE:HST	2020-04-16	MEDIUMBUY	11.000
NYSE:HST	2020-04-15	WEAKBUY	11.270
NYSE:HST	2020-04-14	WEAKBUY	11.440
NYSE:HST	2020-04-13	WEAKBUY	11.410
NYSE:HST	2020-04-09	WEAKBUY	11.910
NYSE:HST	2020-04-08	WEAKBUY	11.260
NYSE:HST	2020-04-07	WEAKBUY	10.690
NYSE:HST	2020-04-06	WEAKBUY	10.420
NYSE:HST	2020-04-03	STRONGBUY	9.060
NYSE:HST	2020-04-02	WEAKBUY	9.550
NYSE:HST	2020-04-01	WEAKBUY	10.280
NYSE:BA	2020-04-29	STRONGBUY	139.000
NYSE:BA	2020-04-28	STRONGBUY	131.300
NYSE:BA	2020-04-27	STRONGBUY	128.680
NYSE:BA	2020-04-24	STRONGBUY	128.980
NYSE:BA	2020-04-23	STRONGBUY	137.740
NYSE:BA	2020-04-22	STRONGBUY	134.970
NYSE:BA	2020-04-21	STRONGBUY	136.330
NYSE:BA	2020-04-20	STRONGBUY	143.610
NYSE:BA	2020-04-17	STRONGBUY	154.000
NYSE:BA	2020-04-16	STRONGBUY	134.240
NYSE:BA	2020-04-15	STRONGBUY	145.980
NYSE:BA	2020-04-14	STRONGBUY	141.000
NYSE:BA	2020-04-13	STRONGBUY	147.330
NYSE:BA	2020-04-09	STRONGBUY	151.840
NYSE:BA	2020-04-08	STRONGBUY	146.870
NYSE:BA	2020-04-07	STRONGBUY	141.580
NYSE:BA	2020-04-06	STRONGSELL	148.770	19.47	3
NYSE:BA	2020-04-03	STRONGBUY	124.520
NYSE:BA	2020-04-02	STRONGBUY	123.270
NYSE:BA	2020-04-01	STRONGSELL	130.700
NYSE:TDG	2020-04-29	HOLD	371.180
NYSE:TDG	2020-04-28	WEAKBUY	336.650
NYSE:TDG	2020-04-27	WEAKBUY	317.450
NYSE:TDG	2020-04-24	MEDIUMBUY	304.920
NYSE:TDG	2020-04-23	WEAKBUY	314.280
NYSE:TDG	2020-04-22	WEAKBUY	304.260
NYSE:TDG	2020-04-21	WEAKBUY	307.750
NYSE:TDG	2020-04-20	WEAKBUY	316.400
NYSE:TDG	2020-04-17	WEAKBUY	337.400
NYSE:TDG	2020-04-16	MEDIUMBUY	300.900
NYSE:TDG	2020-04-15	MEDIUMBUY	316.940
NYSE:TDG	2020-04-14	MEDIUMBUY	318.160
NYSE:TDG	2020-04-13	MEDIUMBUY	313.600
NYSE:TDG	2020-04-09	MEDIUMBUY	344.540
NYSE:TDG	2020-04-08	MEDIUMBUY	328.250
NYSE:TDG	2020-04-07	MEDIUMBUY	286.430
NYSE:TDG	2020-04-06	MEDIUMBUY	288.930
NYSE:TDG	2020-04-03	STRONGBUY	270.310
NYSE:TDG	2020-04-02	STRONGBUY	284.470
NYSE:TDG	2020-04-01	STRONGBUY	272.540
NYSE:MUFG	2020-04-29	HOLD	4.100
NYSE:MUFG	2020-04-28	HOLD	4.020
NYSE:MUFG	2020-04-27	HOLD	3.980
NYSE:MUFG	2020-04-24	HOLD	3.850
NYSE:MUFG	2020-04-23	HOLD	3.870
NYSE:MUFG	2020-04-22	HOLD	3.790
NYSE:MUFG	2020-04-21	HOLD	3.780
NYSE:MUFG	2020-04-20	WEAKBUY	3.820
NYSE:MUFG	2020-04-17	WEAKBUY	3.800
NYSE:MUFG	2020-04-16	HOLD	3.700
NYSE:MUFG	2020-04-15	HOLD	3.780
NYSE:MUFG	2020-04-14	HOLD	3.930
NYSE:MUFG	2020-04-13	HOLD	3.860
NYSE:MUFG	2020-04-09	HOLD	3.760
NYSE:MUFG	2020-04-08	HOLD	3.710
NYSE:MUFG	2020-04-07	HOLD	3.810
NYSE:MUFG	2020-04-06	HOLD	3.720
NYSE:MUFG	2020-04-03	STRONGBUY	3.490
NYSE:MUFG	2020-04-02	STRONGBUY	3.600
NYSE:MUFG	2020-04-01	STRONGBUY	3.600
NYSE:NCLH	2020-04-29	WEAKBUY	16.410
NYSE:NCLH	2020-04-28	WEAKBUY	13.090
NYSE:NCLH	2020-04-27	STRONGBUY	11.440
NYSE:NCLH	2020-04-24	STRONGBUY	10.860
NYSE:NCLH	2020-04-23	STRONGBUY	11.470
NYSE:NCLH	2020-04-22	STRONGBUY	10.870
NYSE:NCLH	2020-04-21	STRONGBUY	11.000
NYSE:NCLH	2020-04-20	WEAKBUY	11.490
NYSE:NCLH	2020-04-17	STRONGBUY	12.380
NYSE:NCLH	2020-04-16	STRONGBUY	11.350
NYSE:NCLH	2020-04-15	STRONGBUY	12.080
NYSE:NCLH	2020-04-14	STRONGSELL	12.350	45.98	11
NYSE:NCLH	2020-04-13	STRONGBUY	11.360
NYSE:NCLH	2020-04-09	STRONGBUY	13.110
NYSE:NCLH	2020-04-08	STRONGBUY	11.720
NYSE:NCLH	2020-04-07	STRONGBUY	11.010
NYSE:NCLH	2020-04-06	STRONGBUY	10.010
NYSE:NCLH	2020-04-03	STRONGBUY	8.460
NYSE:NCLH	2020-04-02	STRONGBUY	8.400
NYSE:NCLH	2020-04-01	STRONGSELL	9.550
NYSE:LYG	2020-04-29	MEDIUMBUY	1.700
NYSE:LYG	2020-04-28	MEDIUMBUY	1.600
NYSE:LYG	2020-04-27	MEDIUMBUY	1.470
NYSE:LYG	2020-04-24	MEDIUMBUY	1.440
NYSE:LYG	2020-04-23	MEDIUMBUY	1.440
NYSE:LYG	2020-04-22	MEDIUMBUY	1.410
NYSE:LYG	2020-04-21	MEDIUMBUY	1.390
NYSE:LYG	2020-04-20	MEDIUMBUY	1.420
NYSE:LYG	2020-04-17	MEDIUMBUY	1.480
NYSE:LYG	2020-04-16	MEDIUMBUY	1.410
NYSE:LYG	2020-04-15	MEDIUMBUY	1.430
NYSE:LYG	2020-04-14	MEDIUMBUY	1.570
NYSE:LYG	2020-04-13	MEDIUMBUY	1.570
NYSE:LYG	2020-04-09	MEDIUMBUY	1.600
NYSE:LYG	2020-04-08	MEDIUMBUY	1.510
NYSE:LYG	2020-04-07	STRONGBUY	1.450
NYSE:LYG	2020-04-06	STRONGBUY	1.420
NYSE:LYG	2020-04-03	STRONGBUY	1.290
NYSE:LYG	2020-04-02	STRONGBUY	1.370
NYSE:LYG	2020-04-01	STRONGBUY	1.310
NYSE:GPS	2020-04-29	WEAKBUY	9.050
NYSE:GPS	2020-04-28	STRONGBUY	8.610
NYSE:GPS	2020-04-27	STRONGBUY	7.790
NYSE:GPS	2020-04-24	STRONGBUY	6.900
NYSE:GPS	2020-04-23	STRONGBUY	7.100
NYSE:GPS	2020-04-22	STRONGBUY	7.110
NYSE:GPS	2020-04-21	STRONGBUY	7.560
NYSE:GPS	2020-04-20	STRONGBUY	7.840
NYSE:GPS	2020-04-17	STRONGBUY	8.350
NYSE:GPS	2020-04-16	STRONGBUY	7.630
NYSE:GPS	2020-04-15	STRONGBUY	7.710
NYSE:GPS	2020-04-14	STRONGBUY	8.430
NYSE:GPS	2020-04-13	STRONGBUY	8.330
NYSE:GPS	2020-04-09	WEAKBUY	9.090
NYSE:GPS	2020-04-08	HOLD	7.850
NYSE:GPS	2020-04-07	HOLD	6.970
NYSE:GPS	2020-04-06	HOLD	6.590
NYSE:GPS	2020-04-03	STRONGBUY	5.650
NYSE:GPS	2020-04-02	STRONGBUY	5.500
NYSE:GPS	2020-04-01	HOLD	5.890
NYSE:BCS	2020-04-29	WEAKBUY	5.520
NYSE:BCS	2020-04-28	WEAKBUY	4.870
NYSE:BCS	2020-04-27	STRONGBUY	4.530
NYSE:BCS	2020-04-24	STRONGBUY	4.420
NYSE:BCS	2020-04-23	STRONGBUY	4.390
NYSE:BCS	2020-04-22	STRONGBUY	4.270
NYSE:BCS	2020-04-21	STRONGBUY	4.260
NYSE:BCS	2020-04-20	STRONGBUY	4.440
NYSE:BCS	2020-04-17	STRONGBUY	4.550
NYSE:BCS	2020-04-16	STRONGBUY	4.300
NYSE:BCS	2020-04-15	STRONGBUY	4.330
NYSE:BCS	2020-04-14	STRONGBUY	4.690
NYSE:BCS	2020-04-13	WEAKBUY	4.720
NYSE:BCS	2020-04-09	WEAKBUY	4.880
NYSE:BCS	2020-04-08	STRONGBUY	4.570
NYSE:BCS	2020-04-07	WEAKBUY	4.530
NYSE:BCS	2020-04-06	STRONGBUY	4.230
NYSE:BCS	2020-04-03	STRONGBUY	3.890
NYSE:BCS	2020-04-02	STRONGBUY	4.010
NYSE:BCS	2020-04-01	STRONGBUY	4.050
NYSE:DAL	2020-04-29	STRONGBUY	27.320
NYSE:DAL	2020-04-28	STRONGBUY	24.340
NYSE:DAL	2020-04-27	STRONGBUY	22.160
NYSE:DAL	2020-04-24	STRONGBUY	22.410
NYSE:DAL	2020-04-23	STRONGBUY	22.480
NYSE:DAL	2020-04-22	STRONGBUY	22.470
NYSE:DAL	2020-04-21	STRONGBUY	23.100
NYSE:DAL	2020-04-20	STRONGBUY	23.640
NYSE:DAL	2020-04-17	STRONGBUY	24.270
NYSE:DAL	2020-04-16	STRONGBUY	22.780
NYSE:DAL	2020-04-15	STRONGBUY	24.350
NYSE:DAL	2020-04-14	STRONGBUY	24.540
NYSE:DAL	2020-04-13	STRONGBUY	23.250
NYSE:DAL	2020-04-09	STRONGBUY	24.390
NYSE:DAL	2020-04-08	STRONGBUY	23.230
NYSE:DAL	2020-04-07	STRONGBUY	22.250
NYSE:DAL	2020-04-06	STRONGBUY	22.320
NYSE:DAL	2020-04-03	STRONGBUY	22.480
NYSE:DAL	2020-04-02	STRONGBUY	22.680
NYSE:DAL	2020-04-01	STRONGBUY	23.870
NYSE:AMOV	2020-04-29	WEAKBUY	12.010
NYSE:AMOV	2020-04-28	WEAKBUY	11.310
NYSE:AMOV	2020-04-27	WEAKBUY	10.786
NYSE:AMOV	2020-04-24	STRONGBUY	10.619
NYSE:AMOV	2020-04-23	STRONGBUY	10.800
NYSE:AMOV	2020-04-22	STRONGBUY	10.500
NYSE:AMOV	2020-04-21	WEAKBUY	11.000
NYSE:AMOV	2020-04-20	WEAKBUY	10.819
NYSE:AMOV	2020-04-17	WEAKBUY	11.100
NYSE:AMOV	2020-04-16	STRONGBUY	10.540
NYSE:AMOV	2020-04-15	WEAKBUY	11.680
NYSE:AMOV	2020-04-14	WEAKBUY	11.590
NYSE:AMOV	2020-04-13	WEAKBUY	12.102
NYSE:AMOV	2020-04-09	WEAKBUY	11.628
NYSE:AMOV	2020-04-08	WEAKBUY	11.890
NYSE:AMOV	2020-04-07	WEAKBUY	11.655
NYSE:AMOV	2020-04-06	STRONGBUY	10.420
NYSE:AMOV	2020-04-03	STRONGBUY	10.970
NYSE:AMOV	2020-04-02	STRONGBUY	10.970
NYSE:AMOV	2020-04-01	HOLD	11.380
NYSE:SPR	2020-04-29	HOLD	23.600
NYSE:SPR	2020-04-28	WEAKBUY	20.500
NYSE:SPR	2020-04-27	STRONGBUY	19.140
NYSE:SPR	2020-04-24	STRONGBUY	18.090
NYSE:SPR	2020-04-23	STRONGBUY	19.340
NYSE:SPR	2020-04-22	STRONGBUY	18.910
NYSE:SPR	2020-04-21	STRONGBUY	19.370
NYSE:SPR	2020-04-20	STRONGBUY	20.870
NYSE:SPR	2020-04-17	STRONGBUY	22.640
NYSE:SPR	2020-04-16	STRONGBUY	19.090
NYSE:SPR	2020-04-15	STRONGBUY	20.920
NYSE:SPR	2020-04-14	STRONGBUY	19.990
NYSE:SPR	2020-04-13	STRONGBUY	20.650
NYSE:SPR	2020-04-09	STRONGBUY	22.580
NYSE:SPR	2020-04-08	STRONGBUY	21.300
NYSE:SPR	2020-04-07	STRONGBUY	18.360
NYSE:SPR	2020-04-06	STRONGBUY	19.450
NYSE:SPR	2020-04-03	STRONGBUY	18.430
NYSE:SPR	2020-04-02	STRONGBUY	18.730
NYSE:SPR	2020-04-01	STRONGBUY	19.610
NYSE:DB	2020-04-29	WEAKBUY	7.670
NYSE:DB	2020-04-28	WEAKBUY	6.850
NYSE:DB	2020-04-27	WEAKBUY	6.690
NYSE:DB	2020-04-24	STRONGBUY	5.950
NYSE:DB	2020-04-23	STRONGBUY	6.180
NYSE:DB	2020-04-22	STRONGBUY	6.090
NYSE:DB	2020-04-21	STRONGBUY	6.080
NYSE:DB	2020-04-20	WEAKBUY	6.330
NYSE:DB	2020-04-17	WEAKBUY	6.540
NYSE:DB	2020-04-16	WEAKBUY	6.220
NYSE:DB	2020-04-15	WEAKBUY	6.230
NYSE:DB	2020-04-14	WEAKBUY	6.850
NYSE:DB	2020-04-13	WEAKBUY	6.520
NYSE:DB	2020-04-09	WEAKBUY	6.690
NYSE:DB	2020-04-08	WEAKBUY	6.540
NYSE:DB	2020-04-07	WEAKBUY	6.640
NYSE:DB	2020-04-06	WEAKBUY	6.380
NYSE:DB	2020-04-03	WEAKBUY	5.900
NYSE:DB	2020-04-02	WEAKBUY	6.020
NYSE:DB	2020-04-01	WEAKBUY	5.960
NYSE:DELL	2020-04-29	STRONGBUY	43.390
NYSE:DELL	2020-04-28	STRONGBUY	40.840
NYSE:DELL	2020-04-27	STRONGBUY	40.190
NYSE:DELL	2020-04-24	STRONGBUY	39.690
NYSE:DELL	2020-04-23	STRONGBUY	38.910
NYSE:DELL	2020-04-22	STRONGBUY	38.750
NYSE:DELL	2020-04-21	STRONGBUY	37.400
NYSE:DELL	2020-04-20	STRONGBUY	40.960
NYSE:DELL	2020-04-17	STRONGBUY	41.510
NYSE:DELL	2020-04-16	STRONGBUY	41.100
NYSE:DELL	2020-04-15	STRONGBUY	40.450
NYSE:DELL	2020-04-14	STRONGBUY	41.340
NYSE:DELL	2020-04-13	STRONGBUY	40.460
NYSE:DELL	2020-04-09	STRONGBUY	41.560
NYSE:DELL	2020-04-08	STRONGBUY	40.380
NYSE:DELL	2020-04-07	STRONGBUY	38.370
NYSE:DELL	2020-04-06	STRONGBUY	38.910
NYSE:DELL	2020-04-03	STRONGBUY	36.440
NYSE:DELL	2020-04-02	STRONGBUY	37.140
NYSE:DELL	2020-04-01	STRONGBUY	36.900
NYSE:LYV	2020-04-29	HOLD	46.530
NYSE:LYV	2020-04-28	HOLD	43.640
NYSE:LYV	2020-04-27	HOLD	42.010
NYSE:LYV	2020-04-24	HOLD	38.240
NYSE:LYV	2020-04-23	HOLD	39.450
NYSE:LYV	2020-04-22	HOLD	36.350
NYSE:LYV	2020-04-21	HOLD	36.470
NYSE:LYV	2020-04-20	HOLD	36.660
NYSE:LYV	2020-04-17	HOLD	38.350
NYSE:LYV	2020-04-16	HOLD	36.400
NYSE:LYV	2020-04-15	HOLD	38.470
NYSE:LYV	2020-04-14	HOLD	41.960
NYSE:LYV	2020-04-13	WEAKBUY	39.410
NYSE:LYV	2020-04-09	STRONGBUY	38.270
NYSE:LYV	2020-04-08	WEAKBUY	37.760
NYSE:LYV	2020-04-07	WEAKBUY	37.850
NYSE:LYV	2020-04-06	STRONGBUY	34.510
NYSE:LYV	2020-04-03	STRONGBUY	33.570
NYSE:LYV	2020-04-02	STRONGBUY	33.950
NYSE:LYV	2020-04-01	HOLD	38.880
NYSE:ITUB	2020-04-29	STRONGBUY	4.470
NYSE:ITUB	2020-04-28	STRONGBUY	4.250
NYSE:ITUB	2020-04-27	STRONGBUY	3.800
NYSE:ITUB	2020-04-24	STRONGBUY	3.660
NYSE:ITUB	2020-04-23	STRONGBUY	4.000
NYSE:ITUB	2020-04-22	STRONGBUY	4.120
NYSE:ITUB	2020-04-21	STRONGBUY	4.050
NYSE:ITUB	2020-04-20	STRONGBUY	4.250
NYSE:ITUB	2020-04-17	STRONGBUY	4.420
NYSE:ITUB	2020-04-16	STRONGBUY	4.310
NYSE:ITUB	2020-04-15	STRONGBUY	4.500
NYSE:ITUB	2020-04-14	STRONGBUY	4.690
NYSE:ITUB	2020-04-13	STRONGBUY	4.620
NYSE:ITUB	2020-04-09	HOLD	4.640
NYSE:ITUB	2020-04-08	HOLD	4.680
NYSE:ITUB	2020-04-07	HOLD	4.380
NYSE:ITUB	2020-04-06	STRONGBUY	4.170
NYSE:ITUB	2020-04-03	STRONGBUY	3.900
NYSE:ITUB	2020-04-02	STRONGBUY	4.100
NYSE:ITUB	2020-04-01	STRONGBUY	4.080
NYSE:TME	2020-04-29	STRONGBUY	11.250
NYSE:TME	2020-04-28	STRONGBUY	10.870
NYSE:TME	2020-04-27	STRONGBUY	11.030
NYSE:TME	2020-04-24	STRONGBUY	10.750
NYSE:TME	2020-04-23	STRONGBUY	10.940
NYSE:TME	2020-04-22	STRONGBUY	11.120
NYSE:TME	2020-04-21	STRONGBUY	10.960
NYSE:TME	2020-04-20	STRONGBUY	11.190
NYSE:TME	2020-04-17	STRONGBUY	10.890
NYSE:TME	2020-04-16	STRONGBUY	10.820
NYSE:TME	2020-04-15	STRONGBUY	10.830
NYSE:TME	2020-04-14	STRONGBUY	11.120
NYSE:TME	2020-04-13	STRONGBUY	10.900
NYSE:TME	2020-04-09	STRONGBUY	10.970
NYSE:TME	2020-04-08	STRONGBUY	10.990
NYSE:TME	2020-04-07	STRONGBUY	10.730
NYSE:TME	2020-04-06	STRONGBUY	10.590
NYSE:TME	2020-04-03	MEDIUMBUY	10.630
NYSE:TME	2020-04-02	MEDIUMBUY	11.010
NYSE:TME	2020-04-01	STRONGBUY	10.120
NYSE:GOL	2020-04-29	STRONGBUY	5.050
NYSE:GOL	2020-04-28	STRONGBUY	4.420
NYSE:GOL	2020-04-27	STRONGBUY	3.960
NYSE:GOL	2020-04-24	STRONGBUY	3.780
NYSE:GOL	2020-04-23	STRONGBUY	4.350
NYSE:GOL	2020-04-22	STRONGBUY	4.390
NYSE:GOL	2020-04-21	STRONGBUY	4.160
NYSE:GOL	2020-04-20	STRONGBUY	4.550
NYSE:GOL	2020-04-17	STRONGBUY	4.640
NYSE:GOL	2020-04-16	STRONGBUY	4.490
NYSE:GOL	2020-04-15	STRONGBUY	4.640
NYSE:GOL	2020-04-14	STRONGBUY	4.450
NYSE:GOL	2020-04-13	STRONGBUY	4.390
NYSE:GOL	2020-04-09	STRONGBUY	4.570
NYSE:GOL	2020-04-08	STRONGBUY	4.620
NYSE:GOL	2020-04-07	WEAKSELL	4.130	17.33	4
NYSE:GOL	2020-04-06	STRONGBUY	3.800
NYSE:GOL	2020-04-03	STRONGBUY	3.520
NYSE:GOL	2020-04-02	STRONGBUY	3.740
NYSE:GOL	2020-04-01	WEAKSELL	3.710

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

AI Trading Ideas

AI Trading NASDAQ Thu, 30 Apr

April 30, 2020April 30, 2020
by admin

Dear Reader,

Our featured stock today is HZNP. If you traded between 2011-11-08 – 2019-08-21 with our AI strategy, you would have made a 1696.71% return. On average a trade made 62.84% and was 70.0 days in the long position. There were a total of 27.0 postions taken over the period.

Here are the AI Trading NASDAQ Thu, 30 Apr buys:

Symbol	Model Accuracy	Price Target
NWSA	0.818359	8.435
EWBC	0.801189	24.230
LBTYK	0.792539	15.115
DISCA	0.787770	20.390
LBTYA	0.772385	16.050
MYL	0.772127	13.740
NXST	0.766613	53.620
MIDD	0.761559	54.000
ADI	0.760396	84.090
EVOP	0.757143	12.710
DAL	0.754098	22.680
NOVT	0.750000	67.250
AMOV	0.749307	10.970
CMPR	0.747715	44.900
DSGX	0.732497	37.930
DSGX	0.732497	38.630
HQY	0.728972	43.920
HTHT	0.711640	28.450
UAL	0.706929	25.650
WB	0.706013	35.240
IPGP	0.703888	102.920
CSOD	0.702346	31.700
CTRP	0.699431	23.000
MRNA	0.676768	51.200
FEYE	0.660569	9.900

Here are the AI Trading NASDAQ Thu, 30 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Symbol	From Date	To Date	Model Accuracy	Acc Profit/Loss	Avg Profit/Loss	Avg Days Invested	Total Positions
NWSA	2014-09-10	2019-11-06	82.0	129.67	18.52	128.0	7.0
EWBC	2000-09-14	2020-03-17	80.0	1406.56	42.62	86.0	33.0
LBTYK	2006-06-26	2019-05-06	79.0	536.94	29.83	73.0	18.0
DISCA	2007-08-08	2020-02-19	79.0	483.57	32.24	97.0	15.0
LBTYA	2004-12-17	2019-09-13	77.0	746.18	35.53	86.0	21.0
MYL	2000-05-09	2020-02-10	77.0	997.42	33.25	96.0	30.0
NXST	2004-12-31	2020-03-26	77.0	2140.77	59.47	102.0	36.0
MIDD	2000-06-13	2020-03-26	76.0	1645.12	49.85	126.0	33.0
ADI	2000-03-22	2019-07-31	76.0	960.11	27.43	69.0	35.0
EVOP	2018-11-30	2018-11-30	76.0	34.31	34.31	190.0	1.0
DAL	2007-07-24	2020-03-27	75.0	1099.53	42.29	79.0	26.0
NOVT	2017-11-24	2020-03-04	75.0	404.41	67.40	175.0	6.0
AMOV	2001-06-07	2019-02-05	75.0	1097.77	42.22	107.0	26.0
CMPR	2006-03-02	2020-03-24	75.0	1267.39	46.94	90.0	27.0
DSGX	2000-03-10	2020-04-17	73.0	1544.55	31.52	62.0	49.0
HQY	2014-09-10	2020-03-26	73.0	645.81	29.35	52.0	22.0
HTHT	2010-04-05	2020-04-29	71.0	1064.22	42.57	83.0	25.0
UAL	2006-03-27	2020-03-25	71.0	1924.38	42.76	57.0	45.0
WB	2014-09-11	2020-01-13	71.0	914.30	50.79	68.0	18.0
IPGP	2007-06-04	2019-11-05	70.0	1195.16	44.27	89.0	27.0
CSOD	2011-05-11	2020-03-26	70.0	701.80	35.09	87.0	20.0
CTRP	2004-01-02	2020-01-21	70.0	1807.50	45.19	77.0	40.0
MRNA	2019-05-31	2020-04-16	68.0	237.21	79.07	139.0	3.0
FEYE	2014-03-05	2020-03-26	66.0	649.61	40.60	63.0	16.0

Detail predictions over the past few days:
Buys:

Symbol	Date	Prediction	Adj Close	P/L %	Days
NWSA	2020-04-29	WEAKBUY	10.500
NWSA	2020-04-28	WEAKBUY	9.810
NWSA	2020-04-27	WEAKBUY	9.460
NWSA	2020-04-24	STRONGBUY	8.830
NWSA	2020-04-23	STRONGBUY	8.675
NWSA	2020-04-22	STRONGBUY	8.435
NWSA	2020-04-21	STRONGBUY	8.435
NWSA	2020-04-20	STRONGBUY	8.770
NWSA	2020-04-17	STRONGBUY	8.900
NWSA	2020-04-16	STRONGBUY	8.435
NWSA	2020-04-15	STRONGBUY	8.930
NWSA	2020-04-14	WEAKBUY	9.415
NWSA	2020-04-13	WEAKBUY	9.390
NWSA	2020-04-09	HOLD	9.490
NWSA	2020-04-08	STRONGBUY	8.950
NWSA	2020-04-07	HOLD	8.790
NWSA	2020-04-06	HOLD	8.930
NWSA	2020-04-03	WEAKBUY	8.180
NWSA	2020-04-02	WEAKBUY	8.200
NWSA	2020-04-01	HOLD	8.640
EWBC	2020-04-29	HOLD	36.410
EWBC	2020-04-28	HOLD	33.800
EWBC	2020-04-27	HOLD	32.120
EWBC	2020-04-24	WEAKBUY	30.370
EWBC	2020-04-23	WEAKBUY	29.530
EWBC	2020-04-22	WEAKBUY	26.980
EWBC	2020-04-21	MEDIUMBUY	27.360
EWBC	2020-04-20	MEDIUMBUY	28.000
EWBC	2020-04-17	MEDIUMBUY	28.010
EWBC	2020-04-16	MEDIUMBUY	25.470
EWBC	2020-04-15	MEDIUMBUY	26.060
EWBC	2020-04-14	MEDIUMBUY	28.560
EWBC	2020-04-13	MEDIUMBUY	29.180
EWBC	2020-04-09	MEDIUMBUY	31.110
EWBC	2020-04-08	MEDIUMBUY	27.550
EWBC	2020-04-07	WEAKBUY	27.020
EWBC	2020-04-06	WEAKBUY	25.430
EWBC	2020-04-03	STRONGBUY	22.780
EWBC	2020-04-02	STRONGBUY	24.230
EWBC	2020-04-01	STRONGBUY	24.370
LBTYK	2020-04-29	HOLD	18.000
LBTYK	2020-04-28	HOLD	17.590
LBTYK	2020-04-27	HOLD	18.210
LBTYK	2020-04-24	HOLD	17.515
LBTYK	2020-04-23	HOLD	17.380
LBTYK	2020-04-22	HOLD	17.080
LBTYK	2020-04-21	HOLD	16.810
LBTYK	2020-04-20	HOLD	17.340
LBTYK	2020-04-17	HOLD	17.290
LBTYK	2020-04-16	HOLD	17.230
LBTYK	2020-04-15	HOLD	17.100
LBTYK	2020-04-14	HOLD	17.390
LBTYK	2020-04-13	HOLD	16.980
LBTYK	2020-04-09	HOLD	17.390
LBTYK	2020-04-08	HOLD	17.300
LBTYK	2020-04-07	HOLD	16.250
LBTYK	2020-04-06	HOLD	16.180
LBTYK	2020-04-03	STRONGBUY	14.840
LBTYK	2020-04-02	STRONGBUY	15.240
LBTYK	2020-04-01	STRONGBUY	15.115
DISCA	2020-04-29	HOLD	24.730
DISCA	2020-04-28	HOLD	23.420
DISCA	2020-04-27	HOLD	22.745
DISCA	2020-04-24	STRONGBUY	21.020
DISCA	2020-04-23	STRONGBUY	20.390
DISCA	2020-04-22	STRONGBUY	20.370
DISCA	2020-04-21	HOLD	20.780
DISCA	2020-04-20	HOLD	21.700
DISCA	2020-04-17	HOLD	22.140
DISCA	2020-04-16	WEAKBUY	21.470
DISCA	2020-04-15	WEAKBUY	21.350
DISCA	2020-04-14	WEAKBUY	22.300
DISCA	2020-04-13	WEAKBUY	21.990
DISCA	2020-04-09	WEAKBUY	22.320
DISCA	2020-04-08	WEAKBUY	21.580
DISCA	2020-04-07	WEAKBUY	20.670
DISCA	2020-04-06	WEAKBUY	19.650
DISCA	2020-04-03	WEAKBUY	18.360
DISCA	2020-04-02	WEAKBUY	18.680
DISCA	2020-04-01	WEAKBUY	19.455
LBTYA	2020-04-29	HOLD	18.830
LBTYA	2020-04-28	HOLD	18.415
LBTYA	2020-04-27	WEAKBUY	19.050
LBTYA	2020-04-24	HOLD	18.380
LBTYA	2020-04-23	HOLD	18.170
LBTYA	2020-04-22	HOLD	17.870
LBTYA	2020-04-21	HOLD	17.620
LBTYA	2020-04-20	HOLD	18.260
LBTYA	2020-04-17	HOLD	18.230
LBTYA	2020-04-16	HOLD	18.180
LBTYA	2020-04-15	HOLD	18.030
LBTYA	2020-04-14	HOLD	18.550
LBTYA	2020-04-13	HOLD	18.080
LBTYA	2020-04-09	HOLD	18.590
LBTYA	2020-04-08	WEAKBUY	18.270
LBTYA	2020-04-07	STRONGBUY	17.260
LBTYA	2020-04-06	WEAKBUY	17.080
LBTYA	2020-04-03	STRONGBUY	15.800
LBTYA	2020-04-02	STRONGBUY	16.190
LBTYA	2020-04-01	STRONGBUY	16.050
MYL	2020-04-29	WEAKBUY	17.320
MYL	2020-04-28	WEAKBUY	16.440
MYL	2020-04-27	WEAKBUY	16.140
MYL	2020-04-24	MEDIUMBUY	15.760
MYL	2020-04-23	MEDIUMBUY	15.300
MYL	2020-04-22	MEDIUMBUY	14.910
MYL	2020-04-21	WEAKBUY	15.130
MYL	2020-04-20	WEAKBUY	15.860
MYL	2020-04-17	WEAKBUY	16.110
MYL	2020-04-16	WEAKBUY	15.500
MYL	2020-04-15	MEDIUMBUY	15.460
MYL	2020-04-14	MEDIUMBUY	16.350
MYL	2020-04-13	MEDIUMBUY	16.060
MYL	2020-04-09	WEAKBUY	16.080
MYL	2020-04-08	WEAKBUY	15.140
MYL	2020-04-07	WEAKBUY	14.370
MYL	2020-04-06	STRONGBUY	14.040
MYL	2020-04-03	STRONGBUY	13.740
MYL	2020-04-02	STRONGBUY	13.920
MYL	2020-04-01	WEAKBUY	14.260
NXST	2020-04-29	HOLD	76.240
NXST	2020-04-28	WEAKBUY	67.620
NXST	2020-04-27	WEAKBUY	64.490
NXST	2020-04-24	WEAKBUY	59.320
NXST	2020-04-23	WEAKBUY	58.750
NXST	2020-04-22	WEAKBUY	56.800
NXST	2020-04-21	WEAKBUY	58.800
NXST	2020-04-20	MEDIUMBUY	61.750
NXST	2020-04-17	WEAKBUY	66.205
NXST	2020-04-16	WEAKBUY	59.140
NXST	2020-04-15	WEAKBUY	59.840
NXST	2020-04-14	WEAKBUY	63.590
NXST	2020-04-13	WEAKBUY	58.570
NXST	2020-04-09	WEAKBUY	62.800
NXST	2020-04-08	WEAKBUY	64.500
NXST	2020-04-07	WEAKBUY	59.210
NXST	2020-04-06	WEAKBUY	58.430
NXST	2020-04-03	STRONGBUY	50.750
NXST	2020-04-02	STRONGBUY	55.600
NXST	2020-04-01	STRONGBUY	53.620
MIDD	2020-04-29	HOLD	60.070
MIDD	2020-04-28	STRONGBUY	55.500
MIDD	2020-04-27	STRONGBUY	54.630
MIDD	2020-04-24	WEAKBUY	51.490
MIDD	2020-04-23	WEAKBUY	52.990
MIDD	2020-04-22	WEAKBUY	51.310
MIDD	2020-04-21	STRONGBUY	49.270
MIDD	2020-04-20	STRONGBUY	48.560
MIDD	2020-04-17	STRONGBUY	51.680
MIDD	2020-04-16	STRONGBUY	49.270
MIDD	2020-04-15	STRONGBUY	50.230
MIDD	2020-04-14	STRONGBUY	54.000
MIDD	2020-04-13	STRONGBUY	52.350
MIDD	2020-04-09	WEAKBUY	58.080
MIDD	2020-04-08	WEAKBUY	55.870
MIDD	2020-04-07	WEAKBUY	53.880
MIDD	2020-04-06	WEAKBUY	51.930
MIDD	2020-04-03	STRONGBUY	48.710
MIDD	2020-04-02	WEAKBUY	52.550
MIDD	2020-04-01	WEAKBUY	53.010
ADI	2020-04-28	WEAKBUY	107.610
ADI	2020-04-27	WEAKBUY	108.030
ADI	2020-04-24	WEAKBUY	105.920
ADI	2020-04-23	WEAKBUY	101.810
ADI	2020-04-22	WEAKBUY	102.120
ADI	2020-04-21	WEAKBUY	96.470
ADI	2020-04-20	WEAKBUY	100.910
ADI	2020-04-17	WEAKBUY	102.800
ADI	2020-04-16	WEAKBUY	101.830
ADI	2020-04-15	WEAKBUY	100.450
ADI	2020-04-14	WEAKBUY	103.020
ADI	2020-04-13	WEAKBUY	99.670
ADI	2020-04-09	WEAKBUY	98.790
ADI	2020-04-08	WEAKBUY	101.400
ADI	2020-04-07	WEAKBUY	96.250
ADI	2020-04-06	WEAKBUY	95.800
ADI	2020-04-03	STRONGBUY	86.560
ADI	2020-04-02	WEAKBUY	87.700
ADI	2020-04-01	STRONGBUY	84.090
ADI	2020-03-31	STRONGBUY	89.650
EVOP	2020-04-29	HOLD	19.590
EVOP	2020-04-28	HOLD	18.200
EVOP	2020-04-27	HOLD	17.500
EVOP	2020-04-24	WEAKBUY	16.460
EVOP	2020-04-23	WEAKBUY	15.660
EVOP	2020-04-22	WEAKBUY	15.130
EVOP	2020-04-21	WEAKBUY	14.450
EVOP	2020-04-20	MEDIUMBUY	14.530
EVOP	2020-04-17	HOLD	14.920
EVOP	2020-04-16	STRONGBUY	12.910
EVOP	2020-04-15	STRONGBUY	13.660
EVOP	2020-04-14	WEAKBUY	15.000
EVOP	2020-04-13	WEAKBUY	14.870
EVOP	2020-04-09	WEAKBUY	15.080
EVOP	2020-04-08	WEAKBUY	14.300
EVOP	2020-04-07	STRONGBUY	13.670
EVOP	2020-04-06	MEDIUMBUY	13.770
EVOP	2020-04-03	STRONGBUY	12.710
EVOP	2020-04-02	STRONGBUY	12.540
EVOP	2020-04-01	MEDIUMBUY	13.070
DAL	2020-04-29	STRONGBUY	27.320
DAL	2020-04-28	STRONGBUY	24.340
DAL	2020-04-27	STRONGBUY	22.160
DAL	2020-04-24	STRONGBUY	22.410
DAL	2020-04-23	STRONGBUY	22.480
DAL	2020-04-22	STRONGBUY	22.470
DAL	2020-04-21	STRONGBUY	23.100
DAL	2020-04-20	STRONGBUY	23.640
DAL	2020-04-17	STRONGBUY	24.270
DAL	2020-04-16	STRONGBUY	22.780
DAL	2020-04-15	STRONGBUY	24.350
DAL	2020-04-14	STRONGBUY	24.540
DAL	2020-04-13	STRONGBUY	23.250
DAL	2020-04-09	STRONGBUY	24.390
DAL	2020-04-08	STRONGBUY	23.230
DAL	2020-04-07	STRONGBUY	22.250
DAL	2020-04-06	STRONGBUY	22.320
DAL	2020-04-03	STRONGBUY	22.480
DAL	2020-04-02	STRONGBUY	22.680
DAL	2020-04-01	STRONGBUY	23.870
NOVT	2020-04-29	HOLD	91.150
NOVT	2020-04-28	HOLD	87.250
NOVT	2020-04-27	HOLD	86.490
NOVT	2020-04-24	MEDIUMBUY	83.130
NOVT	2020-04-23	MEDIUMBUY	81.930
NOVT	2020-04-22	MEDIUMBUY	80.570
NOVT	2020-04-21	MEDIUMBUY	76.380
NOVT	2020-04-20	HOLD	79.950
NOVT	2020-04-17	HOLD	80.600
NOVT	2020-04-16	MEDIUMBUY	79.650
NOVT	2020-04-15	MEDIUMBUY	79.140
NOVT	2020-04-14	MEDIUMBUY	80.750
NOVT	2020-04-13	MEDIUMBUY	78.830
NOVT	2020-04-09	HOLD	81.460
NOVT	2020-04-08	HOLD	78.750
NOVT	2020-04-07	HOLD	74.710
NOVT	2020-04-06	HOLD	74.870
NOVT	2020-04-03	STRONGBUY	67.250
NOVT	2020-04-02	STRONGBUY	70.790
NOVT	2020-04-01	HOLD	76.750
AMOV	2020-04-29	WEAKBUY	12.010
AMOV	2020-04-28	WEAKBUY	11.310
AMOV	2020-04-27	WEAKBUY	10.786
AMOV	2020-04-24	WEAKBUY	10.619
AMOV	2020-04-23	WEAKBUY	10.800
AMOV	2020-04-22	STRONGBUY	10.500
AMOV	2020-04-21	MEDIUMBUY	11.000
AMOV	2020-04-20	WEAKBUY	10.819
AMOV	2020-04-17	WEAKBUY	11.100
AMOV	2020-04-16	STRONGBUY	10.540
AMOV	2020-04-15	WEAKBUY	11.680
AMOV	2020-04-14	WEAKBUY	11.590
AMOV	2020-04-13	WEAKBUY	12.102
AMOV	2020-04-09	WEAKBUY	11.628
AMOV	2020-04-08	WEAKBUY	11.890
AMOV	2020-04-07	WEAKBUY	11.655
AMOV	2020-04-06	STRONGBUY	10.420
AMOV	2020-04-03	STRONGBUY	10.970
AMOV	2020-04-02	STRONGBUY	10.970
AMOV	2020-04-01	WEAKBUY	11.380
CMPR	2020-04-29	HOLD	75.090
CMPR	2020-04-28	HOLD	63.200
CMPR	2020-04-27	HOLD	62.600
CMPR	2020-04-24	HOLD	54.770
CMPR	2020-04-23	HOLD	53.020
CMPR	2020-04-22	MEDIUMBUY	51.190
CMPR	2020-04-21	MEDIUMBUY	47.660
CMPR	2020-04-20	MEDIUMBUY	46.790
CMPR	2020-04-17	MEDIUMBUY	50.190
CMPR	2020-04-16	WEAKBUY	49.620
CMPR	2020-04-15	HOLD	45.760
CMPR	2020-04-14	HOLD	52.560
CMPR	2020-04-13	HOLD	59.040
CMPR	2020-04-09	HOLD	64.320
CMPR	2020-04-08	HOLD	61.160
CMPR	2020-04-07	HOLD	51.740
CMPR	2020-04-06	HOLD	48.880
CMPR	2020-04-03	STRONGBUY	43.860
CMPR	2020-04-02	STRONGBUY	44.900
CMPR	2020-04-01	STRONGBUY	46.660
DSGX	2020-04-29	HOLD	42.920
DSGX	2020-04-28	HOLD	39.780
DSGX	2020-04-27	STRONGBUY	39.870
DSGX	2020-04-24	STRONGBUY	39.440
DSGX	2020-04-23	STRONGBUY	38.880
DSGX	2020-04-22	STRONGBUY	39.480
DSGX	2020-04-21	STRONGBUY	37.930
DSGX	2020-04-20	STRONGBUY	40.130
DSGX	2020-04-17	WEAKSELL	39.780	2.98	1
DSGX	2020-04-16	STRONGBUY	38.630
DSGX	2020-04-15	STRONGBUY	38.000
DSGX	2020-04-14	WEAKSELL	39.330
DSGX	2020-04-13	WEAKSELL	37.580
DSGX	2020-04-09	WEAKSELL	36.910
DSGX	2020-04-08	WEAKSELL	36.720
DSGX	2020-04-07	HOLD	35.630
DSGX	2020-04-06	WEAKSELL	36.010	11.73	20
DSGX	2020-04-03	STRONGBUY	33.010
DSGX	2020-04-02	STRONGBUY	33.060
DSGX	2020-04-01	MEDIUMBUY	33.630
HQY	2020-04-29	STRONGBUY	59.930
HQY	2020-04-28	STRONGBUY	55.370
HQY	2020-04-27	STRONGBUY	52.650
HQY	2020-04-24	STRONGBUY	51.340
HQY	2020-04-23	STRONGBUY	49.370
HQY	2020-04-22	STRONGBUY	48.790
HQY	2020-04-21	STRONGBUY	46.340
HQY	2020-04-20	STRONGBUY	47.960
HQY	2020-04-17	STRONGBUY	46.710
HQY	2020-04-16	STRONGBUY	45.350
HQY	2020-04-15	STRONGBUY	45.830
HQY	2020-04-14	STRONGBUY	48.360
HQY	2020-04-13	STRONGBUY	47.050
HQY	2020-04-09	STRONGBUY	48.890
HQY	2020-04-08	STRONGBUY	50.850
HQY	2020-04-07	STRONGBUY	46.000
HQY	2020-04-06	STRONGBUY	45.000
HQY	2020-04-03	STRONGBUY	41.090
HQY	2020-04-02	STRONGBUY	43.890
HQY	2020-04-01	STRONGBUY	43.920
HTHT	2020-04-29	WEAKSELL	35.660	25.34	21
HTHT	2020-04-28	WEAKBUY	31.980
HTHT	2020-04-27	STRONGBUY	30.560
HTHT	2020-04-24	STRONGBUY	28.910
HTHT	2020-04-23	STRONGBUY	30.660
HTHT	2020-04-22	MEDIUMBUY	31.200
HTHT	2020-04-21	STRONGBUY	29.610
HTHT	2020-04-20	WEAKBUY	30.530
HTHT	2020-04-17	MEDIUMBUY	31.020
HTHT	2020-04-16	STRONGBUY	28.870
HTHT	2020-04-15	STRONGBUY	28.680
HTHT	2020-04-14	STRONGBUY	28.550
HTHT	2020-04-13	STRONGBUY	28.470
HTHT	2020-04-09	STRONGBUY	28.520
HTHT	2020-04-08	STRONGBUY	28.450
HTHT	2020-04-07	STRONGBUY	28.930
HTHT	2020-04-06	MEDIUMBUY	29.280
HTHT	2020-04-03	HOLD	28.570
HTHT	2020-04-02	HOLD	29.170
HTHT	2020-04-01	HOLD	28.130
UAL	2020-04-29	STRONGBUY	31.210
UAL	2020-04-28	STRONGBUY	27.840
UAL	2020-04-27	STRONGBUY	25.000
UAL	2020-04-24	STRONGBUY	25.560
UAL	2020-04-23	STRONGBUY	25.720
UAL	2020-04-22	STRONGBUY	25.880
UAL	2020-04-21	STRONGBUY	27.880
UAL	2020-04-20	STRONGBUY	27.790
UAL	2020-04-17	STRONGBUY	29.080
UAL	2020-04-16	STRONGBUY	28.210
UAL	2020-04-15	STRONGBUY	31.860
UAL	2020-04-14	STRONGBUY	30.900
UAL	2020-04-13	STRONGBUY	28.910
UAL	2020-04-09	STRONGBUY	31.500
UAL	2020-04-08	STRONGBUY	27.510
UAL	2020-04-07	STRONGBUY	24.480
UAL	2020-04-06	STRONGBUY	24.020
UAL	2020-04-03	STRONGBUY	22.885
UAL	2020-04-02	STRONGBUY	23.420
UAL	2020-04-01	STRONGBUY	25.650
WB	2020-04-29	STRONGBUY	36.860
WB	2020-04-28	STRONGBUY	36.650
WB	2020-04-27	STRONGBUY	37.180
WB	2020-04-24	STRONGBUY	36.490
WB	2020-04-23	STRONGBUY	35.950
WB	2020-04-22	STRONGBUY	35.940
WB	2020-04-21	STRONGBUY	35.460
WB	2020-04-20	STRONGBUY	36.260
WB	2020-04-17	STRONGBUY	36.690
WB	2020-04-16	STRONGBUY	35.810
WB	2020-04-15	STRONGBUY	34.900
WB	2020-04-14	STRONGBUY	35.240
WB	2020-04-13	STRONGBUY	34.390
WB	2020-04-09	HOLD	35.620
WB	2020-04-08	HOLD	35.540
WB	2020-04-07	HOLD	36.640
WB	2020-04-06	HOLD	33.880
WB	2020-04-03	HOLD	32.000
WB	2020-04-02	HOLD	32.330
WB	2020-04-01	HOLD	32.000
IPGP	2020-04-29	HOLD	133.000
IPGP	2020-04-28	STRONGBUY	131.090
IPGP	2020-04-27	STRONGBUY	126.080
IPGP	2020-04-24	STRONGBUY	120.900
IPGP	2020-04-23	STRONGBUY	116.340
IPGP	2020-04-22	WEAKBUY	116.510
IPGP	2020-04-21	STRONGBUY	111.650
IPGP	2020-04-20	STRONGBUY	117.940
IPGP	2020-04-17	HOLD	119.050
IPGP	2020-04-16	STRONGBUY	115.480
IPGP	2020-04-15	HOLD	114.440
IPGP	2020-04-14	MEDIUMBUY	120.750
IPGP	2020-04-13	HOLD	116.990
IPGP	2020-04-09	STRONGBUY	119.050
IPGP	2020-04-08	STRONGBUY	117.310
IPGP	2020-04-07	STRONGBUY	114.350
IPGP	2020-04-06	HOLD	113.950
IPGP	2020-04-03	STRONGBUY	102.740
IPGP	2020-04-02	STRONGBUY	102.920
IPGP	2020-04-01	STRONGBUY	105.800
CSOD	2020-04-29	WEAKBUY	34.200
CSOD	2020-04-28	MEDIUMBUY	32.550
CSOD	2020-04-27	MEDIUMBUY	31.590
CSOD	2020-04-24	MEDIUMBUY	30.690
CSOD	2020-04-23	MEDIUMBUY	30.050
CSOD	2020-04-22	STRONGBUY	29.620
CSOD	2020-04-21	STRONGBUY	29.610
CSOD	2020-04-20	STRONGBUY	29.760
CSOD	2020-04-17	STRONGBUY	29.920
CSOD	2020-04-16	STRONGBUY	29.070
CSOD	2020-04-15	STRONGBUY	29.570
CSOD	2020-04-14	STRONGBUY	31.700
CSOD	2020-04-13	STRONGBUY	31.050
CSOD	2020-04-09	MEDIUMBUY	31.560
CSOD	2020-04-08	MEDIUMBUY	30.495
CSOD	2020-04-07	STRONGBUY	29.600
CSOD	2020-04-06	MEDIUMBUY	30.200
CSOD	2020-04-03	MEDIUMBUY	28.280
CSOD	2020-04-02	MEDIUMBUY	29.120
CSOD	2020-04-01	MEDIUMBUY	29.860
CTRP	2020-04-29	HOLD	25.910
CTRP	2020-04-28	STRONGBUY	24.470
CTRP	2020-04-27	STRONGBUY	24.440
CTRP	2020-04-24	STRONGBUY	23.780
CTRP	2020-04-23	STRONGBUY	23.700
CTRP	2020-04-22	STRONGBUY	23.000
CTRP	2020-04-21	STRONGBUY	23.250
CTRP	2020-04-20	WEAKBUY	23.660
CTRP	2020-04-17	WEAKBUY	23.850
CTRP	2020-04-16	WEAKBUY	23.240
CTRP	2020-04-15	WEAKBUY	23.470
CTRP	2020-04-14	WEAKBUY	23.860
CTRP	2020-04-13	HOLD	24.050
CTRP	2020-04-09	HOLD	24.820
CTRP	2020-04-08	HOLD	24.510
CTRP	2020-04-07	HOLD	24.430
CTRP	2020-04-06	WEAKBUY	23.450
CTRP	2020-04-03	MEDIUMBUY	22.010
CTRP	2020-04-02	HOLD	22.360
CTRP	2020-04-01	HOLD	22.150
MRNA	2020-04-29	STRONGBUY	46.370
MRNA	2020-04-28	STRONGBUY	47.880
MRNA	2020-04-27	STRONGBUY	48.050
MRNA	2020-04-24	STRONGBUY	50.500
MRNA	2020-04-23	STRONGBUY	47.440
MRNA	2020-04-22	STRONGBUY	51.200
MRNA	2020-04-21	STRONGBUY	49.260
MRNA	2020-04-20	WEAKSELL	51.690
MRNA	2020-04-17	WEAKSELL	46.850
MRNA	2020-04-16	WEAKSELL	40.600	155.35	202
MRNA	2020-04-15	STRONGBUY	37.250
MRNA	2020-04-14	STRONGBUY	34.660
MRNA	2020-04-13	STRONGBUY	32.900
MRNA	2020-04-09	STRONGBUY	31.860
MRNA	2020-04-08	STRONGBUY	32.420
MRNA	2020-04-07	STRONGBUY	32.020
MRNA	2020-04-06	STRONGBUY	34.640
MRNA	2020-04-03	STRONGBUY	34.840
MRNA	2020-04-02	STRONGBUY	33.200
MRNA	2020-04-01	STRONGBUY	29.670
FEYE	2020-04-29	HOLD	11.040
FEYE	2020-04-28	HOLD	11.420
FEYE	2020-04-27	HOLD	11.520
FEYE	2020-04-24	HOLD	11.260
FEYE	2020-04-23	WEAKBUY	10.950
FEYE	2020-04-22	WEAKBUY	10.660
FEYE	2020-04-21	WEAKBUY	10.560
FEYE	2020-04-20	WEAKBUY	10.875
FEYE	2020-04-17	WEAKBUY	10.800
FEYE	2020-04-16	WEAKBUY	10.780
FEYE	2020-04-15	WEAKBUY	10.410
FEYE	2020-04-14	HOLD	10.870
FEYE	2020-04-13	WEAKBUY	10.700
FEYE	2020-04-09	STRONGBUY	10.660
FEYE	2020-04-08	WEAKBUY	10.410
FEYE	2020-04-07	STRONGBUY	9.890
FEYE	2020-04-06	STRONGBUY	10.060
FEYE	2020-04-03	STRONGBUY	9.320
FEYE	2020-04-02	STRONGBUY	9.900
FEYE	2020-04-01	STRONGBUY	9.870

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

AI Trading Ideas

AI Trading ASX Thu, 30 Apr

April 30, 2020
by admin

Dear Reader,

Our featured stock today is ASX:VVR. If you traded between 2020-02-17 – 2020-02-17 with our AI strategy, you would have made a 39.0% return. On average a trade made 39.0% and was 1291.0 days in the long position. There were a total of 1.0 postions taken over the period.

Here are the AI Trading ASX Thu, 30 Apr buys:

Sorry, no buys today.

Here are the AI Trading ASX Thu, 30 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Sorry, no backtest summaries today.

Detail predictions over the past few days:
Buys:
Sorry, no buys today.

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

Reuters

Oil prices surge over 10% amid early signs of…

April 30, 2020
by admin

MELBOURNE/SINGAPORE (Reuters) – Oil prices jumped on Thursday, extending steep gains in the previous session on signs the U.S. crude glut is not growing as quickly as expected and that gasoline demand battered by COVID-19 restrictions is starting to pick up.

FILE PHOTO: The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, U.S., November 22, 2019. REUTERS/Angus Mordant

West Texas Intermediate (WTI) crude futures CLc1 climbed to a high of $17.35 a barrel and were up 14.3%, or $2.15, at $17.21 at 0350 GMT. The U.S. benchmark surged 22% on Wednesday.

Brent crude LCOc1 rose 10.3%, or $2.33 to $24.87 a barrel in light trading, with the June contract expiring on Thursday. The contract hit a high of $24.91 earlier in the session, having posted a 10% gain on Wednesday.

The most active Brent crude contract for July LCOc2 was up $2.10 or 8.7%, at $26.33 a barrel.

U.S. oil plunged into minus territory last week as the May contract was expiring, but analysts said the market, while still volatile, appears to have found a floor.

“I think we’re closer to an equilibrium price for WTI between $15 and $20. That reflects all of the known knowns – the demand destruction that has led to storage filling up and pending supply cuts,” said Michael McCarthy, chief market strategist at CMC Markets and Stockbroking in Sydney.

U.S. crude inventories grew by 9 million barrels last week to 527.6 million barrels, U.S. Energy Information Administration data showed on Wednesday. This was well below the 10.6 million-barrel rise analysts polled by Reuters had expected.

“In the current environment, the market appears desperate for any positive signs, no matter how mild they seem. The focus this week has been on inventory and demand numbers from the U.S.,” ING’s head of commodities strategy Warren Patterson said.

U.S. gasoline stockpiles dropped by 3.7 million barrels from record highs the previous week, with a slight rise in fuel demand offseting a rebound in refinery output.

“If we see a continuation of this trend in the coming weeks, it could suggest the worst might be behind the oil market,” Patterson said.

U.S. President Donald Trump said his administration will soon release a plan to help the country’s oil companies, which Treasury Secretary Steven Mnuchin said could include adding millions of barrels of oil to already-teeming national reserves.

Private storage in U.S. is approaching full capacity and the government’s Strategic Petroleum Reserve hold only 78 million barrels of spare capacity.

Reporting by Sonali Paul in Melbourne and Koustav Samanta in Singapore; Editing by Tom Hogue and Richard Pullin

Our Standards:The Thomson Reuters Trust Principles.

Source

SeekingAlpha

LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2020…

April 30, 2020
by admin

LivaNova PLC (NASDAQ:LIVN) Q1 2020 Results Conference Call April 29, 2020 8:00 AM ET

Company Participants

Matthew Dodds – Senior Vice President of Corporate Development

Damien McDonald – Chief Executive Officer

Thad Huston – Chief Financial Officer

Melissa Farina – Vice President of Investor Relations

Conference Call Participants

Raj Denhoy – Jefferies

Rick Wise – Stifel

Scott Bardo – Berenberg

Operator

Good day, ladies and gentlemen, and welcome to the LivaNova PLC First Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to introduce the host for today’s conference, Mr. Matthew Dodds, LivaNova’s Senior Vice President of Corporate Development. You may begin, sir.

Matthew Dodds

Thank you, Demetrius, and welcome to our conference call and webcast discussing LivaNova’s financial results for the first quarter of 2020. Joining me on today’s call are Damien McDonald, our Chief Executive Officer; Thad Huston, our Chief Financial Officer; and Melissa Farina, our Vice President of Investor Relations.

Before we begin, I would like to remind you that the discussions during this call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company’s most recent filings and documents furnished to the SEC, including today’s press release that is available on our website. We do not undertake to update any forward-looking statement. Also, the discussions will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today’s press release that is available on our website. We have also posted a presentation to our website that summarizes the points of today’s call. This presentation is complementary to the other call materials and should be used as an enhanced communication tool.

You can find the presentation and press release in the Investor Relations section of our website under News and Events Presentations at investor.livanova.com.

With that, I will now turn the call over to Damien.

Damien McDonald

Thank you, Matt, and thank you for joining us, and I hope you and your families are all safe and well. Before we discuss our first quarter results and updated guidance, I’d like to make a few comments in light of the pandemic. Since the outbreak of COVID-19, our priority has been to continue to support patients’ health care professionals and our employees. We remain focused on providing life-saving technologies and supporting our customers. We are still in the early days of assessing the impact of COVID-19 and the impact that it’s had and it is expected to have on our business.

I would like to take this moment to thank all our associates worldwide who have shown remarkable resilience through this crisis, particularly those on the front line and in our manufacturing facilities who have maintained our supply chain. As Thad and I will outline during the call, in the first quarter of 2020, COVID-19 started to impact the Rest of World region in mid-February, followed by Europe in early March, and the U.S. in mid-March.

I’m going to start off by discussing some recent highlights, and our sales results by business. After my comments, Thad will provide you with additional detail on the financials and our revised 2020 guidance. Then I will wrap up with closing comments before moving on to Q&A.

In late February, we entered into a research collaboration with Verily as part of our RECOVER depression study. This will allow us to capture biomarkers of depression and data on patient behavior using technology and analytics provided by Verily. These data will provide further insights into depressive episodes and a patient’s response to VNS Therapy and its impact on DTD.

At the ACC and World Congress of Cardiology meeting in March, we presented 2 posters. The posters reviewed the benefits of Autonomic Regulation Therapy or ART and further support for the rationale for the ANTHEM-HFrEF heart failure pivotal study by reporting the long-term improvement in autonomic tone, baroreceptor sensitivity and cardiac electrical stability produced by VNS.

In April, we received FDA emergency use authorization or EUA for several cardiovascular products for ECMO therapy. The EUA temporarily expands the application of devices for ECMO therapy to greater than 6 hours in response to COVID-19. Product indications for use have been modified accordingly for many products within our cardiopulmonary and ACS portfolios. We also received CE Mark approval for the Bi-Flow ECMO cannula. This cannula is designed to reduce the risk of limb ischemia, a significant and all-too-common complication from ECMO therapy.

Lastly, earlier this week, we announced the conclusion of a series of debt covenant amendments, which materially modify the status of our current credit agreements. These amendments include adjustments to covenant calculations and temporary updates for certain limits on financial ratios. These amended agreements provide us additional assurance and flexibility to better manage the business through the pandemic.

Now I’ll discuss our 3 growth drivers: epilepsy, advanced circulatory support and the Rest of World region. All net sales results will be stated on a constant currency basis. U.S. epilepsy sales declined in the mid-single digits versus the first quarter of 2019. This decrease is attributable to the impact on new patient implants because of COVID-19. Our U.S. business was tracking well until mid-March when we saw a steep drop in new patient implants. And some impact to replacement implants. In 2020, we now expect our U.S. epilepsy business excluding DTD, sales to decline in the mid-teens due to the impact of COVID-19 on elective surgery. We currently expect the second quarter to see the largest impact with the business recovering as we move through the year. We are forecasting sales to return to near pre COVID levels in the fourth quarter.

Advanced circulatory support sales were $11 million in the quarter, an increase of nearly 30% from the first quarter of 2019. The growth was driven by deeper penetration of existing accounts of Protek Duo kits used to right ventricular recovery and TandemLung respiratory support kits also saw an acceleration in the quarter. The limited rollout of LifeSPARC is going well, and we are on track to start the U.S. commercial release at the end of this quarter. We now expect our ACS business to grow above 30% in 2020.

Rest of World sales were $64 million in the quarter, growing 1% versus the first quarter of 2019. The region was primarily impacted by COVID-19 with some execution issues in Japan and the Middle East. Turning now to difficult-to-treat depression. Sales in the quarter were $1.4 million up more than 70% versus the first quarter of 2019. Our current estimate is that the enrollment in the RECOVER depression study will be impacted by COVID-19 for 6 months, and we now expect DTD sales of approximately $5 million to $10 million for the year.

We currently expect to enroll our 250th patient by the end of the second quarter of 2021. In heart failure, our ANTHEM-HFrEF U.S. pivotal trial has enrolled more than 200 patients. We have temporarily paused enrollment in accordance with site restrictions due COVID-19, though we are supporting patients and physicians by using remote technology to remain engaged. We now expect to reach 300 patients in the second quarter of 2021.

I’ll now turn the call over to Thad for an overview of our financial results. Thad?

Thad Huston

Thank you, Damien. I’m going to discuss the first quarter results in greater detail and then provide an update on our 2020 guidance.

Sales for the first quarter were $242 million, a decline of 1.8% compared to the same quarter of prior year. Cardiovascular sales were $152 million, down 0.2% from the first quarter of 2019. Cardiopulmonary sales were $116 million in the quarter, a decline of 2.2% versus the first quarter of 2019. Heart-lung machines sales declined in the mid-single digits, primarily due to difficult year-over-year comparisons globally. Oxygenators sales grew in the low single digits related to strong performance in the Rest of World region including Southeast Asia, Eastern Europe and Brazil. Turning to heart valves. Sales for Heart Valves were $25 million in the quarter, an increase of [0.6%] versus the first quarter of 2019.

Heart Valves benefited from an easier comparison related to our transition to direct sales that occurred in certain markets in the Rest of World region in the second half of 2019.

Now let’s turn to Neuromodulation. Sales were $90 million, which is a decline of 4.6%, versus the first quarter of 2019. Until mid-March, U.S. Neuromodulation have been tracking to a mid- to high single-digit growth rate for the quarter. Neuromodulation sales in Europe grew in the mid-single digits, led by the U.K. and Germany. The Rest of World region declined in the mid-teens, in part due to softness in the Middle East.

Adjusted gross margin as a percent of net sales in the quarter was 68.3%, down 100 basis points from the first quarter of 2019. The margin decline was primarily driven by mix from lower Neuromodulation sales. Adjusted R&D expense in the first quarter is $41 million compared to $37 million in the first quarter of 2019. R&D as a percentage of net sales was 16.9% versus 14.7% in the first quarter of 2019.

The R&D increase is due to higher costs associated with the continued enrollment of the ANTHEM-HFrEF, heart failure pivotal trial and progress in the RECOVERY depression study. Adjusted SG&A expense for the first quarter was $104 million compared to $105 million in the first quarter of 2019. SG&A as a percentage of net sales was 42.8%, up from 41.6% for the first quarter of 2019. Adjusted operating income from continuing operations was $21 million compared to $33 million in the first quarter of last year.

Adjusted operating income margin from continuing operations was 8.7% compared to 12.9% in the first quarter of 2019. Our adjusted effective tax rate in the quarter was 8.2%, an improvement from 15.5% in the first quarter of 2019. The lower tax rate is related to previous tax planning initiatives. Finally, adjusted diluted EPS from continuing operations in the quarter was $0.33 compared to $0.54 for the first quarter of 2019.

Moving to cash flow. Our cash flow from operations, excluding payments for onetime integration and restructuring costs through the first quarter of 2020, was $25 million compared to $24 million in the same quarter the previous year. Capital spending for the first quarter was — of 2020 was $9 million, which is $3 million higher than the first quarter of 2019.

Our cash balance at March 31, 2020, was $126 million, up from $61 million at December 31, 2019. Our net debt at quarter end was $400 million, up from $272 million at year-end 2019 as we get an additional $115 million in 3T legal costs this quarter.

As Damien highlighted previously, in light of recent market developments, we have implemented a number of actions designed to strengthen our liquidity position and promote financial resiliency. Among these actions, we have secured amendments to certain covenants prior to December 31, 2020. These amendments include adjustments on covenant calculations and an update for certain ratios on calculations of debt-to-EBITDA and EBITDA to net interest payable. In addition, we are in the process of evaluating strategic financing alternatives to fund our short- and medium-term capital needs. Among these alternatives, we have been analyzing a potential offering of equity, equity-linked or debt securities. Discussions concerning these potential transactions are ongoing, and no assurance can be given that the transaction will be consummated or as to the ultimate terms of any transaction.

Now turning to our updated 2020 guidance. Given the current COVID-19 challenges, we are providing revised guidance for the second quarter and the full year. We believe it is important to provide updated guidance as we are in a period of additional uncertainty, and we’ve expanded our sales and EPS ranges to address this. For the full year, we are now expecting 2020 sales to decline between 7% and 17% on a constant currency basis.

If current exchange rates remain unchanged, the company’s full year revenue guidance will be negatively impacted by 1 to 2 percentage points. We now expect our global epilepsy business to decline in the range of 10% to 15% due to the COVID-19’s impact on elective procedures. The largest impact is expected to incur — occur in the second quarter with a gradual recovery occurring in the back half of the year and a return to growth in the fourth quarter.

DTD sales are now expected to fall in a range of $5 million to $10 million. Sales in our cardiovascular portfolio are estimated to decline in the mid-single digits with strong growth coming from ACS, largely offset by the late-stage replacement cycle of HLMs and the impact of lower cardiac surgery procedure volumes and Heart Valves, in particular.

On the expense side, we have executed actions to offset some of the expected sales impact. Specifically, we’ve instituted a hiring freeze and are participating in government-sponsored work programs. We have reduced spend related to travel, marketing events, field presence, and we’ve shifted to working with our customers and stakeholders using remote methods. We’ve reduced our discretionary spend related to consulting and contingency staffing. And finally, we’ve balanced our manufacturing output to coincide with demand.

Now turning back to the rest of the P&L. Adjusted gross margin is projected to be in the range of 66% to 68%. We expect adjusted R&D to be in the range of 14.5% to 15.5% of sales and adjusted SG&A to be in the range of 40% to 41% of sales, driven in large part due to our decline in revenue, spending reductions and investments in DTD. We are projecting adjusted operating margin from continuing operations to be in the 10.5% to 12.5% range. Our adjusted effective tax rate is expected to be in the range of 10% to 12%. We are adjusting — we are estimating adjusted diluted earnings per share for continuing operations in the range of $1.40 to $1.70. The share count is expected to be approximately 49 million.

Our adjusted cash flow from operations, excluding integration, restructuring, 3T product remediation and litigation payments, is projected to be in the range of $80 million to $100 million. The integration and restructuring expenses are expected to be in the range of $10 million to $20 million compared to $44 million in 2019.

Capital spending is projected to range between $20 million and $25 million, and depreciation and amortization expense is expected to be approximately $28 million. For the second quarter, we are expecting sales to decline in the range of 30% to 45% and the loss per share to be in the range of $0.25 to $0.35.

So with that, I’ll turn the call back to Damien for some final comments.

Damien McDonald

Thanks, Thad. I’d like to finish by acknowledging the selfless dedication of health care professionals around the world. Their extraordinary efforts continue, and we wish health and safety for them and their families. We look forward to updating you on our continued progress and delivering on our commitments to drive shareholder value. And with that Demetrius, we’re open for questions.

Question-and-Answer Session

Operator

[Operator Instructions] And our first question comes from Raj Denhoy with with Jefferies.

Raj Denhoy

I wonder if maybe we could start with the trajectory of the business here as you move through April. I appreciate it’s been tough for most companies. Is there anything you can offer in terms of how things have trended here just in the first month of the second quarter?

Damien McDonald

Yes, Raj it’s a good question. I would say that I characterize this as modest signs of light. We’ve seen our monitoring of hospital by hospital, state-by-state in our weekly calls internally. We’ve seen modest improvements in some hospitals, some areas, some states, little green shoots in a few countries in Europe as they’ve changed their regulations around what they consider essential and elective. And similarly, some smart signs of growth in China. So again, early days, but we are seeing small, modest signs of light.

Raj Denhoy

Understood. I guess, I’m just trying to reconcile that with the guidance cut rate, which is pretty substantial on the top line. And also, I guess, the commentary in terms of resumption, particularly in VNS, by the fourth quarter back to kind of pre COVID levels. And so I guess the question is really around your confidence in the current outlook, right? Because things aren’t very fluid at this point. So just trying to the gauge kind of the airbands around what you offered in terms of guidance at this point?

Thad Huston

Yes, I would just add. I mean, I think to me, the way we think about the guidance and the range is — it’s highly fluid and there’s a level of uncertainty. And so we purposely put some fairly broad ranges for the quarter and also for the full year. But again, we’re monitoring it weekly. We’re studying the market. We’re even looking at kind of a state by state, country-by-country view. And again, we’re going to continue to monitor, but we’re increasing in terms of some of the confidence, again, around just seeing some modest progress, as Damien described.

Raj Denhoy

Okay. Maybe just one last one on kind of the operating expenses, right? So again, everybody’s models are slightly different. But in ours, it looks like the combination of R&D and SG&A is coming down by about $100 million from where we were previously. And so I’m trying to get at where that is coming from, and if those cuts are sort of — how deep that is in a sense. And so when things do come back, how much of this cost reduction you’ve embarked on is going to be sort of difficult to recover from or how quickly can it kind of snap back?

Thad Huston

No. I think to me, I described the number of things that we are doing to protect the income. But at the same time, it’s really important that we continue to invest in the long term. And so we are continuing to support our trials. Of course, enrollment is obviously going to be affected because of just delays in the challenges of just getting clinical trials up and running. We are working and taking advantage of headcount freezes, travel restrictions and obviously, any government support to help us protect, again, some of the expense cuts. But we are trying to balance short and long term, of course.

Damien McDonald

So to that end, Raj, we’ve ring-fenced studies that are critical to our long-term value creation, like RECOVER and ANTHEM trials. We’ve ring-fenced new product development around key things like LifeSPARC and Polaris, and Iris, and other things that are less critical, less urgent, we’ve put those on hold.

Operator

And our next question comes from Rick Wise with Stifel.

Rick Wise

Okay. Sorry about that. Maybe start off with LifeSPARC. Clearly, you have some optimistic thoughts about recovery there, expected to deliver at least 30% ACS growth for 2020. Maybe just update us on where you are with your ability to supply the product on the manufacturing side? And does COVID accelerate LifeSPARC demand? Pull forward demand? Just some more color and support of that particular positive piece of your outlook?

Damien McDonald

Yes. So 2 things there. First, on the supply and manufacturing. I will tell you, I think the team made great progress there in our weekly Friday call with that team. I continue to be impressed with how they run the project management of that and our component supply that we talked about at the end of last quarter is moving well. And so we still expect to be able to execute the commercial release in the second half, as we announced earlier. So I’m really pleased with that progress.

On the demand overall, I think we’ve seen great demand from our existing accounts. So we are in an account penetration play here. So it’s existing accounts that are using more protect to, more TandemLung, that’s the respiratory support product. But interestingly, the right ventricle also needs to be supported when you have these events in this respiratory distress. So that’s why I think we’re seeing this uptick in ProtekDuo. So I think the teams continued to execute well there, and we see strong performance from that group in the U.S. and in a few countries internationally. So I think that’s why we’re a bit more bullish on the full year results.

Matthew Dodds

So Rick, it’s Matt, also. We talked about before, one of the keys of LifeSPARC is getting more controllers, also the ease of use of this controller. We can expand the footprint. Today, we’re in less than 200 centers in the U.S. There’s room to go to 500 or more. ECMO is a very valuable device for respiratory distress, as you’ve heard. So that’s a key component. The back half of the year is expanding, not just going deeper into accounts, as Damien said. But this will give us the ability to expand into a lot of new accounts who will find this product very easy to use and will then embrace an ECMO practice.

Rick Wise

Okay. Turning to — thank you, Matt. Turning to the DTD trial. If I heard you correctly, correct me if I’m wrong, you had 250 patients enrolled by the end of the second quarter. I think you talked about the $5 million to $10 million contribution impact as well. But maybe if you could expand on your comments there, how does — talk about restarting the trial as things recover. What should we expect? What are you expecting? And Damien, how does the time line shift — the time line — how do the time lines that you’ve articulated in the recent past shift now in light of this pause in enrollment?

Damien McDonald

Yes. So to get to that last part of that question, we think a shift of about 6 months is what we’re forecasting. What happens? It’s really about patient enrollment and the implant sequence. That’s what’s slowing down. What’s not slowing down is this team’s work on the infrastructure of setting up the trial. So they’ve continued to work diligently on-site activation, and we’ve been doing a number of remote site activations, I think, which is fairly novel process.

We’ve also continued to work on patient identification and patient awareness of the study and done a number of digital activities to engage with people in that DTD community to push them to be aware of the trial. So related to that, we’re also continuing our work on how to engage with the private payers. And a recent hire of a specialist for health economics and reimbursement in that area is a really important key step that this guy has experience in this space and patient advocacy from pharma. And I’m expecting a lot of engagement there as we continue that process. So infrastructure is still progressing. It’s really about patient enrollment and implant that’s the slowing step here, and that’s why we’re saying plus 6 months for the target that we previously talked about.

Rick Wise

Great. And just last for me. Obviously, on the debt and financing side, you’ve made some important and critical progress with your covenants and some of the details you’ve announced. I mean, can you expand on your comments what kind of funding do you feel like you need? When is it needed? And how — maybe you can give us more concrete input about what to expect, how you’re approaching this? And just how you’re thinking about — does the lower end of the guidance, maybe another way to say it, drive the need for financing? Or if you hit the upper end, you need less? I’m not sure how to put it all in context.

Thad Huston

Sure. Yes. I think as we stated, we’ve amended the covenants of all of our facilities to give us enough room for, let’s call it, the next 15 months, which is usually the period that you want to test from an audit perspective that, of course, going beyond that is ultimately what we’re looking at. So I think that gives us a lot of flexibility, and we continue to look at other facilities. So for example, we had ended the quarter with $126 million in cash, and we added recently another facility from Barclays last week. And we’re just going to continue to look at what else could we do.

We feel that even with the downsides that we have a number of different levers that we could pull on the expense side to protect income and cash flow. And with the facilities we have, is sufficient to meet our liquidity and our debt obligations. But I think this has taught us all lessons is to just evaluate different strategic financing alternatives and to have additional capacity. And so we are looking at the offerings of potentially equity debt just looking at what else could we do just to firm up and have more additional headroom. But I don’t have major concerns. It’s just been, obviously, we’ve had to address what was a really strong balance sheet 2 years ago. We were — our leverage was well below 1x net debt to EBITDA.

But given the 3T liability and the payments that we’ve made, our debt levels went a bit higher. So of course, we needed some additional headroom with covenants, but we’re looking at just additional instruments.

Rick Wise

So just to follow-up quickly on that. So you’re saying this is more thinking long term, and this is something that — when you talk about the additional financing that you very much want to have nice to have, important to have, but not so critical, not necessarily anxiety proposing for the next 6, 12 months. I’m not sure exactly what you’re saying, Thad?

Thad Huston

Yes. No, no. I think it’s both, right? So to me, there’s a level of uncertainty, Rick, in this environment. So we want to cover short term, right? And at the same time, we’ve been in the process of looking at restructuring our current facilities. And so if you look at the details of what we have, we a repayment schedule of our $350 million facility in Q3 and Q1 next year of $70 million in those 2 time periods. We also look at other instruments to try to balance debt and equity depending on the scenario. So it’s kind of a short-term creating more headroom, but then also taking longer-term steps, just to recapitalize the company structure. Is that clear?

Rick Wise

Yes. Thank you for the thorough detail.

Operator

And our next question comes from Scott Bardo with Berenberg.

Scott Bardo

Damien, yes, so just a little bit more understanding, please, of the guidance framework. And obviously, I appreciate you’ve taken a stab at this guidance framework. Just to understand it fully, I think you said that you would anticipate cardiovascular to be down about mid-single digit for the full year, was that right? That’s your base case assumption?

Damien McDonald

Yes, mid- to high single-digit for the full year. Yes.

Scott Bardo

And just to understand that a bit further with respect to the cardiopulmonary business, which has been largely for CABG procedures and so forth, normalized world, not considered deferrable or less likelihood to defer, have you seen or are you seeing signals that, that should decline? And what is the compensatory effect, you think, from the additional ECMO provision that you now have? Does that confer a degree of stability to that business that wasn’t there before? Just really want to understand those moving parts a bit more, please.

Damien McDonald

Yes. I think, obviously, what we’ve talked about here is we expect the biggest decline in Q2 with elective procedures being down, and that’s going to impact oxygenators largely. And now our ECMO business unit. So the TandemLife business plus the small ECMO business we had in our cardiopulmonary portfolio is up, and we’ve seen a small increase there. But not to offset the Oxy and HLM business. So the business is growing. It’s an important part of this, but it’s also a very complex part of the procedures. And you don’t always goes back from ventilator to ECMO. And so we’re pleased to see the uptick, but we’re not banking on that being a full compensatory effect for all the cardiopulmonary portfolio.

Matthew Dodds

And Scott, it’s Matt. I would say — I know you like to go into detail on this. Probably if there’s one area to think about it being under pressure in cardiovascular, it’s going to be capital equipment in the U.S. and Europe, right? So HLMs, ATS, that’s where we’re forecasting to see a big hit on that business. So that’s not truly procedures. That’s more of a capital component.

Scott Bardo

Okay. That’s helpful. And again, the walk-through is a significant impact in Q2, still declines in Q3, more normalization in the fourth quarter. Is that how you think about it? And any recent noises from hospitals about reactivating elected procedures or at least starting as early as now soon? Have you baked in a relatively conservative negative assumption here? That’s what I’m trying to understand.

Damien McDonald

Your opening statements is how we’ve modeled it. And again, what we try to explain is that we are looking at this weekly with our commercial teams in Europe and international country-by-country in the U.S., hospital by hospital, state by state. Again, I think everyone is aware that the state differences in the U.S. are very, very compelling. So that’s where we’ve tried to be a bit more granular on the state level differences. But that’s — our model broadly is how you summarized it.

Scott Bardo

Okay. And so in nature of the question for Neuromodulation, please. So clearly understand you’re expecting some sharp decline. So just to understand this further, is it your expectation that you see a relatively stable replacement business, which is 50% of — or so of these U.S. sales, is my understanding? And so that new patients are significantly down for the next few quarters. Is that basically the flow?

Damien McDonald

Back to the same idea about the model. Biggest impact in Q2, a small recovery in Q3, getting back to sort of normal sales in Q4. And I would say on NPI versus the OS, we’ve seen a more dramatic impact on the new NPIs, the new patient implants, and a slight decrease in the end of service. And again, very much impacted by differences in what people consider are elective. The U.K. and Germany, for example, just this last week that battery replacements are an essential surgery. So we’re monitoring this country by country, state by state.

Scott Bardo

Okay. Understood. And sorry, just a last clarification. Your revenue framework is outlining potential for down 17% sales. I’m not sure I understand that in the context of your biggest business, cardiovascular, being, let’s say, mid-single digit. It seems to me that or even mid- to high single digit, that wouldn’t make sense given the commentary of 10%, 15% Neuromodulation decline. So are you essentially saying that the most likely scenario is the low end of the range? I just want to understand that.

Matthew Dodds

Scott, it’s Matt. So no, what we did, if you look at the growth rates we gave by the major businesses, you’re going to fall in the middle of that minus 7% to 17%. We just want to have a slightly wider range, given all the uncertainty right now. So we’re not encouraging you to go to the right to the worst part of the range.

Scott Bardo

Okay. Understood. And encouraging that you see things returning to more normalized volume in Q4. Of course, with no crystal ball, but that seems a sensible assumption to me. Now as we think about 2021, and I think this is more of a relevant number to look at, can you at least give us some sense of where you think you can recover the business to, according to your sort of midterm plan? Should we expect an earnings number that’s at or above 2019? Is that a good sense actually as to how this business trajectory recovers over the next 12, 24 months?

Thad Huston

Yes. I would say it’s a bit premature to predict 2021 at this point. I do think that, again, depending on kind of how — whether it’s a V-shape recovery or U Shape or W. We just don’t know at this point, Scott. But again, we are going to take every action that we can to firm up the business to ensure that we’re making both short and long-term decisions to get this thing back to where it should be, whether it’s the previous 2019 results or the previous guidance on 2020, we just don’t know at this point.

Scott Bardo

Okay. And last question then, please, for me. And again, I congratulate you for extending the terms of your covenants. But I wanted to understand a little bit better the concept of equity or equity-linked debt. Obviously, leaving over shares are broadly trading where they were when you merged in 2015. So I would argue your shares are not really in a position of strength. Why would it make sense to consider equity when debt is cheap and you have headroom in your covenants, and more importantly, has this experience where debt has got a little bit ahead of where you would like it changed your thoughts on acquiring loss-making developmental assets? Or the very high levels of internal investment you make, which are artificially compressing your margins?

Thad Huston

Great question, and you’re absolutely right. It’s how we see it as well with this balance of what is kind of the right kind of facilities that could help us as LivaNova, where we’re trading today, looking at our relative valuation, looking at the various tools in the market, and how is the market developing for these tools as well? And we’re trying to balance a little bit of equity, a little bit of debt.

But try to find the right kind of thing to address kind of short and long-term capital needs. We haven’t decided. And again, we’re exploring options. And we just wanted to highlight that today. But you’re absolutely right. I think we would also think about very carefully about doing future M&A, especially dilutive deals. The TandemLife deals are accretive, immediately accelerate growth. Those are the types of acquisitions that we had obviously be keen on continuing to do.

Operator

Ladies and gentlemen, this concludes our Q&A portion of today’s conference. I would like to turn the call back over to Matt Dodds for any further closing remarks.

Matthew Dodds

Okay. Well, Demetrius, thanks very much. Thank you for everyone for joining us, and we look forward to continued conversation and reporting on our shareholder value creation as we move forward. Be safe, everyone.

Operator

Ladies and gentlemen, this concludes today’s conference call. Thank you for participating, and you may now disconnect. Everyone have a great day.

Source

AI Trading Ideas

AI Trading ASX Thu, 30 Apr

April 30, 2020April 30, 2020
by admin

Dear Reader,

Our featured stock today is ASX:NST. If you traded between 2019-12-16 – 2020-02-27 with our AI strategy, you would have made a 1115436162.52% return. On average a trade made 557718081.26% and was 2876.0 days in the long position. There were a total of 2.0 postions taken over the period.

Here are the AI Trading ASX Thu, 30 Apr buys:

Symbol	Model Accuracy	Price Target
ASX:VVR	0.921147	2.400
ASX:TLS	0.862403	3.200
ASX:SCP	0.855098	2.260
ASX:ASX	0.845855	81.490
ASX:RHC	0.821059	64.290
ASX:BKL	0.809308	81.700
ASX:BAP	0.807947	4.670
ASX:CNU	0.806299	6.710
ASX:COH	0.801034	181.180
ASX:GWA	0.795866	2.480
ASX:ECX	0.777778	0.565
ASX:A2M	0.777487	16.820
ASX:NHC	0.777424	1.555
ASX:UWL	0.773810	1.170
ASX:HLS	0.770000	2.420
ASX:NXT	0.765957	8.610
ASX:DMP	0.765333	49.640
ASX:EM1	0.761711	0.023
ASX:DOW	0.748864	3.680
ASX:ALU	0.721997	32.110

Here are the AI Trading ASX Thu, 30 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Symbol	From Date	To Date	Model Accuracy	Acc Profit/Loss	Avg Profit/Loss	Avg Days Invested	Total Positions
ASX:VVR	2019-12-03	2020-04-09	92.0	1.195186e+08	23903729.22	22.0	5.0
ASX:TLS	2020-01-15	2020-04-16	86.0	1.007220e+08	25180504.11	29.0	4.0
ASX:SCP	2019-12-18	2020-04-07	86.0	1.425085e+08	28501695.99	27.0	5.0
ASX:BKL	2019-12-16	2020-03-30	81.0	1.167583e+07	3891944.96	2441.0	3.0
ASX:BAP	2020-04-16	2020-04-16	81.0	1.857620e+07	18576195.86	1763.0	1.0
ASX:CNU	2019-11-13	2020-03-30	81.0	5.925231e+07	14813078.32	556.0	4.0
ASX:ECX	2020-01-14	2020-04-20	78.0	6.690419e+07	16726047.32	453.0	4.0
ASX:A2M	2019-11-05	2020-03-30	78.0	9.790514e+07	48952571.77	893.0	2.0
ASX:NHC	2020-01-23	2020-03-24	78.0	2.592387e+08	86412908.25	2002.0	3.0
ASX:UWL	2019-12-03	2020-04-06	77.0	2.483456e+08	62086398.51	92.0	4.0
ASX:HLS	2019-10-23	2020-04-27	77.0	4.977520e+07	12443798.93	92.0	4.0
ASX:NXT	2019-10-24	2020-04-02	77.0	3.174866e+07	10582886.19	1114.0	3.0
ASX:DMP	2020-03-24	2020-03-24	77.0	3.419410e+03	3419.41	5401.0	1.0
ASX:EM1	2000-03-29	2019-07-04	76.0	4.584050e+03	47.75	53.0	96.0
ASX:DOW	2020-04-16	2020-04-16	75.0	3.819000e+02	381.90	7344.0	1.0

Detail predictions over the past few days:
Buys:

Symbol	Date	Prediction	Adj Close	P/L %	Days
ASX:VVR	2020-04-28	STRONGBUY	2.350
ASX:VVR	2020-04-27	STRONGBUY	2.380
ASX:VVR	2020-04-24	STRONGBUY	2.370
ASX:VVR	2020-04-23	STRONGBUY	2.390
ASX:VVR	2020-04-22	STRONGBUY	2.400
ASX:VVR	2020-04-21	STRONGBUY	2.350
ASX:VVR	2020-04-20	STRONGBUY	2.460
ASX:VVR	2020-04-17	STRONGBUY	2.480
ASX:VVR	2020-04-16	STRONGBUY	2.410
ASX:VVR	2020-04-15	STRONGBUY	2.400
ASX:VVR	2020-04-14	STRONGBUY	2.360
ASX:VVR	2020-04-09	STRONGSELL	373421.000	1.63065e+07	13
ASX:VVR	2020-04-08	STRONGBUY	2.320
ASX:VVR	2020-04-07	STRONGBUY	2.300
ASX:VVR	2020-04-06	STRONGBUY	2.330
ASX:VVR	2020-04-03	STRONGBUY	2.300
ASX:VVR	2020-04-02	STRONGBUY	2.300
ASX:VVR	2020-04-01	STRONGBUY	2.340
ASX:VVR	2020-03-31	STRONGBUY	2.300
ASX:VVR	2020-03-30	STRONGBUY	2.330
ASX:TLS	2020-04-28	HOLD	3.070
ASX:TLS	2020-04-27	HOLD	3.080
ASX:TLS	2020-04-24	HOLD	3.050
ASX:TLS	2020-04-23	HOLD	3.020
ASX:TLS	2020-04-22	HOLD	3.030
ASX:TLS	2020-04-21	HOLD	3.040
ASX:TLS	2020-04-20	HOLD	3.090
ASX:TLS	2020-04-17	HOLD	3.160
ASX:TLS	2020-04-16	STRONGSELL	695185.000	2.17244e+07	15
ASX:TLS	2020-04-15	HOLD	3.120
ASX:TLS	2020-04-14	HOLD	3.160
ASX:TLS	2020-04-09	HOLD	3.140
ASX:TLS	2020-04-08	HOLD	3.100
ASX:TLS	2020-04-07	STRONGBUY	3.130
ASX:TLS	2020-04-06	STRONGBUY	678247.000
ASX:TLS	2020-04-03	HOLD	3.110
ASX:TLS	2020-04-02	STRONGBUY	3.160
ASX:TLS	2020-04-01	STRONGBUY	3.200
ASX:TLS	2020-03-31	STRONGBUY	3.070
ASX:TLS	2020-03-30	STRONGSELL	999353.000	2.85528e+07	27
ASX:SCP	2020-04-28	STRONGBUY	2.190
ASX:SCP	2020-04-27	STRONGBUY	2.220
ASX:SCP	2020-04-24	STRONGBUY	2.210
ASX:SCP	2020-04-23	STRONGBUY	2.210
ASX:SCP	2020-04-22	STRONGBUY	2.230
ASX:SCP	2020-04-21	STRONGBUY	2.150
ASX:SCP	2020-04-20	STRONGBUY	2.260
ASX:SCP	2020-04-17	STRONGBUY	2.240
ASX:SCP	2020-04-16	STRONGBUY	2.150
ASX:SCP	2020-04-15	STRONGBUY	2.250
ASX:SCP	2020-04-14	STRONGBUY	2.170
ASX:SCP	2020-04-09	STRONGBUY	2.260
ASX:SCP	2020-04-08	STRONGBUY	2.210
ASX:SCP	2020-04-07	STRONGSELL	517035.000	2.28776e+07	11
ASX:SCP	2020-04-06	STRONGBUY	2.360
ASX:SCP	2020-04-03	STRONGBUY	2.250
ASX:SCP	2020-04-02	STRONGBUY	2.210
ASX:SCP	2020-04-01	STRONGBUY	2.270
ASX:SCP	2020-03-31	STRONGBUY	2.270
ASX:SCP	2020-03-30	STRONGBUY	2.290
ASX:ASX	2020-04-28	STRONGBUY	83.000
ASX:ASX	2020-04-27	STRONGBUY	83.520
ASX:ASX	2020-04-24	STRONGBUY	81.490
ASX:ASX	2020-04-23	STRONGBUY	82.020
ASX:ASX	2020-04-22	HOLD	82.140
ASX:ASX	2020-04-21	HOLD	81.500
ASX:ASX	2020-04-20	HOLD	80.690
ASX:ASX	2020-04-17	HOLD	83.000
ASX:ASX	2020-04-16	HOLD	81.500
ASX:ASX	2020-04-15	HOLD	80.770
ASX:ASX	2020-04-14	HOLD	79.290
ASX:ASX	2020-04-09	HOLD	79.540
ASX:ASX	2020-04-08	HOLD	79.500
ASX:ASX	2020-04-07	HOLD	77.510
ASX:ASX	2020-04-06	HOLD	82.370
ASX:ASX	2020-04-03	HOLD	77.660
ASX:ASX	2020-04-02	HOLD	77.630
ASX:ASX	2020-04-01	HOLD	80.500
ASX:ASX	2020-03-31	HOLD	77.090
ASX:ASX	2020-03-30	HOLD	370386.000
ASX:RHC	2020-04-29	HOLD	63.000
ASX:RHC	2020-04-28	HOLD	62.300
ASX:RHC	2020-04-27	HOLD	64.230
ASX:RHC	2020-04-24	HOLD	61.940
ASX:RHC	2020-04-23	HOLD	60.520
ASX:RHC	2020-04-22	HOLD	579930.000
ASX:RHC	2020-04-21	STRONGBUY	64.290
ASX:RHC	2020-04-20	STRONGBUY	65.500
ASX:RHC	2020-04-17	HOLD	67.200
ASX:RHC	2020-04-16	HOLD	64.050
ASX:RHC	2020-04-15	HOLD	64.000
ASX:RHC	2020-04-14	HOLD	64.160
ASX:RHC	2020-04-09	HOLD	61.200
ASX:RHC	2020-04-08	WEAKBUY	58.720
ASX:RHC	2020-04-07	HOLD	60.580
ASX:RHC	2020-04-06	HOLD	60.530
ASX:RHC	2020-04-03	HOLD	56.840
ASX:RHC	2020-04-02	HOLD	59.550
ASX:RHC	2020-04-01	HOLD	61.870
ASX:RHC	2020-03-31	HOLD	57.280
ASX:BKL	2020-04-28	STRONGBUY	72.410
ASX:BKL	2020-04-27	STRONGBUY	71.810
ASX:BKL	2020-04-24	STRONGBUY	71.140
ASX:BKL	2020-04-23	STRONGBUY	71.060
ASX:BKL	2020-04-22	STRONGBUY	75.050
ASX:BKL	2020-04-21	STRONGBUY	78.960
ASX:BKL	2020-04-20	STRONGBUY	81.700
ASX:BKL	2020-04-17	STRONGBUY	80.000
ASX:BKL	2020-04-16	HOLD	78.170
ASX:BKL	2020-04-15	HOLD	76.820
ASX:BKL	2020-04-14	HOLD	75.370
ASX:BKL	2020-04-09	HOLD	75.510
ASX:BKL	2020-04-08	HOLD	74.910
ASX:BKL	2020-04-07	HOLD	75.690
ASX:BKL	2020-04-06	HOLD	75.960
ASX:BKL	2020-04-03	HOLD	72.430
ASX:BKL	2020-04-02	HOLD	73.410
ASX:BKL	2020-04-01	HOLD	74.400
ASX:BKL	2020-03-31	HOLD	72.950
ASX:BKL	2020-03-30	STRONGSELL	755738.000	1.1006e+06	28
ASX:BAP	2020-04-29	STRONGBUY	4.870
ASX:BAP	2020-04-28	STRONGBUY	4.770
ASX:BAP	2020-04-27	STRONGBUY	4.730
ASX:BAP	2020-04-24	STRONGBUY	4.660
ASX:BAP	2020-04-23	STRONGBUY	4.530
ASX:BAP	2020-04-22	STRONGBUY	4.670
ASX:BAP	2020-04-21	STRONGBUY	4.500
ASX:BAP	2020-04-20	MEDIUMBUY	4.670
ASX:BAP	2020-04-17	MEDIUMBUY	4.900
ASX:BAP	2020-04-16	STRONGSELL	561580.000	1.85762e+07	1763
ASX:BAP	2020-04-15	STRONGBUY	4.810
ASX:BAP	2020-04-14	STRONGBUY	4.650
ASX:BAP	2020-04-09	HOLD	179624.000
ASX:BAP	2020-04-08	STRONGBUY	4.140
ASX:BAP	2020-04-07	STRONGBUY	4.120
ASX:BAP	2020-04-06	STRONGBUY	4.150
ASX:BAP	2020-04-03	STRONGBUY	3.900
ASX:BAP	2020-04-02	STRONGBUY	4.320
ASX:BAP	2020-04-01	STRONGBUY	4.220
ASX:BAP	2020-03-31	STRONGBUY	4.090
ASX:CNU	2020-04-29	STRONGBUY	6.820
ASX:CNU	2020-04-28	STRONGBUY	6.800
ASX:CNU	2020-04-27	STRONGBUY	6.590
ASX:CNU	2020-04-24	STRONGBUY	6.390
ASX:CNU	2020-04-23	STRONGBUY	6.390
ASX:CNU	2020-04-22	STRONGBUY	6.610
ASX:CNU	2020-04-21	STRONGBUY	6.610
ASX:CNU	2020-04-20	STRONGBUY	6.740
ASX:CNU	2020-04-17	STRONGBUY	6.760
ASX:CNU	2020-04-16	STRONGBUY	266067.000
ASX:CNU	2020-04-15	STRONGBUY	6.550
ASX:CNU	2020-04-14	STRONGBUY	6.450
ASX:CNU	2020-04-09	STRONGBUY	6.380
ASX:CNU	2020-04-08	STRONGBUY	6.590
ASX:CNU	2020-04-07	STRONGBUY	6.650
ASX:CNU	2020-04-06	STRONGBUY	6.790
ASX:CNU	2020-04-03	STRONGBUY	6.680
ASX:CNU	2020-04-02	STRONGBUY	6.560
ASX:CNU	2020-04-01	STRONGBUY	6.710
ASX:CNU	2020-03-31	STRONGBUY	6.610
ASX:COH	2020-04-28	HOLD	185.920
ASX:COH	2020-04-27	HOLD	184.580
ASX:COH	2020-04-24	HOLD	179.260
ASX:COH	2020-04-23	STRONGBUY	179.340
ASX:COH	2020-04-22	STRONGBUY	181.950
ASX:COH	2020-04-21	STRONGBUY	181.180
ASX:COH	2020-04-20	STRONGBUY	185.510
ASX:COH	2020-04-17	HOLD	194.140
ASX:COH	2020-04-16	WEAKBUY	194.650
ASX:COH	2020-04-15	WEAKBUY	195.070
ASX:COH	2020-04-14	WEAKBUY	197.560
ASX:COH	2020-04-09	HOLD	189.500
ASX:COH	2020-04-08	HOLD	182.910
ASX:COH	2020-04-07	WEAKBUY	183.180
ASX:COH	2020-04-06	WEAKBUY	191.370
ASX:COH	2020-04-03	WEAKBUY	182.020
ASX:COH	2020-04-02	WEAKBUY	190.000
ASX:COH	2020-04-01	WEAKBUY	195.500
ASX:COH	2020-03-31	WEAKBUY	187.450
ASX:COH	2020-03-30	WEAKBUY	182.810
ASX:GWA	2020-04-27	STRONGBUY	2.340
ASX:GWA	2020-04-24	STRONGBUY	2.300
ASX:GWA	2020-04-23	STRONGBUY	2.280
ASX:GWA	2020-04-22	WEAKBUY	2.360
ASX:GWA	2020-04-21	STRONGBUY	2.340
ASX:GWA	2020-04-20	WEAKBUY	2.440
ASX:GWA	2020-04-17	STRONGBUY	2.480
ASX:GWA	2020-04-16	STRONGBUY	2.460
ASX:GWA	2020-04-15	WEAKBUY	2.470
ASX:GWA	2020-04-14	STRONGBUY	2.450
ASX:GWA	2020-04-09	WEAKBUY	2.490
ASX:GWA	2020-04-08	WEAKBUY	2.370
ASX:GWA	2020-04-07	WEAKBUY	2.390
ASX:GWA	2020-04-06	STRONGBUY	2.420
ASX:GWA	2020-04-03	WEAKBUY	2.350
ASX:GWA	2020-04-02	WEAKBUY	2.420
ASX:GWA	2020-04-01	WEAKBUY	2.620
ASX:GWA	2020-03-31	WEAKBUY	2.600
ASX:GWA	2020-03-30	WEAKBUY	2.690
ASX:GWA	2020-03-27	WEAKBUY	2.580
ASX:ECX	2020-04-29	STRONGBUY	0.655
ASX:ECX	2020-04-28	STRONGBUY	0.625
ASX:ECX	2020-04-27	STRONGBUY	0.695
ASX:ECX	2020-04-24	STRONGBUY	0.570
ASX:ECX	2020-04-23	STRONGBUY	0.575
ASX:ECX	2020-04-22	STRONGBUY	0.565
ASX:ECX	2020-04-21	STRONGBUY	0.590
ASX:ECX	2020-04-20	STRONGSELL	386677.000	2.66673e+07	52
ASX:ECX	2020-04-17	STRONGBUY	0.760
ASX:ECX	2020-04-16	STRONGBUY	0.790
ASX:ECX	2020-04-15	STRONGBUY	0.865
ASX:ECX	2020-04-14	STRONGBUY	0.870
ASX:ECX	2020-04-09	STRONGBUY	0.800
ASX:ECX	2020-04-08	STRONGBUY	0.740
ASX:ECX	2020-04-07	STRONGBUY	0.695
ASX:ECX	2020-04-06	STRONGBUY	0.655
ASX:ECX	2020-04-03	STRONGBUY	0.650
ASX:ECX	2020-04-02	STRONGBUY	0.650
ASX:ECX	2020-04-01	STRONGBUY	0.700
ASX:ECX	2020-03-31	STRONGBUY	0.680
ASX:A2M	2020-04-28	HOLD	18.930
ASX:A2M	2020-04-27	HOLD	18.770
ASX:A2M	2020-04-24	HOLD	18.650
ASX:A2M	2020-04-23	HOLD	18.590
ASX:A2M	2020-04-22	WEAKBUY	18.620
ASX:A2M	2020-04-21	WEAKBUY	18.310
ASX:A2M	2020-04-20	WEAKBUY	18.730
ASX:A2M	2020-04-17	WEAKBUY	19.000
ASX:A2M	2020-04-16	MEDIUMBUY	19.000
ASX:A2M	2020-04-15	MEDIUMBUY	18.100
ASX:A2M	2020-04-14	STRONGBUY	17.480
ASX:A2M	2020-04-09	STRONGBUY	16.920
ASX:A2M	2020-04-08	STRONGBUY	16.820
ASX:A2M	2020-04-07	STRONGBUY	17.050
ASX:A2M	2020-04-06	STRONGBUY	16.880
ASX:A2M	2020-04-03	STRONGBUY	16.620
ASX:A2M	2020-04-02	STRONGBUY	16.670
ASX:A2M	2020-04-01	STRONGBUY	16.820
ASX:A2M	2020-03-31	STRONGBUY	16.600
ASX:A2M	2020-03-30	STRONGSELL	720521.000	6.2006e+06	144
ASX:NHC	2020-04-29	STRONGBUY	1.475
ASX:NHC	2020-04-28	STRONGBUY	1.405
ASX:NHC	2020-04-27	STRONGBUY	1.425
ASX:NHC	2020-04-24	STRONGBUY	1.480
ASX:NHC	2020-04-23	STRONGBUY	1.425
ASX:NHC	2020-04-22	STRONGBUY	1.395
ASX:NHC	2020-04-21	STRONGBUY	1.345
ASX:NHC	2020-04-20	STRONGBUY	1.465
ASX:NHC	2020-04-17	STRONGBUY	1.620
ASX:NHC	2020-04-16	STRONGBUY	1.595
ASX:NHC	2020-04-15	STRONGBUY	1.550
ASX:NHC	2020-04-14	STRONGBUY	1.565
ASX:NHC	2020-04-09	STRONGBUY	1.480
ASX:NHC	2020-04-08	STRONGBUY	1.475
ASX:NHC	2020-04-07	HOLD	1.520
ASX:NHC	2020-04-06	STRONGBUY	1.555
ASX:NHC	2020-04-03	STRONGBUY	1.450
ASX:NHC	2020-04-02	WEAKBUY	1.425
ASX:NHC	2020-04-01	WEAKBUY	1.450
ASX:NHC	2020-03-31	WEAKBUY	1.390
ASX:UWL	2020-04-28	HOLD	1.515
ASX:UWL	2020-04-27	HOLD	1.375
ASX:UWL	2020-04-24	WEAKBUY	1.370
ASX:UWL	2020-04-23	WEAKBUY	1.340
ASX:UWL	2020-04-22	STRONGBUY	1.170
ASX:UWL	2020-04-21	STRONGBUY	1.185
ASX:UWL	2020-04-20	STRONGSELL	958939.000
ASX:UWL	2020-04-17	WEAKSELL	1.280
ASX:UWL	2020-04-16	WEAKSELL	1.225
ASX:UWL	2020-04-15	WEAKSELL	1.280
ASX:UWL	2020-04-14	WEAKSELL	1.290
ASX:UWL	2020-04-09	WEAKSELL	1.230
ASX:UWL	2020-04-08	WEAKSELL	1.200
ASX:UWL	2020-04-07	WEAKSELL	1.220
ASX:UWL	2020-04-06	STRONGSELL	642015.000	4.14202e+07	55
ASX:UWL	2020-04-03	STRONGBUY	1.125
ASX:UWL	2020-04-02	STRONGBUY	1.100
ASX:UWL	2020-04-01	STRONGBUY	1.155
ASX:UWL	2020-03-31	STRONGBUY	1.170
ASX:UWL	2020-03-30	STRONGBUY	1.105
ASX:HLS	2020-04-29	WEAKBUY	2.500
ASX:HLS	2020-04-28	WEAKBUY	2.510
ASX:HLS	2020-04-27	STRONGSELL	733791.000	3.03218e+07	4
ASX:HLS	2020-04-24	HOLD	2.400
ASX:HLS	2020-04-23	STRONGBUY	2.420
ASX:HLS	2020-04-22	STRONGBUY	2.420
ASX:HLS	2020-04-21	HOLD	2.380
ASX:HLS	2020-04-20	HOLD	2.450
ASX:HLS	2020-04-17	HOLD	2.470
ASX:HLS	2020-04-16	HOLD	2.450
ASX:HLS	2020-04-15	HOLD	2.350
ASX:HLS	2020-04-14	WEAKBUY	2.340
ASX:HLS	2020-04-09	WEAKBUY	2.050
ASX:HLS	2020-04-08	WEAKBUY	2.000
ASX:HLS	2020-04-07	HOLD	1.990
ASX:HLS	2020-04-06	HOLD	2.010
ASX:HLS	2020-04-03	WEAKBUY	2.050
ASX:HLS	2020-04-02	WEAKBUY	2.120
ASX:HLS	2020-04-01	WEAKBUY	2.120
ASX:HLS	2020-03-31	WEAKBUY	2.070
ASX:NXT	2020-04-29	STRONGBUY	8.630
ASX:NXT	2020-04-28	STRONGBUY	8.500
ASX:NXT	2020-04-27	STRONGBUY	8.380
ASX:NXT	2020-04-24	STRONGBUY	8.480
ASX:NXT	2020-04-23	STRONGBUY	8.610
ASX:NXT	2020-04-22	STRONGBUY	8.440
ASX:NXT	2020-04-21	WEAKBUY	8.530
ASX:NXT	2020-04-20	WEAKBUY	8.900
ASX:NXT	2020-04-17	WEAKBUY	8.830
ASX:NXT	2020-04-16	STRONGBUY	9.160
ASX:NXT	2020-04-15	WEAKBUY	9.280
ASX:NXT	2020-04-14	WEAKBUY	9.270
ASX:NXT	2020-04-09	WEAKBUY	8.670
ASX:NXT	2020-04-08	WEAKBUY	8.400
ASX:NXT	2020-04-07	MEDIUMBUY	8.640
ASX:NXT	2020-04-06	MEDIUMBUY	8.780
ASX:NXT	2020-04-03	MEDIUMBUY	9.200
ASX:NXT	2020-04-02	STRONGSELL	434545.000	5.80157e+06	36
ASX:NXT	2020-04-01	STRONGBUY	9.180
ASX:NXT	2020-03-31	STRONGBUY	8.920
ASX:DMP	2020-04-29	WEAKBUY	54.600
ASX:DMP	2020-04-28	WEAKBUY	53.590
ASX:DMP	2020-04-27	WEAKBUY	50.830
ASX:DMP	2020-04-24	WEAKBUY	47.900
ASX:DMP	2020-04-23	STRONGBUY	49.640
ASX:DMP	2020-04-22	STRONGBUY	50.810
ASX:DMP	2020-04-21	WEAKBUY	50.650
ASX:DMP	2020-04-20	WEAKBUY	51.800
ASX:DMP	2020-04-17	WEAKBUY	52.000
ASX:DMP	2020-04-16	WEAKBUY	50.000
ASX:DMP	2020-04-15	WEAKBUY	50.380
ASX:DMP	2020-04-14	WEAKBUY	49.580
ASX:DMP	2020-04-09	WEAKBUY	49.800
ASX:DMP	2020-04-08	WEAKBUY	49.420
ASX:DMP	2020-04-07	HOLD	48.300
ASX:DMP	2020-04-06	HOLD	50.000
ASX:DMP	2020-04-03	HOLD	48.800
ASX:DMP	2020-04-02	HOLD	51.330
ASX:DMP	2020-04-01	HOLD	50.240
ASX:DMP	2020-03-31	HOLD	51.100
ASX:EM1	2019-08-19	STRONGBUY	0.017
ASX:EM1	2019-08-16	STRONGBUY	0.016
ASX:EM1	2019-08-15	STRONGBUY	0.016
ASX:EM1	2019-08-14	STRONGBUY	0.018
ASX:EM1	2019-08-13	STRONGBUY	0.015
ASX:EM1	2019-08-12	STRONGBUY	0.017
ASX:EM1	2019-08-09	STRONGBUY	0.017
ASX:EM1	2019-08-08	STRONGBUY	0.019
ASX:EM1	2019-08-07	STRONGBUY	0.018
ASX:EM1	2019-08-06	STRONGBUY	0.018
ASX:EM1	2019-08-05	STRONGBUY	0.019
ASX:EM1	2019-08-02	STRONGBUY	0.019
ASX:EM1	2019-08-01	STRONGBUY	0.018
ASX:EM1	2019-07-31	STRONGBUY	0.018
ASX:EM1	2019-07-30	STRONGBUY	0.021
ASX:EM1	2019-07-29	STRONGBUY	0.022
ASX:EM1	2019-07-26	HOLD	0.022
ASX:EM1	2019-07-25	STRONGBUY	0.023
ASX:EM1	2019-07-24	STRONGBUY	0.022
ASX:EM1	2019-07-23	HOLD	0.024
ASX:DOW	2020-04-28	STRONGBUY	3.680
ASX:DOW	2020-04-27	STRONGBUY	3.710
ASX:DOW	2020-04-24	HOLD	3.530
ASX:DOW	2020-04-23	HOLD	3.630
ASX:DOW	2020-04-22	HOLD	3.560
ASX:DOW	2020-04-21	HOLD	3.520
ASX:DOW	2020-04-20	WEAKSELL	3.770
ASX:DOW	2020-04-17	WEAKSELL	3.800
ASX:DOW	2020-04-16	WEAKSELL	3.820	381.9	7344
ASX:DOW	2020-04-15	HOLD	3.930
ASX:DOW	2020-04-14	HOLD	3.950
ASX:DOW	2020-04-09	HOLD	3.810
ASX:DOW	2020-04-08	HOLD	3.540
ASX:DOW	2020-04-07	HOLD	3.470
ASX:DOW	2020-04-06	HOLD	3.430
ASX:DOW	2020-04-03	HOLD	3.150
ASX:DOW	2020-04-02	HOLD	3.510
ASX:DOW	2020-04-01	HOLD	514347.000
ASX:DOW	2020-03-31	STRONGBUY	2.980
ASX:DOW	2020-03-30	STRONGBUY	2.850
ASX:ALU	2020-04-29	STRONGBUY	33.360
ASX:ALU	2020-04-28	STRONGBUY	33.030
ASX:ALU	2020-04-27	STRONGBUY	33.210
ASX:ALU	2020-04-24	STRONGBUY	31.300
ASX:ALU	2020-04-23	STRONGBUY	30.840
ASX:ALU	2020-04-22	STRONGBUY	30.860
ASX:ALU	2020-04-21	STRONGBUY	30.700
ASX:ALU	2020-04-20	STRONGBUY	32.110
ASX:ALU	2020-04-17	STRONGBUY	32.350
ASX:ALU	2020-04-16	HOLD	31.550
ASX:ALU	2020-04-15	HOLD	31.720
ASX:ALU	2020-04-14	HOLD	31.340
ASX:ALU	2020-04-09	HOLD	30.930
ASX:ALU	2020-04-08	HOLD	30.230
ASX:ALU	2020-04-07	HOLD	30.450
ASX:ALU	2020-04-06	HOLD	29.880
ASX:ALU	2020-04-03	HOLD	27.030
ASX:ALU	2020-04-02	WEAKBUY	27.320
ASX:ALU	2020-04-01	HOLD	28.680
ASX:ALU	2020-03-31	HOLD	28.590

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

AI Trading Ideas

AI Trading NYSE Wed, 29 Apr

April 29, 2020April 29, 2020
by admin

Dear Reader,

Our featured stock today is NYSE:CNQ. If you traded between 2000-10-04 – 2020-01-17 with our AI strategy, you would have made a 1363.64% return. On average a trade made 31.71% and was 82.0 days in the long position. There were a total of 43.0 postions taken over the period.

Here are the AI Trading NYSE Wed, 29 Apr buys:

Symbol	Model Accuracy	Price Target
NYSE:PBA	0.831006	19.2966
NYSE:PBA	0.831006	20.3091
NYSE:ALLY	0.809313	12.9500
NYSE:CUK	0.808453	7.5000
NYSE:GE	0.804925	7.2300
NYSE:HMC	0.801072	20.8800
NYSE:VFC	0.795712	48.6800
NYSE:ABEV	0.795204	2.2000
NYSE:HST	0.790351	10.6200
NYSE:BA	0.787702	146.8700
NYSE:BA	0.787702	124.5200
NYSE:TDG	0.777568	284.4700
NYSE:CCL	0.774866	13.1700
NYSE:MUFG	0.754533	3.6000
NYSE:NCLH	0.753223	11.3500
NYSE:NCLH	0.753223	8.4600
NYSE:LYG	0.751625	1.3100
NYSE:GPS	0.750447	5.6500
NYSE:BCS	0.749256	4.0100
NYSE:DAL	0.747692	23.8700
NYSE:AMOV	0.746713	10.9700
NYSE:ING	0.739130	5.1500
NYSE:SPR	0.738828	19.6100
NYSE:DB	0.733175	6.0900
NYSE:BBD	0.729932	4.0600
NYSE:DELL	0.729167	37.1400
NYSE:LYV	0.727019	33.5700
NYSE:ITUB	0.705925	4.1000
NYSE:TME	0.673469	10.7300
NYSE:GOL	0.661629	4.5700
NYSE:GOL	0.661629	3.5200

Here are the AI Trading NYSE Wed, 29 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Symbol	From Date	To Date	Model Accuracy	Acc Profit/Loss	Avg Profit/Loss	Avg Days Invested	Total Positions
NYSE:PBA	2012-05-14	2020-04-13	83.0	243.02	30.38	166.0	8.0
NYSE:ALLY	2016-06-08	2020-03-26	81.0	135.67	27.13	127.0	5.0
NYSE:CUK	2001-03-12	2020-03-26	81.0	692.59	34.63	143.0	20.0
NYSE:GE	2000-01-13	2020-03-26	80.0	542.65	28.56	93.0	19.0
NYSE:HMC	1998-07-24	2020-03-26	80.0	559.89	24.34	67.0	23.0
NYSE:VFC	1998-11-25	2020-03-26	80.0	681.63	35.88	188.0	19.0
NYSE:ABEV	2001-02-13	2020-03-26	80.0	1360.08	61.82	167.0	22.0
NYSE:HST	1999-01-15	2020-03-26	79.0	868.31	34.73	69.0	25.0
NYSE:BA	2000-01-19	2020-04-06	79.0	935.49	51.97	197.0	18.0
NYSE:TDG	2008-01-04	2020-03-26	78.0	872.97	109.12	431.0	8.0
NYSE:CCL	1998-04-06	2020-03-27	77.0	1073.01	31.56	72.0	34.0
NYSE:MUFG	2001-10-03	2020-03-26	75.0	785.61	30.22	61.0	26.0
NYSE:NCLH	2014-02-12	2020-04-14	75.0	323.00	35.89	127.0	9.0
NYSE:LYG	2002-05-06	2020-03-25	75.0	1367.85	39.08	58.0	35.0
NYSE:GPS	1998-08-24	2019-09-16	75.0	1487.40	36.28	78.0	41.0
NYSE:BCS	1998-02-06	2020-03-26	75.0	1515.89	37.90	68.0	40.0
NYSE:DAL	2007-07-24	2020-03-26	75.0	1123.82	37.46	69.0	30.0
NYSE:AMOV	2001-06-07	2020-03-04	75.0	1173.46	46.94	123.0	25.0
NYSE:ING	1998-07-30	2020-03-25	74.0	1657.35	40.42	86.0	41.0
NYSE:SPR	2007-07-25	2020-03-26	74.0	892.97	37.21	100.0	24.0
NYSE:DB	1998-05-26	2020-03-26	73.0	1609.82	32.85	64.0	49.0
NYSE:BBD	2002-08-08	2020-03-26	73.0	2109.58	49.06	84.0	43.0
NYSE:DELL	2019-05-30	2020-03-26	73.0	100.89	33.63	60.0	3.0
NYSE:LYV	2006-02-13	2020-03-27	73.0	1160.44	40.02	62.0	29.0
NYSE:ITUB	2002-04-12	2020-03-13	71.0	1670.03	37.11	73.0	45.0
NYSE:TME	2019-04-03	2020-02-11	67.0	68.85	34.42	81.0	2.0
NYSE:GOL	2004-09-24	2020-04-07	66.0	2740.28	47.25	54.0	58.0

Detail predictions over the past few days:
Buys:

Symbol	Date	Prediction	Adj Close	P/L %	Days
NYSE:PBA	2020-04-28	WEAKBUY	21.620
NYSE:PBA	2020-04-27	WEAKBUY	20.460
NYSE:PBA	2020-04-24	WEAKBUY	20.210
NYSE:PBA	2020-04-23	WEAKBUY	19.920
NYSE:PBA	2020-04-22	STRONGBUY	19.297
NYSE:PBA	2020-04-21	STRONGBUY	18.622
NYSE:PBA	2020-04-20	WEAKBUY	19.336
NYSE:PBA	2020-04-17	WEAKBUY	20.230
NYSE:PBA	2020-04-16	WEAKBUY	18.830
NYSE:PBA	2020-04-15	WEAKBUY	19.058
NYSE:PBA	2020-04-14	WEAKSELL	20.001
NYSE:PBA	2020-04-13	WEAKSELL	19.793	-2.54	4
NYSE:PBA	2020-04-09	STRONGBUY	20.309
NYSE:PBA	2020-04-08	STRONGBUY	19.277
NYSE:PBA	2020-04-07	WEAKSELL	19.545
NYSE:PBA	2020-04-06	WEAKSELL	19.307	15.84	7
NYSE:PBA	2020-04-03	STRONGBUY	17.282
NYSE:PBA	2020-04-02	STRONGBUY	17.838
NYSE:PBA	2020-04-01	STRONGBUY	16.507
NYSE:PBA	2020-03-31	STRONGBUY	18.671
NYSE:ALLY	2020-04-27	MEDIUMBUY	15.200
NYSE:ALLY	2020-04-24	WEAKBUY	14.300
NYSE:ALLY	2020-04-23	MEDIUMBUY	14.300
NYSE:ALLY	2020-04-22	MEDIUMBUY	14.020
NYSE:ALLY	2020-04-21	MEDIUMBUY	14.180
NYSE:ALLY	2020-04-20	MEDIUMBUY	15.050
NYSE:ALLY	2020-04-17	MEDIUMBUY	15.370
NYSE:ALLY	2020-04-16	MEDIUMBUY	13.560
NYSE:ALLY	2020-04-15	MEDIUMBUY	14.160
NYSE:ALLY	2020-04-14	MEDIUMBUY	15.160
NYSE:ALLY	2020-04-13	MEDIUMBUY	15.750
NYSE:ALLY	2020-04-09	MEDIUMBUY	16.830
NYSE:ALLY	2020-04-08	MEDIUMBUY	15.220
NYSE:ALLY	2020-04-07	MEDIUMBUY	14.390
NYSE:ALLY	2020-04-06	MEDIUMBUY	13.840
NYSE:ALLY	2020-04-03	STRONGBUY	11.980
NYSE:ALLY	2020-04-02	STRONGBUY	12.950
NYSE:ALLY	2020-04-01	STRONGBUY	12.930
NYSE:ALLY	2020-03-31	WEAKBUY	14.430
NYSE:ALLY	2020-03-30	WEAKBUY	15.320
NYSE:CUK	2020-04-28	MEDIUMBUY	12.970
NYSE:CUK	2020-04-27	MEDIUMBUY	11.770
NYSE:CUK	2020-04-24	STRONGBUY	10.770
NYSE:CUK	2020-04-23	STRONGBUY	11.010
NYSE:CUK	2020-04-22	STRONGBUY	10.560
NYSE:CUK	2020-04-21	STRONGBUY	10.840
NYSE:CUK	2020-04-20	STRONGBUY	11.110
NYSE:CUK	2020-04-17	STRONGBUY	11.790
NYSE:CUK	2020-04-16	STRONGBUY	10.920
NYSE:CUK	2020-04-15	STRONGBUY	11.330
NYSE:CUK	2020-04-14	STRONGBUY	11.710
NYSE:CUK	2020-04-13	STRONGBUY	10.690
NYSE:CUK	2020-04-09	STRONGBUY	11.540
NYSE:CUK	2020-04-08	STRONGBUY	11.150
NYSE:CUK	2020-04-07	STRONGBUY	10.450
NYSE:CUK	2020-04-06	STRONGBUY	9.340
NYSE:CUK	2020-04-03	STRONGBUY	7.930
NYSE:CUK	2020-04-02	STRONGBUY	7.500
NYSE:CUK	2020-04-01	STRONGBUY	8.160
NYSE:CUK	2020-03-31	STRONGSELL	11.930
NYSE:GE	2020-04-28	STRONGBUY	6.800
NYSE:GE	2020-04-27	STRONGBUY	6.430
NYSE:GE	2020-04-24	STRONGBUY	6.260
NYSE:GE	2020-04-23	STRONGBUY	6.520
NYSE:GE	2020-04-22	STRONGBUY	6.430
NYSE:GE	2020-04-21	STRONGBUY	6.480
NYSE:GE	2020-04-20	STRONGBUY	6.510
NYSE:GE	2020-04-17	STRONGBUY	6.840
NYSE:GE	2020-04-16	STRONGBUY	6.240
NYSE:GE	2020-04-15	STRONGBUY	6.500
NYSE:GE	2020-04-14	STRONGBUY	6.930
NYSE:GE	2020-04-13	STRONGBUY	7.020
NYSE:GE	2020-04-09	STRONGBUY	7.140
NYSE:GE	2020-04-08	STRONGBUY	7.300
NYSE:GE	2020-04-07	STRONGBUY	7.030
NYSE:GE	2020-04-06	STRONGBUY	7.230
NYSE:GE	2020-04-03	STRONGBUY	6.730
NYSE:GE	2020-04-02	HOLD	6.900
NYSE:GE	2020-04-01	HOLD	7.040
NYSE:GE	2020-03-31	HOLD	7.940
NYSE:HMC	2020-04-28	HOLD	23.330
NYSE:HMC	2020-04-27	HOLD	23.570
NYSE:HMC	2020-04-24	HOLD	22.730
NYSE:HMC	2020-04-23	HOLD	22.480
NYSE:HMC	2020-04-22	HOLD	21.860
NYSE:HMC	2020-04-21	HOLD	21.780
NYSE:HMC	2020-04-20	HOLD	22.330
NYSE:HMC	2020-04-17	HOLD	22.630
NYSE:HMC	2020-04-16	STRONGBUY	21.010
NYSE:HMC	2020-04-15	HOLD	21.410
NYSE:HMC	2020-04-14	HOLD	22.040
NYSE:HMC	2020-04-13	HOLD	21.910
NYSE:HMC	2020-04-09	HOLD	22.330
NYSE:HMC	2020-04-08	HOLD	22.130
NYSE:HMC	2020-04-07	HOLD	21.700
NYSE:HMC	2020-04-06	HOLD	21.480
NYSE:HMC	2020-04-03	STRONGBUY	19.860
NYSE:HMC	2020-04-02	STRONGBUY	20.880
NYSE:HMC	2020-04-01	STRONGBUY	21.080
NYSE:HMC	2020-03-31	HOLD	22.460
NYSE:VFC	2020-04-28	HOLD	59.500
NYSE:VFC	2020-04-27	STRONGBUY	57.710
NYSE:VFC	2020-04-24	STRONGBUY	54.570
NYSE:VFC	2020-04-23	STRONGBUY	54.350
NYSE:VFC	2020-04-22	STRONGBUY	54.270
NYSE:VFC	2020-04-21	STRONGBUY	53.340
NYSE:VFC	2020-04-20	STRONGBUY	55.830
NYSE:VFC	2020-04-17	STRONGBUY	57.500
NYSE:VFC	2020-04-16	STRONGBUY	54.850
NYSE:VFC	2020-04-15	STRONGBUY	55.850
NYSE:VFC	2020-04-14	HOLD	59.570
NYSE:VFC	2020-04-13	HOLD	57.500
NYSE:VFC	2020-04-09	HOLD	59.210
NYSE:VFC	2020-04-08	HOLD	57.990
NYSE:VFC	2020-04-07	HOLD	56.340
NYSE:VFC	2020-04-06	HOLD	54.670
NYSE:VFC	2020-04-03	STRONGBUY	48.880
NYSE:VFC	2020-04-02	STRONGBUY	49.120
NYSE:VFC	2020-04-01	STRONGBUY	48.680
NYSE:VFC	2020-03-31	STRONGBUY	54.080
NYSE:ABEV	2020-04-28	STRONGBUY	2.130
NYSE:ABEV	2020-04-27	STRONGBUY	2.080
NYSE:ABEV	2020-04-24	STRONGBUY	2.000
NYSE:ABEV	2020-04-23	STRONGBUY	2.120
NYSE:ABEV	2020-04-22	STRONGBUY	2.170
NYSE:ABEV	2020-04-21	STRONGBUY	2.230
NYSE:ABEV	2020-04-20	STRONGBUY	2.240
NYSE:ABEV	2020-04-17	STRONGBUY	2.220
NYSE:ABEV	2020-04-16	STRONGBUY	2.200
NYSE:ABEV	2020-04-15	STRONGBUY	2.290
NYSE:ABEV	2020-04-14	MEDIUMBUY	2.360
NYSE:ABEV	2020-04-13	WEAKSELL	2.360
NYSE:ABEV	2020-04-09	WEAKSELL	2.400
NYSE:ABEV	2020-04-08	WEAKSELL	2.410
NYSE:ABEV	2020-04-07	WEAKSELL	2.370
NYSE:ABEV	2020-04-06	WEAKSELL	2.230
NYSE:ABEV	2020-04-03	WEAKSELL	2.180
NYSE:ABEV	2020-04-02	WEAKSELL	2.310
NYSE:ABEV	2020-04-01	WEAKSELL	2.250
NYSE:ABEV	2020-03-31	WEAKSELL	2.300
NYSE:HST	2020-04-28	MEDIUMBUY	11.690
NYSE:HST	2020-04-27	STRONGBUY	11.570
NYSE:HST	2020-04-24	STRONGBUY	11.100
NYSE:HST	2020-04-23	STRONGBUY	10.810
NYSE:HST	2020-04-22	STRONGBUY	10.620
NYSE:HST	2020-04-21	STRONGBUY	10.560
NYSE:HST	2020-04-20	MEDIUMBUY	10.800
NYSE:HST	2020-04-17	MEDIUMBUY	11.370
NYSE:HST	2020-04-16	MEDIUMBUY	11.000
NYSE:HST	2020-04-15	WEAKBUY	11.270
NYSE:HST	2020-04-14	WEAKBUY	11.440
NYSE:HST	2020-04-13	WEAKBUY	11.410
NYSE:HST	2020-04-09	WEAKBUY	11.910
NYSE:HST	2020-04-08	WEAKBUY	11.260
NYSE:HST	2020-04-07	WEAKBUY	10.690
NYSE:HST	2020-04-06	WEAKBUY	10.420
NYSE:HST	2020-04-03	STRONGBUY	9.060
NYSE:HST	2020-04-02	WEAKBUY	9.550
NYSE:HST	2020-04-01	WEAKBUY	10.280
NYSE:HST	2020-03-31	WEAKBUY	11.040
NYSE:BA	2020-04-28	STRONGBUY	131.300
NYSE:BA	2020-04-27	STRONGBUY	128.680
NYSE:BA	2020-04-24	STRONGBUY	128.980
NYSE:BA	2020-04-23	STRONGBUY	137.740
NYSE:BA	2020-04-22	STRONGBUY	134.970
NYSE:BA	2020-04-21	STRONGBUY	136.330
NYSE:BA	2020-04-20	STRONGBUY	143.610
NYSE:BA	2020-04-17	STRONGBUY	154.000
NYSE:BA	2020-04-16	STRONGBUY	134.240
NYSE:BA	2020-04-15	STRONGBUY	145.980
NYSE:BA	2020-04-14	STRONGBUY	141.000
NYSE:BA	2020-04-13	STRONGBUY	147.330
NYSE:BA	2020-04-09	STRONGBUY	151.840
NYSE:BA	2020-04-08	STRONGBUY	146.870
NYSE:BA	2020-04-07	STRONGBUY	141.580
NYSE:BA	2020-04-06	STRONGSELL	148.770	19.47	3
NYSE:BA	2020-04-03	STRONGBUY	124.520
NYSE:BA	2020-04-02	STRONGBUY	123.270
NYSE:BA	2020-04-01	STRONGSELL	130.700
NYSE:BA	2020-03-31	STRONGSELL	149.140
NYSE:TDG	2020-04-28	WEAKBUY	336.650
NYSE:TDG	2020-04-27	WEAKBUY	317.450
NYSE:TDG	2020-04-24	MEDIUMBUY	304.920
NYSE:TDG	2020-04-23	WEAKBUY	314.280
NYSE:TDG	2020-04-22	WEAKBUY	304.260
NYSE:TDG	2020-04-21	WEAKBUY	307.750
NYSE:TDG	2020-04-20	WEAKBUY	316.400
NYSE:TDG	2020-04-17	WEAKBUY	337.400
NYSE:TDG	2020-04-16	MEDIUMBUY	300.900
NYSE:TDG	2020-04-15	MEDIUMBUY	316.940
NYSE:TDG	2020-04-14	MEDIUMBUY	318.160
NYSE:TDG	2020-04-13	MEDIUMBUY	313.600
NYSE:TDG	2020-04-09	MEDIUMBUY	344.540
NYSE:TDG	2020-04-08	MEDIUMBUY	328.250
NYSE:TDG	2020-04-07	MEDIUMBUY	286.430
NYSE:TDG	2020-04-06	MEDIUMBUY	288.930
NYSE:TDG	2020-04-03	STRONGBUY	270.310
NYSE:TDG	2020-04-02	STRONGBUY	284.470
NYSE:TDG	2020-04-01	STRONGBUY	272.540
NYSE:TDG	2020-03-31	MEDIUMBUY	320.190
NYSE:CCL	2020-04-28	STRONGBUY	14.460
NYSE:CCL	2020-04-27	STRONGBUY	12.980
NYSE:CCL	2020-04-24	STRONGBUY	11.910
NYSE:CCL	2020-04-23	STRONGBUY	12.170
NYSE:CCL	2020-04-22	STRONGBUY	11.640
NYSE:CCL	2020-04-21	STRONGBUY	11.840
NYSE:CCL	2020-04-20	STRONGBUY	12.220
NYSE:CCL	2020-04-17	STRONGBUY	12.560
NYSE:CCL	2020-04-16	STRONGBUY	11.850
NYSE:CCL	2020-04-15	STRONGBUY	12.380
NYSE:CCL	2020-04-14	STRONGBUY	12.510
NYSE:CCL	2020-04-13	STRONGBUY	11.500
NYSE:CCL	2020-04-09	STRONGBUY	12.420
NYSE:CCL	2020-04-08	STRONGBUY	11.990
NYSE:CCL	2020-04-07	STRONGBUY	11.300
NYSE:CCL	2020-04-06	STRONGBUY	10.210
NYSE:CCL	2020-04-03	STRONGBUY	8.490
NYSE:CCL	2020-04-02	STRONGBUY	7.970
NYSE:CCL	2020-04-01	STRONGBUY	8.800
NYSE:CCL	2020-03-31	STRONGBUY	13.170
NYSE:MUFG	2020-04-28	HOLD	4.020
NYSE:MUFG	2020-04-27	HOLD	3.980
NYSE:MUFG	2020-04-24	HOLD	3.850
NYSE:MUFG	2020-04-23	HOLD	3.870
NYSE:MUFG	2020-04-22	HOLD	3.790
NYSE:MUFG	2020-04-21	HOLD	3.780
NYSE:MUFG	2020-04-20	WEAKBUY	3.820
NYSE:MUFG	2020-04-17	WEAKBUY	3.800
NYSE:MUFG	2020-04-16	HOLD	3.700
NYSE:MUFG	2020-04-15	HOLD	3.780
NYSE:MUFG	2020-04-14	HOLD	3.930
NYSE:MUFG	2020-04-13	HOLD	3.860
NYSE:MUFG	2020-04-09	HOLD	3.760
NYSE:MUFG	2020-04-08	HOLD	3.710
NYSE:MUFG	2020-04-07	HOLD	3.810
NYSE:MUFG	2020-04-06	HOLD	3.720
NYSE:MUFG	2020-04-03	STRONGBUY	3.490
NYSE:MUFG	2020-04-02	STRONGBUY	3.600
NYSE:MUFG	2020-04-01	STRONGBUY	3.600
NYSE:MUFG	2020-03-31	HOLD	3.660
NYSE:NCLH	2020-04-28	WEAKBUY	13.090
NYSE:NCLH	2020-04-27	STRONGBUY	11.440
NYSE:NCLH	2020-04-24	STRONGBUY	10.860
NYSE:NCLH	2020-04-23	STRONGBUY	11.470
NYSE:NCLH	2020-04-22	STRONGBUY	10.870
NYSE:NCLH	2020-04-21	STRONGBUY	11.000
NYSE:NCLH	2020-04-20	WEAKBUY	11.490
NYSE:NCLH	2020-04-17	STRONGBUY	12.380
NYSE:NCLH	2020-04-16	STRONGBUY	11.350
NYSE:NCLH	2020-04-15	STRONGBUY	12.080
NYSE:NCLH	2020-04-14	STRONGSELL	12.350	45.98	11
NYSE:NCLH	2020-04-13	STRONGBUY	11.360
NYSE:NCLH	2020-04-09	STRONGBUY	13.110
NYSE:NCLH	2020-04-08	STRONGBUY	11.720
NYSE:NCLH	2020-04-07	STRONGBUY	11.010
NYSE:NCLH	2020-04-06	STRONGBUY	10.010
NYSE:NCLH	2020-04-03	STRONGBUY	8.460
NYSE:NCLH	2020-04-02	STRONGBUY	8.400
NYSE:NCLH	2020-04-01	STRONGSELL	9.550
NYSE:NCLH	2020-03-31	STRONGSELL	10.960
NYSE:LYG	2020-04-28	MEDIUMBUY	1.600
NYSE:LYG	2020-04-27	MEDIUMBUY	1.470
NYSE:LYG	2020-04-24	MEDIUMBUY	1.440
NYSE:LYG	2020-04-23	MEDIUMBUY	1.440
NYSE:LYG	2020-04-22	MEDIUMBUY	1.410
NYSE:LYG	2020-04-21	MEDIUMBUY	1.390
NYSE:LYG	2020-04-20	MEDIUMBUY	1.420
NYSE:LYG	2020-04-17	MEDIUMBUY	1.480
NYSE:LYG	2020-04-16	MEDIUMBUY	1.410
NYSE:LYG	2020-04-15	MEDIUMBUY	1.430
NYSE:LYG	2020-04-14	MEDIUMBUY	1.570
NYSE:LYG	2020-04-13	MEDIUMBUY	1.570
NYSE:LYG	2020-04-09	MEDIUMBUY	1.600
NYSE:LYG	2020-04-08	MEDIUMBUY	1.510
NYSE:LYG	2020-04-07	STRONGBUY	1.450
NYSE:LYG	2020-04-06	STRONGBUY	1.420
NYSE:LYG	2020-04-03	STRONGBUY	1.290
NYSE:LYG	2020-04-02	STRONGBUY	1.370
NYSE:LYG	2020-04-01	STRONGBUY	1.310
NYSE:LYG	2020-03-31	STRONGBUY	1.510
NYSE:GPS	2020-04-28	STRONGBUY	8.610
NYSE:GPS	2020-04-27	STRONGBUY	7.790
NYSE:GPS	2020-04-24	STRONGBUY	6.900
NYSE:GPS	2020-04-23	STRONGBUY	7.100
NYSE:GPS	2020-04-22	STRONGBUY	7.110
NYSE:GPS	2020-04-21	STRONGBUY	7.560
NYSE:GPS	2020-04-20	STRONGBUY	7.840
NYSE:GPS	2020-04-17	STRONGBUY	8.350
NYSE:GPS	2020-04-16	STRONGBUY	7.630
NYSE:GPS	2020-04-15	STRONGBUY	7.710
NYSE:GPS	2020-04-14	STRONGBUY	8.430
NYSE:GPS	2020-04-13	STRONGBUY	8.330
NYSE:GPS	2020-04-09	WEAKBUY	9.090
NYSE:GPS	2020-04-08	HOLD	7.850
NYSE:GPS	2020-04-07	HOLD	6.970
NYSE:GPS	2020-04-06	HOLD	6.590
NYSE:GPS	2020-04-03	STRONGBUY	5.650
NYSE:GPS	2020-04-02	STRONGBUY	5.500
NYSE:GPS	2020-04-01	HOLD	5.890
NYSE:GPS	2020-03-31	HOLD	7.040
NYSE:BCS	2020-04-28	WEAKBUY	4.870
NYSE:BCS	2020-04-27	STRONGBUY	4.530
NYSE:BCS	2020-04-24	STRONGBUY	4.420
NYSE:BCS	2020-04-23	STRONGBUY	4.390
NYSE:BCS	2020-04-22	STRONGBUY	4.270
NYSE:BCS	2020-04-21	STRONGBUY	4.260
NYSE:BCS	2020-04-20	STRONGBUY	4.440
NYSE:BCS	2020-04-17	STRONGBUY	4.550
NYSE:BCS	2020-04-16	STRONGBUY	4.300
NYSE:BCS	2020-04-15	STRONGBUY	4.330
NYSE:BCS	2020-04-14	STRONGBUY	4.690
NYSE:BCS	2020-04-13	WEAKBUY	4.720
NYSE:BCS	2020-04-09	WEAKBUY	4.880
NYSE:BCS	2020-04-08	STRONGBUY	4.570
NYSE:BCS	2020-04-07	WEAKBUY	4.530
NYSE:BCS	2020-04-06	STRONGBUY	4.230
NYSE:BCS	2020-04-03	STRONGBUY	3.890
NYSE:BCS	2020-04-02	STRONGBUY	4.010
NYSE:BCS	2020-04-01	STRONGBUY	4.050
NYSE:BCS	2020-03-31	WEAKBUY	4.530
NYSE:DAL	2020-04-28	STRONGBUY	24.340
NYSE:DAL	2020-04-27	STRONGBUY	22.160
NYSE:DAL	2020-04-24	STRONGBUY	22.410
NYSE:DAL	2020-04-23	STRONGBUY	22.480
NYSE:DAL	2020-04-22	STRONGBUY	22.470
NYSE:DAL	2020-04-21	STRONGBUY	23.100
NYSE:DAL	2020-04-20	STRONGBUY	23.640
NYSE:DAL	2020-04-17	STRONGBUY	24.270
NYSE:DAL	2020-04-16	STRONGBUY	22.780
NYSE:DAL	2020-04-15	STRONGBUY	24.350
NYSE:DAL	2020-04-14	STRONGBUY	24.540
NYSE:DAL	2020-04-13	STRONGBUY	23.250
NYSE:DAL	2020-04-09	STRONGBUY	24.390
NYSE:DAL	2020-04-08	STRONGBUY	23.230
NYSE:DAL	2020-04-07	STRONGBUY	22.250
NYSE:DAL	2020-04-06	STRONGBUY	22.320
NYSE:DAL	2020-04-03	STRONGBUY	22.480
NYSE:DAL	2020-04-02	STRONGBUY	22.680
NYSE:DAL	2020-04-01	STRONGBUY	23.870
NYSE:DAL	2020-03-31	STRONGBUY	28.530
NYSE:AMOV	2020-04-28	WEAKBUY	11.310
NYSE:AMOV	2020-04-27	WEAKBUY	10.786
NYSE:AMOV	2020-04-24	STRONGBUY	10.619
NYSE:AMOV	2020-04-23	STRONGBUY	10.800
NYSE:AMOV	2020-04-22	STRONGBUY	10.500
NYSE:AMOV	2020-04-21	WEAKBUY	11.000
NYSE:AMOV	2020-04-20	WEAKBUY	10.819
NYSE:AMOV	2020-04-17	WEAKBUY	11.100
NYSE:AMOV	2020-04-16	STRONGBUY	10.540
NYSE:AMOV	2020-04-15	WEAKBUY	11.680
NYSE:AMOV	2020-04-14	WEAKBUY	11.590
NYSE:AMOV	2020-04-13	WEAKBUY	12.102
NYSE:AMOV	2020-04-09	WEAKBUY	11.628
NYSE:AMOV	2020-04-08	WEAKBUY	11.890
NYSE:AMOV	2020-04-07	WEAKBUY	11.655
NYSE:AMOV	2020-04-06	STRONGBUY	10.420
NYSE:AMOV	2020-04-03	STRONGBUY	10.970
NYSE:AMOV	2020-04-02	STRONGBUY	10.970
NYSE:AMOV	2020-04-01	HOLD	11.380
NYSE:AMOV	2020-03-31	HOLD	11.700
NYSE:ING	2020-04-28	STRONGBUY	5.530
NYSE:ING	2020-04-27	STRONGBUY	5.310
NYSE:ING	2020-04-24	STRONGBUY	5.030
NYSE:ING	2020-04-23	STRONGBUY	5.160
NYSE:ING	2020-04-22	STRONGBUY	5.070
NYSE:ING	2020-04-21	STRONGBUY	4.930
NYSE:ING	2020-04-20	STRONGBUY	5.070
NYSE:ING	2020-04-17	STRONGBUY	5.260
NYSE:ING	2020-04-16	STRONGBUY	4.980
NYSE:ING	2020-04-15	STRONGBUY	5.100
NYSE:ING	2020-04-14	STRONGBUY	5.630
NYSE:ING	2020-04-13	STRONGBUY	5.770
NYSE:ING	2020-04-09	STRONGBUY	5.930
NYSE:ING	2020-04-08	STRONGBUY	5.760
NYSE:ING	2020-04-07	STRONGBUY	5.650
NYSE:ING	2020-04-06	STRONGBUY	5.480
NYSE:ING	2020-04-03	STRONGBUY	4.930
NYSE:ING	2020-04-02	STRONGBUY	5.100
NYSE:ING	2020-04-01	STRONGBUY	5.100
NYSE:ING	2020-03-31	STRONGBUY	5.150
NYSE:SPR	2020-04-28	WEAKBUY	20.500
NYSE:SPR	2020-04-27	STRONGBUY	19.140
NYSE:SPR	2020-04-24	STRONGBUY	18.090
NYSE:SPR	2020-04-23	STRONGBUY	19.340
NYSE:SPR	2020-04-22	STRONGBUY	18.910
NYSE:SPR	2020-04-21	STRONGBUY	19.370
NYSE:SPR	2020-04-20	STRONGBUY	20.870
NYSE:SPR	2020-04-17	STRONGBUY	22.640
NYSE:SPR	2020-04-16	STRONGBUY	19.090
NYSE:SPR	2020-04-15	STRONGBUY	20.920
NYSE:SPR	2020-04-14	STRONGBUY	19.990
NYSE:SPR	2020-04-13	STRONGBUY	20.650
NYSE:SPR	2020-04-09	STRONGBUY	22.580
NYSE:SPR	2020-04-08	STRONGBUY	21.300
NYSE:SPR	2020-04-07	STRONGBUY	18.360
NYSE:SPR	2020-04-06	STRONGBUY	19.450
NYSE:SPR	2020-04-03	STRONGBUY	18.430
NYSE:SPR	2020-04-02	STRONGBUY	18.730
NYSE:SPR	2020-04-01	STRONGBUY	19.610
NYSE:SPR	2020-03-31	STRONGBUY	23.930
NYSE:DB	2020-04-28	WEAKBUY	6.850
NYSE:DB	2020-04-27	WEAKBUY	6.690
NYSE:DB	2020-04-24	STRONGBUY	5.950
NYSE:DB	2020-04-23	STRONGBUY	6.180
NYSE:DB	2020-04-22	STRONGBUY	6.090
NYSE:DB	2020-04-21	STRONGBUY	6.080
NYSE:DB	2020-04-20	WEAKBUY	6.330
NYSE:DB	2020-04-17	WEAKBUY	6.540
NYSE:DB	2020-04-16	WEAKBUY	6.220
NYSE:DB	2020-04-15	WEAKBUY	6.230
NYSE:DB	2020-04-14	WEAKBUY	6.850
NYSE:DB	2020-04-13	WEAKBUY	6.520
NYSE:DB	2020-04-09	WEAKBUY	6.690
NYSE:DB	2020-04-08	WEAKBUY	6.540
NYSE:DB	2020-04-07	WEAKBUY	6.640
NYSE:DB	2020-04-06	WEAKBUY	6.380
NYSE:DB	2020-04-03	WEAKBUY	5.900
NYSE:DB	2020-04-02	WEAKBUY	6.020
NYSE:DB	2020-04-01	WEAKBUY	5.960
NYSE:DB	2020-03-31	WEAKBUY	6.420
NYSE:BBD	2020-04-28	STRONGBUY	3.600
NYSE:BBD	2020-04-27	STRONGBUY	3.240
NYSE:BBD	2020-04-24	STRONGBUY	3.120
NYSE:BBD	2020-04-23	STRONGBUY	3.480
NYSE:BBD	2020-04-22	STRONGBUY	3.600
NYSE:BBD	2020-04-21	STRONGBUY	3.520
NYSE:BBD	2020-04-20	STRONGBUY	3.670
NYSE:BBD	2020-04-17	STRONGBUY	3.850
NYSE:BBD	2020-04-16	STRONGBUY	3.770
NYSE:BBD	2020-04-15	STRONGBUY	3.900
NYSE:BBD	2020-04-14	STRONGBUY	4.050
NYSE:BBD	2020-04-13	STRONGBUY	4.380
NYSE:BBD	2020-04-09	STRONGBUY	4.370
NYSE:BBD	2020-04-08	STRONGBUY	4.380
NYSE:BBD	2020-04-07	STRONGBUY	4.120
NYSE:BBD	2020-04-06	STRONGBUY	3.960
NYSE:BBD	2020-04-03	STRONGBUY	3.550
NYSE:BBD	2020-04-02	STRONGBUY	3.790
NYSE:BBD	2020-04-01	STRONGBUY	3.780
NYSE:BBD	2020-03-31	STRONGBUY	4.060
NYSE:DELL	2020-04-28	STRONGBUY	40.840
NYSE:DELL	2020-04-27	STRONGBUY	40.190
NYSE:DELL	2020-04-24	STRONGBUY	39.690
NYSE:DELL	2020-04-23	STRONGBUY	38.910
NYSE:DELL	2020-04-22	STRONGBUY	38.750
NYSE:DELL	2020-04-21	STRONGBUY	37.400
NYSE:DELL	2020-04-20	STRONGBUY	40.960
NYSE:DELL	2020-04-17	STRONGBUY	41.510
NYSE:DELL	2020-04-16	STRONGBUY	41.100
NYSE:DELL	2020-04-15	STRONGBUY	40.450
NYSE:DELL	2020-04-14	STRONGBUY	41.340
NYSE:DELL	2020-04-13	STRONGBUY	40.460
NYSE:DELL	2020-04-09	STRONGBUY	41.560
NYSE:DELL	2020-04-08	STRONGBUY	40.380
NYSE:DELL	2020-04-07	STRONGBUY	38.370
NYSE:DELL	2020-04-06	STRONGBUY	38.910
NYSE:DELL	2020-04-03	STRONGBUY	36.440
NYSE:DELL	2020-04-02	STRONGBUY	37.140
NYSE:DELL	2020-04-01	STRONGBUY	36.900
NYSE:DELL	2020-03-31	WEAKSELL	39.550
NYSE:LYV	2020-04-28	HOLD	43.640
NYSE:LYV	2020-04-27	HOLD	42.010
NYSE:LYV	2020-04-24	HOLD	38.240
NYSE:LYV	2020-04-23	HOLD	39.450
NYSE:LYV	2020-04-22	HOLD	36.350
NYSE:LYV	2020-04-21	HOLD	36.470
NYSE:LYV	2020-04-20	HOLD	36.660
NYSE:LYV	2020-04-17	HOLD	38.350
NYSE:LYV	2020-04-16	HOLD	36.400
NYSE:LYV	2020-04-15	WEAKBUY	38.470
NYSE:LYV	2020-04-14	HOLD	41.960
NYSE:LYV	2020-04-13	WEAKBUY	39.410
NYSE:LYV	2020-04-09	STRONGBUY	38.270
NYSE:LYV	2020-04-08	WEAKBUY	37.760
NYSE:LYV	2020-04-07	WEAKBUY	37.850
NYSE:LYV	2020-04-06	STRONGBUY	34.510
NYSE:LYV	2020-04-03	STRONGBUY	33.570
NYSE:LYV	2020-04-02	STRONGBUY	33.950
NYSE:LYV	2020-04-01	HOLD	38.880
NYSE:LYV	2020-03-31	WEAKSELL	45.460
NYSE:ITUB	2020-04-28	STRONGBUY	4.250
NYSE:ITUB	2020-04-27	STRONGBUY	3.800
NYSE:ITUB	2020-04-24	STRONGBUY	3.660
NYSE:ITUB	2020-04-23	STRONGBUY	4.000
NYSE:ITUB	2020-04-22	STRONGBUY	4.120
NYSE:ITUB	2020-04-21	STRONGBUY	4.050
NYSE:ITUB	2020-04-20	STRONGBUY	4.250
NYSE:ITUB	2020-04-17	STRONGBUY	4.420
NYSE:ITUB	2020-04-16	STRONGBUY	4.310
NYSE:ITUB	2020-04-15	STRONGBUY	4.500
NYSE:ITUB	2020-04-14	STRONGBUY	4.690
NYSE:ITUB	2020-04-13	STRONGBUY	4.620
NYSE:ITUB	2020-04-09	HOLD	4.640
NYSE:ITUB	2020-04-08	HOLD	4.680
NYSE:ITUB	2020-04-07	HOLD	4.380
NYSE:ITUB	2020-04-06	STRONGBUY	4.170
NYSE:ITUB	2020-04-03	STRONGBUY	3.900
NYSE:ITUB	2020-04-02	STRONGBUY	4.100
NYSE:ITUB	2020-04-01	STRONGBUY	4.080
NYSE:ITUB	2020-03-31	HOLD	4.486
NYSE:TME	2020-04-28	STRONGBUY	10.870
NYSE:TME	2020-04-27	STRONGBUY	11.030
NYSE:TME	2020-04-24	STRONGBUY	10.750
NYSE:TME	2020-04-23	STRONGBUY	10.940
NYSE:TME	2020-04-22	STRONGBUY	11.120
NYSE:TME	2020-04-21	STRONGBUY	10.960
NYSE:TME	2020-04-20	STRONGBUY	11.190
NYSE:TME	2020-04-17	STRONGBUY	10.890
NYSE:TME	2020-04-16	STRONGBUY	10.820
NYSE:TME	2020-04-15	STRONGBUY	10.830
NYSE:TME	2020-04-14	STRONGBUY	11.120
NYSE:TME	2020-04-13	STRONGBUY	10.900
NYSE:TME	2020-04-09	STRONGBUY	10.970
NYSE:TME	2020-04-08	STRONGBUY	10.990
NYSE:TME	2020-04-07	STRONGBUY	10.730
NYSE:TME	2020-04-06	STRONGBUY	10.590
NYSE:TME	2020-04-03	MEDIUMBUY	10.630
NYSE:TME	2020-04-02	MEDIUMBUY	11.010
NYSE:TME	2020-04-01	STRONGBUY	10.120
NYSE:TME	2020-03-31	MEDIUMBUY	10.060
NYSE:GOL	2020-04-28	STRONGBUY	4.420
NYSE:GOL	2020-04-27	STRONGBUY	3.960
NYSE:GOL	2020-04-24	STRONGBUY	3.780
NYSE:GOL	2020-04-23	STRONGBUY	4.350
NYSE:GOL	2020-04-22	STRONGBUY	4.390
NYSE:GOL	2020-04-21	STRONGBUY	4.160
NYSE:GOL	2020-04-20	STRONGBUY	4.550
NYSE:GOL	2020-04-17	STRONGBUY	4.640
NYSE:GOL	2020-04-16	STRONGBUY	4.490
NYSE:GOL	2020-04-15	STRONGBUY	4.640
NYSE:GOL	2020-04-14	STRONGBUY	4.450
NYSE:GOL	2020-04-13	STRONGBUY	4.390
NYSE:GOL	2020-04-09	STRONGBUY	4.570
NYSE:GOL	2020-04-08	STRONGBUY	4.620
NYSE:GOL	2020-04-07	WEAKSELL	4.130	17.33	4
NYSE:GOL	2020-04-06	STRONGBUY	3.800
NYSE:GOL	2020-04-03	STRONGBUY	3.520
NYSE:GOL	2020-04-02	STRONGBUY	3.740
NYSE:GOL	2020-04-01	WEAKSELL	3.710
NYSE:GOL	2020-03-31	WEAKSELL	4.270

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

AI Trading Ideas

AI Trading NASDAQ Wed, 29 Apr

April 29, 2020April 29, 2020
by admin

Dear Reader,

Our featured stock today is ILMN. If you traded between 2000-09-01 – 2019-07-10 with our AI strategy, you would have made a 2305.83% return. On average a trade made 43.51% and was 74.0 days in the long position. There were a total of 53.0 postions taken over the period.

Here are the AI Trading NASDAQ Wed, 29 Apr buys:

Symbol	Model Accuracy	Price Target
NWSA	0.818359	8.435
EWBC	0.801189	24.230
LBTYK	0.792539	15.115
DISCA	0.787770	20.390
LBTYA	0.772385	16.050
MYL	0.772127	13.740
NXST	0.766613	53.620
MIDD	0.761559	54.000
ADI	0.760396	84.090
EVOP	0.757143	12.710
NOVT	0.750000	67.250
AMOV	0.749307	10.970
CMPR	0.747715	44.900
DSGX	0.732497	37.930
DSGX	0.732497	38.630
HQY	0.728972	43.920
SAVE	0.724138	12.890
AAL	0.723288	12.190
JBLU	0.722181	8.950
IQ	0.715232	17.800
HTHT	0.711640	28.450
UAL	0.706929	25.650
WB	0.706013	35.240
IPGP	0.703888	102.920
CSOD	0.702346	31.700
CTRP	0.699431	23.000
MRNA	0.676768	51.200
FEYE	0.660569	9.900
UVXY	0.545312	58.560

Here are the AI Trading NASDAQ Wed, 29 Apr sells:

You must be logged in to view this content.
Log In

Back-testing and model summaries:

Symbol	From Date	To Date	Model Accuracy	Acc Profit/Loss	Avg Profit/Loss	Avg Days Invested	Total Positions
NWSA	2014-09-10	2019-11-06	82.0	129.67	18.52	128.0	7.0
EWBC	2000-09-14	2020-03-17	80.0	1406.56	42.62	86.0	33.0
LBTYK	2006-06-26	2019-05-06	79.0	536.94	29.83	73.0	18.0
DISCA	2007-08-08	2020-02-19	79.0	483.57	32.24	97.0	15.0
LBTYA	2004-12-17	2019-09-13	77.0	746.18	35.53	86.0	21.0
MYL	2000-05-09	2020-02-10	77.0	997.42	33.25	96.0	30.0
NXST	2004-12-31	2020-03-26	77.0	2146.04	59.61	102.0	36.0
MIDD	2000-06-13	2020-03-26	76.0	1640.76	49.72	127.0	33.0
ADI	2000-03-22	2019-07-31	76.0	960.11	27.43	69.0	35.0
EVOP	2018-11-30	2018-11-30	76.0	34.31	34.31	190.0	1.0
NOVT	2017-11-24	2020-03-04	75.0	407.50	67.92	175.0	6.0
AMOV	2001-06-07	2019-02-05	75.0	1097.77	42.22	107.0	26.0
CMPR	2006-03-02	2020-03-24	75.0	1267.39	46.94	90.0	27.0
DSGX	2000-03-10	2020-04-17	73.0	1544.55	31.52	62.0	49.0
HQY	2014-09-10	2020-03-26	73.0	649.82	29.54	52.0	22.0
SAVE	2011-07-15	2020-03-26	72.0	745.26	43.84	97.0	17.0
AAL	2006-01-04	2020-03-25	72.0	2200.90	44.92	57.0	49.0
JBLU	2002-05-09	2020-03-25	72.0	1520.64	37.09	66.0	41.0
IQ	2018-06-19	2020-02-19	72.0	361.48	51.64	54.0	7.0
HTHT	2010-04-05	2020-02-12	71.0	1038.88	43.29	85.0	24.0
UAL	2006-03-27	2020-03-25	71.0	1924.38	42.76	57.0	45.0
WB	2014-09-11	2020-01-13	71.0	914.30	50.79	68.0	18.0
IPGP	2007-06-04	2019-11-05	70.0	1200.42	44.46	89.0	27.0
CSOD	2011-05-11	2020-03-26	70.0	707.85	35.39	86.0	20.0
CTRP	2004-01-02	2020-01-21	70.0	1811.42	45.29	77.0	40.0
MRNA	2019-05-30	2020-04-16	68.0	240.51	80.17	137.0	3.0
FEYE	2014-03-05	2020-03-26	66.0	649.61	40.60	63.0	16.0
UVXY	2011-11-25	2020-03-13	55.0	492.83	13.69	63.0	36.0

Detail predictions over the past few days:
Buys:

Symbol	Date	Prediction	Adj Close	P/L %	Days
NWSA	2020-04-28	WEAKBUY	9.810
NWSA	2020-04-27	WEAKBUY	9.460
NWSA	2020-04-24	STRONGBUY	8.830
NWSA	2020-04-23	STRONGBUY	8.675
NWSA	2020-04-22	STRONGBUY	8.435
NWSA	2020-04-21	STRONGBUY	8.435
NWSA	2020-04-20	STRONGBUY	8.770
NWSA	2020-04-17	STRONGBUY	8.900
NWSA	2020-04-16	STRONGBUY	8.435
NWSA	2020-04-15	STRONGBUY	8.930
NWSA	2020-04-14	WEAKBUY	9.415
NWSA	2020-04-13	WEAKBUY	9.390
NWSA	2020-04-09	HOLD	9.490
NWSA	2020-04-08	STRONGBUY	8.950
NWSA	2020-04-07	HOLD	8.790
NWSA	2020-04-06	HOLD	8.930
NWSA	2020-04-03	WEAKBUY	8.180
NWSA	2020-04-02	WEAKBUY	8.200
NWSA	2020-04-01	HOLD	8.640
NWSA	2020-03-31	HOLD	8.975
EWBC	2020-04-28	HOLD	33.800
EWBC	2020-04-27	HOLD	32.120
EWBC	2020-04-24	WEAKBUY	30.370
EWBC	2020-04-23	WEAKBUY	29.530
EWBC	2020-04-22	WEAKBUY	26.980
EWBC	2020-04-21	MEDIUMBUY	27.360
EWBC	2020-04-20	MEDIUMBUY	28.000
EWBC	2020-04-17	MEDIUMBUY	28.010
EWBC	2020-04-16	MEDIUMBUY	25.470
EWBC	2020-04-15	MEDIUMBUY	26.060
EWBC	2020-04-14	MEDIUMBUY	28.560
EWBC	2020-04-13	MEDIUMBUY	29.180
EWBC	2020-04-09	MEDIUMBUY	31.110
EWBC	2020-04-08	MEDIUMBUY	27.550
EWBC	2020-04-07	WEAKBUY	27.020
EWBC	2020-04-06	WEAKBUY	25.430
EWBC	2020-04-03	STRONGBUY	22.780
EWBC	2020-04-02	STRONGBUY	24.230
EWBC	2020-04-01	STRONGBUY	24.370
EWBC	2020-03-31	WEAKBUY	25.740
LBTYK	2020-04-28	HOLD	17.590
LBTYK	2020-04-27	HOLD	18.210
LBTYK	2020-04-24	HOLD	17.515
LBTYK	2020-04-23	HOLD	17.380
LBTYK	2020-04-22	HOLD	17.080
LBTYK	2020-04-21	HOLD	16.810
LBTYK	2020-04-20	HOLD	17.340
LBTYK	2020-04-17	HOLD	17.290
LBTYK	2020-04-16	HOLD	17.230
LBTYK	2020-04-15	HOLD	17.100
LBTYK	2020-04-14	HOLD	17.390
LBTYK	2020-04-13	HOLD	16.980
LBTYK	2020-04-09	HOLD	17.390
LBTYK	2020-04-08	HOLD	17.300
LBTYK	2020-04-07	HOLD	16.250
LBTYK	2020-04-06	HOLD	16.180
LBTYK	2020-04-03	STRONGBUY	14.840
LBTYK	2020-04-02	STRONGBUY	15.240
LBTYK	2020-04-01	STRONGBUY	15.115
LBTYK	2020-03-31	STRONGBUY	15.710
DISCA	2020-04-28	HOLD	23.420
DISCA	2020-04-27	HOLD	22.745
DISCA	2020-04-24	STRONGBUY	21.020
DISCA	2020-04-23	STRONGBUY	20.390
DISCA	2020-04-22	STRONGBUY	20.370
DISCA	2020-04-21	HOLD	20.780
DISCA	2020-04-20	HOLD	21.700
DISCA	2020-04-17	HOLD	22.140
DISCA	2020-04-16	WEAKBUY	21.470
DISCA	2020-04-15	WEAKBUY	21.350
DISCA	2020-04-14	WEAKBUY	22.300
DISCA	2020-04-13	WEAKBUY	21.990
DISCA	2020-04-09	WEAKBUY	22.320
DISCA	2020-04-08	WEAKBUY	21.580
DISCA	2020-04-07	WEAKBUY	20.670
DISCA	2020-04-06	WEAKBUY	19.650
DISCA	2020-04-03	WEAKBUY	18.360
DISCA	2020-04-02	WEAKBUY	18.680
DISCA	2020-04-01	WEAKBUY	19.455
DISCA	2020-03-31	WEAKBUY	19.440
LBTYA	2020-04-28	HOLD	18.415
LBTYA	2020-04-27	WEAKBUY	19.050
LBTYA	2020-04-24	HOLD	18.380
LBTYA	2020-04-23	HOLD	18.170
LBTYA	2020-04-22	HOLD	17.870
LBTYA	2020-04-21	HOLD	17.620
LBTYA	2020-04-20	HOLD	18.260
LBTYA	2020-04-17	HOLD	18.230
LBTYA	2020-04-16	HOLD	18.180
LBTYA	2020-04-15	HOLD	18.030
LBTYA	2020-04-14	HOLD	18.550
LBTYA	2020-04-13	HOLD	18.080
LBTYA	2020-04-09	HOLD	18.590
LBTYA	2020-04-08	WEAKBUY	18.270
LBTYA	2020-04-07	STRONGBUY	17.260
LBTYA	2020-04-06	WEAKBUY	17.080
LBTYA	2020-04-03	STRONGBUY	15.800
LBTYA	2020-04-02	STRONGBUY	16.190
LBTYA	2020-04-01	STRONGBUY	16.050
LBTYA	2020-03-31	STRONGBUY	16.510
MYL	2020-04-28	WEAKBUY	16.440
MYL	2020-04-27	WEAKBUY	16.140
MYL	2020-04-24	MEDIUMBUY	15.760
MYL	2020-04-23	MEDIUMBUY	15.300
MYL	2020-04-22	MEDIUMBUY	14.910
MYL	2020-04-21	WEAKBUY	15.130
MYL	2020-04-20	WEAKBUY	15.860
MYL	2020-04-17	WEAKBUY	16.110
MYL	2020-04-16	WEAKBUY	15.500
MYL	2020-04-15	MEDIUMBUY	15.460
MYL	2020-04-14	MEDIUMBUY	16.350
MYL	2020-04-13	MEDIUMBUY	16.060
MYL	2020-04-09	WEAKBUY	16.080
MYL	2020-04-08	WEAKBUY	15.140
MYL	2020-04-07	WEAKBUY	14.370
MYL	2020-04-06	STRONGBUY	14.040
MYL	2020-04-03	STRONGBUY	13.740
MYL	2020-04-02	STRONGBUY	13.920
MYL	2020-04-01	WEAKBUY	14.260
MYL	2020-03-31	WEAKBUY	14.910
NXST	2020-04-28	WEAKBUY	67.620
NXST	2020-04-27	WEAKBUY	64.490
NXST	2020-04-24	WEAKBUY	59.320
NXST	2020-04-23	WEAKBUY	58.750
NXST	2020-04-22	WEAKBUY	56.800
NXST	2020-04-21	WEAKBUY	58.800
NXST	2020-04-20	MEDIUMBUY	61.750
NXST	2020-04-17	WEAKBUY	66.205
NXST	2020-04-16	WEAKBUY	59.140
NXST	2020-04-15	WEAKBUY	59.840
NXST	2020-04-14	WEAKBUY	63.590
NXST	2020-04-13	WEAKBUY	58.570
NXST	2020-04-09	WEAKBUY	62.800
NXST	2020-04-08	WEAKBUY	64.500
NXST	2020-04-07	WEAKBUY	59.210
NXST	2020-04-06	WEAKBUY	58.430
NXST	2020-04-03	STRONGBUY	50.750
NXST	2020-04-02	STRONGBUY	55.600
NXST	2020-04-01	STRONGBUY	53.620
NXST	2020-03-31	STRONGBUY	57.730
MIDD	2020-04-28	STRONGBUY	55.500
MIDD	2020-04-27	STRONGBUY	54.630
MIDD	2020-04-24	WEAKBUY	51.490
MIDD	2020-04-23	WEAKBUY	52.990
MIDD	2020-04-22	WEAKBUY	51.310
MIDD	2020-04-21	STRONGBUY	49.270
MIDD	2020-04-20	STRONGBUY	48.560
MIDD	2020-04-17	STRONGBUY	51.680
MIDD	2020-04-16	STRONGBUY	49.270
MIDD	2020-04-15	STRONGBUY	50.230
MIDD	2020-04-14	STRONGBUY	54.000
MIDD	2020-04-13	STRONGBUY	52.350
MIDD	2020-04-09	WEAKBUY	58.080
MIDD	2020-04-08	WEAKBUY	55.870
MIDD	2020-04-07	WEAKBUY	53.880
MIDD	2020-04-06	WEAKBUY	51.930
MIDD	2020-04-03	STRONGBUY	48.710
MIDD	2020-04-02	WEAKBUY	52.550
MIDD	2020-04-01	WEAKBUY	53.010
MIDD	2020-03-31	WEAKBUY	56.880
ADI	2020-04-28	WEAKBUY	107.610
ADI	2020-04-27	WEAKBUY	108.030
ADI	2020-04-24	WEAKBUY	105.920
ADI	2020-04-23	WEAKBUY	101.810
ADI	2020-04-22	WEAKBUY	102.120
ADI	2020-04-21	WEAKBUY	96.470
ADI	2020-04-20	WEAKBUY	100.910
ADI	2020-04-17	WEAKBUY	102.800
ADI	2020-04-16	WEAKBUY	101.830
ADI	2020-04-15	WEAKBUY	100.450
ADI	2020-04-14	WEAKBUY	103.020
ADI	2020-04-13	WEAKBUY	99.670
ADI	2020-04-09	WEAKBUY	98.790
ADI	2020-04-08	WEAKBUY	101.400
ADI	2020-04-07	WEAKBUY	96.250
ADI	2020-04-06	WEAKBUY	95.800
ADI	2020-04-03	STRONGBUY	86.560
ADI	2020-04-02	WEAKBUY	87.700
ADI	2020-04-01	STRONGBUY	84.090
ADI	2020-03-31	STRONGBUY	89.650
EVOP	2020-04-28	HOLD	18.200
EVOP	2020-04-27	HOLD	17.500
EVOP	2020-04-24	WEAKBUY	16.460
EVOP	2020-04-23	WEAKBUY	15.660
EVOP	2020-04-22	WEAKBUY	15.130
EVOP	2020-04-21	WEAKBUY	14.450
EVOP	2020-04-20	MEDIUMBUY	14.530
EVOP	2020-04-17	HOLD	14.920
EVOP	2020-04-16	STRONGBUY	12.910
EVOP	2020-04-15	STRONGBUY	13.660
EVOP	2020-04-14	WEAKBUY	15.000
EVOP	2020-04-13	WEAKBUY	14.870
EVOP	2020-04-09	WEAKBUY	15.080
EVOP	2020-04-08	WEAKBUY	14.300
EVOP	2020-04-07	STRONGBUY	13.670
EVOP	2020-04-06	MEDIUMBUY	13.770
EVOP	2020-04-03	STRONGBUY	12.710
EVOP	2020-04-02	STRONGBUY	12.540
EVOP	2020-04-01	MEDIUMBUY	13.070
EVOP	2020-03-31	WEAKBUY	15.300
NOVT	2020-04-28	HOLD	87.250
NOVT	2020-04-27	HOLD	86.490
NOVT	2020-04-24	MEDIUMBUY	83.130
NOVT	2020-04-23	MEDIUMBUY	81.930
NOVT	2020-04-22	MEDIUMBUY	80.570
NOVT	2020-04-21	MEDIUMBUY	76.380
NOVT	2020-04-20	HOLD	79.950
NOVT	2020-04-17	HOLD	80.600
NOVT	2020-04-16	MEDIUMBUY	79.650
NOVT	2020-04-15	MEDIUMBUY	79.140
NOVT	2020-04-14	MEDIUMBUY	80.750
NOVT	2020-04-13	MEDIUMBUY	78.830
NOVT	2020-04-09	HOLD	81.460
NOVT	2020-04-08	HOLD	78.750
NOVT	2020-04-07	HOLD	74.710
NOVT	2020-04-06	HOLD	74.870
NOVT	2020-04-03	STRONGBUY	67.250
NOVT	2020-04-02	STRONGBUY	70.790
NOVT	2020-04-01	HOLD	76.750
NOVT	2020-03-31	HOLD	79.880
AMOV	2020-04-28	WEAKBUY	11.310
AMOV	2020-04-27	WEAKBUY	10.786
AMOV	2020-04-24	WEAKBUY	10.619
AMOV	2020-04-23	WEAKBUY	10.800
AMOV	2020-04-22	STRONGBUY	10.500
AMOV	2020-04-21	WEAKBUY	11.000
AMOV	2020-04-20	WEAKBUY	10.819
AMOV	2020-04-17	WEAKBUY	11.100
AMOV	2020-04-16	STRONGBUY	10.540
AMOV	2020-04-15	WEAKBUY	11.680
AMOV	2020-04-14	WEAKBUY	11.590
AMOV	2020-04-13	WEAKBUY	12.102
AMOV	2020-04-09	WEAKBUY	11.628
AMOV	2020-04-08	WEAKBUY	11.890
AMOV	2020-04-07	WEAKBUY	11.655
AMOV	2020-04-06	STRONGBUY	10.420
AMOV	2020-04-03	STRONGBUY	10.970
AMOV	2020-04-02	STRONGBUY	10.970
AMOV	2020-04-01	WEAKBUY	11.380
AMOV	2020-03-31	WEAKBUY	11.700
CMPR	2020-04-28	HOLD	63.200
CMPR	2020-04-27	HOLD	62.600
CMPR	2020-04-24	HOLD	54.770
CMPR	2020-04-23	HOLD	53.020
CMPR	2020-04-22	MEDIUMBUY	51.190
CMPR	2020-04-21	MEDIUMBUY	47.660
CMPR	2020-04-20	MEDIUMBUY	46.790
CMPR	2020-04-17	MEDIUMBUY	50.190
CMPR	2020-04-16	WEAKBUY	49.620
CMPR	2020-04-15	HOLD	45.760
CMPR	2020-04-14	HOLD	52.560
CMPR	2020-04-13	HOLD	59.040
CMPR	2020-04-09	HOLD	64.320
CMPR	2020-04-08	HOLD	61.160
CMPR	2020-04-07	HOLD	51.740
CMPR	2020-04-06	HOLD	48.880
CMPR	2020-04-03	STRONGBUY	43.860
CMPR	2020-04-02	STRONGBUY	44.900
CMPR	2020-04-01	STRONGBUY	46.660
CMPR	2020-03-31	HOLD	53.200
DSGX	2020-04-28	HOLD	39.780
DSGX	2020-04-27	STRONGBUY	39.870
DSGX	2020-04-24	STRONGBUY	39.440
DSGX	2020-04-23	STRONGBUY	38.880
DSGX	2020-04-22	STRONGBUY	39.480
DSGX	2020-04-21	STRONGBUY	37.930
DSGX	2020-04-20	STRONGBUY	40.130
DSGX	2020-04-17	WEAKSELL	39.780	2.98	1
DSGX	2020-04-16	STRONGBUY	38.630
DSGX	2020-04-15	STRONGBUY	38.000
DSGX	2020-04-14	WEAKSELL	39.330
DSGX	2020-04-13	WEAKSELL	37.580
DSGX	2020-04-09	WEAKSELL	36.910
DSGX	2020-04-08	WEAKSELL	36.720
DSGX	2020-04-07	HOLD	35.630
DSGX	2020-04-06	WEAKSELL	36.010	11.73	20
DSGX	2020-04-03	STRONGBUY	33.010
DSGX	2020-04-02	STRONGBUY	33.060
DSGX	2020-04-01	MEDIUMBUY	33.630
DSGX	2020-03-31	STRONGBUY	34.390
HQY	2020-04-28	STRONGBUY	55.370
HQY	2020-04-27	STRONGBUY	52.650
HQY	2020-04-24	STRONGBUY	51.340
HQY	2020-04-23	STRONGBUY	49.370
HQY	2020-04-22	STRONGBUY	48.790
HQY	2020-04-21	STRONGBUY	46.340
HQY	2020-04-20	STRONGBUY	47.960
HQY	2020-04-17	STRONGBUY	46.710
HQY	2020-04-16	STRONGBUY	45.350
HQY	2020-04-15	STRONGBUY	45.830
HQY	2020-04-14	STRONGBUY	48.360
HQY	2020-04-13	STRONGBUY	47.050
HQY	2020-04-09	STRONGBUY	48.890
HQY	2020-04-08	STRONGBUY	50.850
HQY	2020-04-07	STRONGBUY	46.000
HQY	2020-04-06	STRONGBUY	45.000
HQY	2020-04-03	STRONGBUY	41.090
HQY	2020-04-02	STRONGBUY	43.890
HQY	2020-04-01	STRONGBUY	43.920
HQY	2020-03-31	STRONGBUY	50.590
SAVE	2020-04-28	WEAKBUY	14.340
SAVE	2020-04-27	STRONGBUY	12.250
SAVE	2020-04-24	STRONGBUY	12.150
SAVE	2020-04-23	STRONGBUY	11.800
SAVE	2020-04-22	WEAKBUY	11.930
SAVE	2020-04-21	WEAKBUY	12.750
SAVE	2020-04-20	WEAKBUY	12.950
SAVE	2020-04-17	STRONGBUY	13.350
SAVE	2020-04-16	STRONGBUY	12.660
SAVE	2020-04-15	STRONGBUY	13.760
SAVE	2020-04-14	STRONGBUY	13.880
SAVE	2020-04-13	STRONGBUY	13.320
SAVE	2020-04-09	STRONGBUY	14.080
SAVE	2020-04-08	STRONGBUY	12.510
SAVE	2020-04-07	STRONGBUY	11.440
SAVE	2020-04-06	STRONGBUY	10.470
SAVE	2020-04-03	STRONGBUY	10.510
SAVE	2020-04-02	STRONGBUY	10.530
SAVE	2020-04-01	STRONGBUY	11.320
SAVE	2020-03-31	STRONGBUY	12.890
AAL	2020-04-28	STRONGBUY	11.260
AAL	2020-04-27	STRONGBUY	10.020
AAL	2020-04-24	STRONGBUY	10.310
AAL	2020-04-23	STRONGBUY	10.250
AAL	2020-04-22	STRONGBUY	10.270
AAL	2020-04-21	STRONGBUY	11.000
AAL	2020-04-20	STRONGBUY	11.060
AAL	2020-04-17	STRONGBUY	11.570
AAL	2020-04-16	STRONGBUY	11.070
AAL	2020-04-15	STRONGBUY	12.290
AAL	2020-04-14	STRONGBUY	11.945
AAL	2020-04-13	STRONGBUY	11.560
AAL	2020-04-09	STRONGBUY	12.510
AAL	2020-04-08	STRONGBUY	11.330
AAL	2020-04-07	STRONGBUY	10.220
AAL	2020-04-06	STRONGBUY	9.500
AAL	2020-04-03	STRONGBUY	9.390
AAL	2020-04-02	STRONGBUY	10.060
AAL	2020-04-01	STRONGBUY	10.690
AAL	2020-03-31	STRONGBUY	12.190
JBLU	2020-04-28	STRONGBUY	9.020
JBLU	2020-04-27	STRONGBUY	8.120
JBLU	2020-04-24	STRONGBUY	7.950
JBLU	2020-04-23	STRONGBUY	8.010
JBLU	2020-04-22	STRONGBUY	7.860
JBLU	2020-04-21	STRONGBUY	8.330
JBLU	2020-04-20	STRONGBUY	8.630
JBLU	2020-04-17	STRONGBUY	8.980
JBLU	2020-04-16	STRONGBUY	8.730
JBLU	2020-04-15	STRONGBUY	9.190
JBLU	2020-04-14	STRONGBUY	9.240
JBLU	2020-04-13	STRONGBUY	9.030
JBLU	2020-04-09	STRONGBUY	9.500
JBLU	2020-04-08	STRONGBUY	9.030
JBLU	2020-04-07	STRONGBUY	8.760
JBLU	2020-04-06	STRONGBUY	7.730
JBLU	2020-04-03	STRONGBUY	7.480
JBLU	2020-04-02	STRONGBUY	7.630
JBLU	2020-04-01	STRONGBUY	8.110
JBLU	2020-03-31	STRONGBUY	8.950
IQ	2020-04-28	STRONGBUY	16.650
IQ	2020-04-27	STRONGBUY	17.220
IQ	2020-04-24	STRONGBUY	17.760
IQ	2020-04-23	STRONGBUY	18.140
IQ	2020-04-22	STRONGBUY	18.430
IQ	2020-04-21	STRONGBUY	18.570
IQ	2020-04-20	STRONGBUY	19.250
IQ	2020-04-17	STRONGBUY	19.280
IQ	2020-04-16	STRONGBUY	19.240
IQ	2020-04-15	STRONGBUY	18.450
IQ	2020-04-14	STRONGBUY	18.050
IQ	2020-04-13	STRONGBUY	17.430
IQ	2020-04-09	STRONGBUY	17.370
IQ	2020-04-08	STRONGBUY	16.510
IQ	2020-04-07	STRONGBUY	17.300
IQ	2020-04-06	STRONGBUY	16.760
IQ	2020-04-03	STRONGBUY	17.060
IQ	2020-04-02	STRONGBUY	17.900
IQ	2020-04-01	STRONGBUY	18.180
IQ	2020-03-31	STRONGBUY	17.800
HTHT	2020-04-28	WEAKBUY	31.980
HTHT	2020-04-27	STRONGBUY	30.560
HTHT	2020-04-24	STRONGBUY	28.910
HTHT	2020-04-23	STRONGBUY	30.660
HTHT	2020-04-22	MEDIUMBUY	31.200
HTHT	2020-04-21	STRONGBUY	29.610
HTHT	2020-04-20	WEAKBUY	30.530
HTHT	2020-04-17	MEDIUMBUY	31.020
HTHT	2020-04-16	STRONGBUY	28.870
HTHT	2020-04-15	STRONGBUY	28.680
HTHT	2020-04-14	STRONGBUY	28.550
HTHT	2020-04-13	STRONGBUY	28.470
HTHT	2020-04-09	STRONGBUY	28.520
HTHT	2020-04-08	STRONGBUY	28.450
HTHT	2020-04-07	STRONGBUY	28.930
HTHT	2020-04-06	MEDIUMBUY	29.280
HTHT	2020-04-03	HOLD	28.570
HTHT	2020-04-02	HOLD	29.170
HTHT	2020-04-01	HOLD	28.130
HTHT	2020-03-31	HOLD	28.730
UAL	2020-04-28	STRONGBUY	27.840
UAL	2020-04-27	STRONGBUY	25.000
UAL	2020-04-24	STRONGBUY	25.560
UAL	2020-04-23	STRONGBUY	25.720
UAL	2020-04-22	STRONGBUY	25.880
UAL	2020-04-21	STRONGBUY	27.880
UAL	2020-04-20	STRONGBUY	27.790
UAL	2020-04-17	STRONGBUY	29.080
UAL	2020-04-16	STRONGBUY	28.210
UAL	2020-04-15	STRONGBUY	31.860
UAL	2020-04-14	STRONGBUY	30.900
UAL	2020-04-13	STRONGBUY	28.910
UAL	2020-04-09	STRONGBUY	31.500
UAL	2020-04-08	STRONGBUY	27.510
UAL	2020-04-07	STRONGBUY	24.480
UAL	2020-04-06	STRONGBUY	24.020
UAL	2020-04-03	STRONGBUY	22.885
UAL	2020-04-02	STRONGBUY	23.420
UAL	2020-04-01	STRONGBUY	25.650
UAL	2020-03-31	STRONGBUY	31.550
WB	2020-04-28	STRONGBUY	36.650
WB	2020-04-27	STRONGBUY	37.180
WB	2020-04-24	STRONGBUY	36.490
WB	2020-04-23	STRONGBUY	35.950
WB	2020-04-22	STRONGBUY	35.940
WB	2020-04-21	STRONGBUY	35.460
WB	2020-04-20	STRONGBUY	36.260
WB	2020-04-17	STRONGBUY	36.690
WB	2020-04-16	STRONGBUY	35.810
WB	2020-04-15	STRONGBUY	34.900
WB	2020-04-14	STRONGBUY	35.240
WB	2020-04-13	STRONGBUY	34.390
WB	2020-04-09	HOLD	35.620
WB	2020-04-08	HOLD	35.540
WB	2020-04-07	HOLD	36.640
WB	2020-04-06	HOLD	33.880
WB	2020-04-03	HOLD	32.000
WB	2020-04-02	HOLD	32.330
WB	2020-04-01	HOLD	32.000
WB	2020-03-31	HOLD	33.110
IPGP	2020-04-28	STRONGBUY	131.090
IPGP	2020-04-27	STRONGBUY	126.080
IPGP	2020-04-24	STRONGBUY	120.900
IPGP	2020-04-23	STRONGBUY	116.340
IPGP	2020-04-22	WEAKBUY	116.510
IPGP	2020-04-21	STRONGBUY	111.650
IPGP	2020-04-20	STRONGBUY	117.940
IPGP	2020-04-17	HOLD	119.050
IPGP	2020-04-16	STRONGBUY	115.480
IPGP	2020-04-15	HOLD	114.440
IPGP	2020-04-14	MEDIUMBUY	120.750
IPGP	2020-04-13	HOLD	116.990
IPGP	2020-04-09	STRONGBUY	119.050
IPGP	2020-04-08	STRONGBUY	117.310
IPGP	2020-04-07	STRONGBUY	114.350
IPGP	2020-04-06	HOLD	113.950
IPGP	2020-04-03	STRONGBUY	102.740
IPGP	2020-04-02	STRONGBUY	102.920
IPGP	2020-04-01	STRONGBUY	105.800
IPGP	2020-03-31	HOLD	110.280
CSOD	2020-04-28	MEDIUMBUY	32.550
CSOD	2020-04-27	MEDIUMBUY	31.590
CSOD	2020-04-24	MEDIUMBUY	30.690
CSOD	2020-04-23	MEDIUMBUY	30.050
CSOD	2020-04-22	STRONGBUY	29.620
CSOD	2020-04-21	STRONGBUY	29.610
CSOD	2020-04-20	STRONGBUY	29.760
CSOD	2020-04-17	STRONGBUY	29.920
CSOD	2020-04-16	STRONGBUY	29.070
CSOD	2020-04-15	STRONGBUY	29.570
CSOD	2020-04-14	STRONGBUY	31.700
CSOD	2020-04-13	STRONGBUY	31.050
CSOD	2020-04-09	MEDIUMBUY	31.560
CSOD	2020-04-08	MEDIUMBUY	30.495
CSOD	2020-04-07	STRONGBUY	29.600
CSOD	2020-04-06	MEDIUMBUY	30.200
CSOD	2020-04-03	MEDIUMBUY	28.280
CSOD	2020-04-02	MEDIUMBUY	29.120
CSOD	2020-04-01	MEDIUMBUY	29.860
CSOD	2020-03-31	MEDIUMBUY	31.750
CTRP	2020-04-28	STRONGBUY	24.470
CTRP	2020-04-27	STRONGBUY	24.440
CTRP	2020-04-24	STRONGBUY	23.780
CTRP	2020-04-23	STRONGBUY	23.700
CTRP	2020-04-22	STRONGBUY	23.000
CTRP	2020-04-21	STRONGBUY	23.250
CTRP	2020-04-20	WEAKBUY	23.660
CTRP	2020-04-17	WEAKBUY	23.850
CTRP	2020-04-16	WEAKBUY	23.240
CTRP	2020-04-15	WEAKBUY	23.470
CTRP	2020-04-14	WEAKBUY	23.860
CTRP	2020-04-13	HOLD	24.050
CTRP	2020-04-09	HOLD	24.820
CTRP	2020-04-08	HOLD	24.510
CTRP	2020-04-07	HOLD	24.430
CTRP	2020-04-06	WEAKBUY	23.450
CTRP	2020-04-03	MEDIUMBUY	22.010
CTRP	2020-04-02	HOLD	22.360
CTRP	2020-04-01	HOLD	22.150
CTRP	2020-03-31	HOLD	23.450
MRNA	2020-04-28	STRONGBUY	47.880
MRNA	2020-04-27	STRONGBUY	48.050
MRNA	2020-04-24	STRONGBUY	50.500
MRNA	2020-04-23	STRONGBUY	47.440
MRNA	2020-04-22	STRONGBUY	51.200
MRNA	2020-04-21	STRONGBUY	49.260
MRNA	2020-04-20	WEAKSELL	51.690
MRNA	2020-04-17	WEAKSELL	46.850
MRNA	2020-04-16	WEAKSELL	40.600	155.35	202
MRNA	2020-04-15	STRONGBUY	37.250
MRNA	2020-04-14	STRONGBUY	34.660
MRNA	2020-04-13	STRONGBUY	32.900
MRNA	2020-04-09	STRONGBUY	31.860
MRNA	2020-04-08	STRONGBUY	32.420
MRNA	2020-04-07	STRONGBUY	32.020
MRNA	2020-04-06	STRONGBUY	34.640
MRNA	2020-04-03	STRONGBUY	34.840
MRNA	2020-04-02	STRONGBUY	33.200
MRNA	2020-04-01	STRONGBUY	29.670
MRNA	2020-03-31	STRONGBUY	29.950
FEYE	2020-04-28	HOLD	11.420
FEYE	2020-04-27	HOLD	11.520
FEYE	2020-04-24	HOLD	11.260
FEYE	2020-04-23	WEAKBUY	10.950
FEYE	2020-04-22	WEAKBUY	10.660
FEYE	2020-04-21	WEAKBUY	10.560
FEYE	2020-04-20	WEAKBUY	10.875
FEYE	2020-04-17	WEAKBUY	10.800
FEYE	2020-04-16	WEAKBUY	10.780
FEYE	2020-04-15	WEAKBUY	10.410
FEYE	2020-04-14	HOLD	10.870
FEYE	2020-04-13	WEAKBUY	10.700
FEYE	2020-04-09	STRONGBUY	10.660
FEYE	2020-04-08	WEAKBUY	10.410
FEYE	2020-04-07	STRONGBUY	9.890
FEYE	2020-04-06	STRONGBUY	10.060
FEYE	2020-04-03	STRONGBUY	9.320
FEYE	2020-04-02	STRONGBUY	9.900
FEYE	2020-04-01	STRONGBUY	9.870
FEYE	2020-03-31	WEAKSELL	10.580
UVXY	2020-04-28	STRONGBUY	44.180
UVXY	2020-04-27	STRONGBUY	43.100
UVXY	2020-04-24	STRONGBUY	48.700
UVXY	2020-04-23	STRONGBUY	53.100
UVXY	2020-04-22	STRONGBUY	53.380
UVXY	2020-04-21	STRONGBUY	57.440
UVXY	2020-04-20	STRONGBUY	51.260
UVXY	2020-04-17	STRONGBUY	44.650
UVXY	2020-04-16	STRONGBUY	47.530
UVXY	2020-04-15	STRONGBUY	47.220
UVXY	2020-04-14	STRONGBUY	42.100
UVXY	2020-04-13	STRONGBUY	47.800
UVXY	2020-04-09	STRONGBUY	49.470
UVXY	2020-04-08	STRONGBUY	50.960
UVXY	2020-04-07	STRONGBUY	52.700
UVXY	2020-04-06	STRONGBUY	50.600
UVXY	2020-04-03	STRONGBUY	56.590
UVXY	2020-04-02	STRONGBUY	60.410
UVXY	2020-04-01	STRONGBUY	65.930
UVXY	2020-03-31	STRONGBUY	58.560

Sells:

You must be logged in to view this content.
Log In

Thanks for subscribing and happy investing!

The Third Perspective Team

Reuters

White House official warns of negative shocks before rebound…

April 29, 2020
by admin

WASHINGTON (Reuters) – Top Trump adminstration officials on Tuesday predicted a strong economic rebound in the fourth quarter as the coronavirus fades, but a senior White House adviser warned that near-term unemployment and GDP data will be a “very grave” negative shock.

FILE PHOTO: White House Council of Economic Advisers Chairman Kevin Hassett addresses reporters during the daily briefing at the White House in Washington, U.S. February 22, 2018. REUTERS/Jonathan Ernst

Kevin Hassett, senior economic adviser to President Donald Trump told CNN that unemployment could reach 16-20%, and GDP output could fall as much as 30-40% on annualized basis in the second quarter, a prediction in line with Wall Street and Congressional Budget Office forecasts.

“I’m just saying that we’re going to have the biggest shock since the Great Depression,” Hassett told reporters at the White House. “It’s a very grave shock and something we need to take seriously.”

He added that the first quarter GDP growth number being released on Wednesday would likely be negative, telling CNN that this “will be just the very tip of the iceberg of a few months of negative news that’s unlike anything you’ve ever seen.”

Earlier, U.S. Treasury Secretary Steven Mnuchin predicted that the economy could rebound by late summer as states allow the reopening of businesses that have been closed to slow the spread of the coronavirus.

“As states start opening up, I think you’re going to see a lot of demand come back,” Mnuchin told Fox Business Network. “Now again, the states are going to open up slowly, so you’re going to see June and July pick up, but I think by August and September, you’re going to see a big bounce back from what has been a very rocky period.”

Trump, at a White House event on Tuesday, also shifted the focus away from the near term, saying that the fourth quarter “is going to be really strong and I think next year is going to be a tremendous year.”

“The third quarter is a transition quarter. The second quarter is what it is,” Trump added.

Hassett said that a “prudent” fourth coronavirus rescue bill would be important to securing strong growth later in the year.

In a current program aimed at keeping small business workers from being laid off, Mnuchin said the Treasury will audit all larger loans over $2 million and warned that companies could face criminal liability if it turns out they did not truly need the money.

“Anybody that took the money that they shouldn’t have taken — one, it won’t be forgiven, and two, they may be subject to criminal liability, which is a big deal,” Mnuchin told Fox Business.

Mnuchin’s comments came as more public companies and better-financed entities have decided to return funds or forego their loan allocations after the Treasury put out new guidance last week excluding well-financed publicly traded companies from the forgivable loans meant to fund payrolls and other expenses during virus-related closures.

On Monday, the Los Angeles Lakers basketball team returned a $4.6 million loan it received through the program. Mnuchin told Fox Business Network he was “outraged” by the Lakers’ request even though he was a fan of the top NBA team.

After running out of funds in less than two weeks, the Paycheck Protection Program was relaunched on Monday with an additional $310 billion appropriated by Congress, but suffered technical glitches. Mnuchin said that these had largely been fixed on Tuesday.

Reporting by David Lawder and Susan Heavey; Editing by Chizu Nomiyama

Our Standards:The Thomson Reuters Trust Principles.

Source

SeekingAlpha

Akamai Technologies, Inc. (AKAM) CEO Tom Leighton on Q1…

April 29, 2020
by admin

Akamai Technologies, Inc. (NASDAQ:AKAM) Q1 2020 Results Conference Call April 28, 2020 4:30 PM ET

Company Participants

Tom Barth – Head, IR

Tom Leighton – CEO

Ed McGowan – CFO

Conference Call Participants

Will Power – Baird

Keith Weiss – Morgan Stanley

James Fish – Piper Sandler

Sterling Auty – JP Morgan

Caroline Liu – Goldman Sachs

James Breen – William Blair

Michael Turits – Raymond James

Tim Horan – Oppenheimer

Colby Synesael – Cowen

Rishi Jaluria – D.A. Davidson

Lee Krowl – B. Riley

Jeff Van Rhee – Craig-Hallum

Brandon Nispel – KeyBanc Capital Markets

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the First Quarter 2020 Akamai Technologies, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]

It is now my pleasure to introduce Head of Investor Relations, Tom Barth.

Tom Barth

Thank you, operator. Good afternoon, everyone. And thank you for joining Akamai’s First Quarter 2020 Earnings Conference Call. Speaking today will be Tom Leighton, Akamai’s Chief Executive Officer; and Ed McGowan, Akamai’s Chief Financial Officer.

Before we get started, please note that today’s comments include forward-looking statements including statements regarding revenue and earnings guidance. These forward-looking statements are subject to risks and uncertainties and involve a number of factors that could cause actual results to differ material from those expressed or implied by such statements.

Additional information concerning these factors is contained in Akamai’s filings with the SEC, including our annual report on Form 10-K and quarterly reports on Form 10-Q. The forward-looking statements included in this call represent the Company’s view on April 28, 2020. Akamai disclaims any obligation to update these statements to reflect future events or circumstances.

As a reminder, we will be referring to some non-GAAP financial metrics during today’s call. A detailed reconciliation of GAAP and non-GAAP metrics can be found under the financial portion of the Investor Relations section at akamai.com.

And with that, let me turn the call over to Tom.

Tom Leighton

Thanks, Tom. And thank you all for joining us today.

Before I get into the numbers, I want to acknowledge how much the world has been disrupted by the COVID-19 pandemic. All of our lives have been impacted in ways that would have been hard to imagine only a short while ago.

At Akamai, our primary concern is for the health and safety of our employees, their loved ones, our customers and partners, and the communities where we work and live. Fortunately, we’re in a position where almost all of our employees can work remotely, and we’ve been doing that successfully for the last two months.

We’ve also implemented special measures to protect employees who need to travel, for example, to a data or operation center. And we’re doing what we can to help employees to face especially challenging situations as a result of the pandemic.

As businesses and consumers around the globe adjust their routines in the interest of public health, the internet is being used at a scale that the world has never experienced. In addition to the hundreds of millions of people who’ve been working from home, governments are leveraging the internet to keep citizens informed and to provide economic assistance. Houses of worship are streaming services and communities are engaging online to relieve the social isolation felt by many. And of course, education, commerce and entertainment are now almost entirely online.

As much of the world hunkers down in place, Akamai is continuing to work behind the scenes to keep the internet functioning as a lifeline for organizations and people everywhere. I’ll talk more in a minute about Akamai’s unique role during the pandemic and the impact of the pandemic on our business. But first, I’ll review our Q1 financial performance.

I’m pleased to report that Akamai had a very strong first quarter on both the top and bottom lines. Revenue was $764 million, up 8% year-over-year and up 9% in constant currency. Non-GAAP operating margin in Q1 was 30%, up 1 point over Q4 and consistent with Q1 of last year. Non-GAAP EPS in Q1 was $1.20 per diluted share, up 9% year-over-year and up 11% in constant currency.

These excellent results were driven by the continued strong performance of our security solutions, greater than expected traffic levels, and by our continued focus on operational efficiency. As more business is conducted over the internet, the ability to scale becomes critical. And when it comes to scale, Akamai is the clear leader.

Traffic on our platform increased dramatically in March as enterprises turned to Akamai to move more of their operations online. Despite the cancellation or postponement of major sporting events, like March Madness, and Champions League Soccer, our traffic increased by about 30% over a four-week period at the end of Q1. Traffic reached a peak of 167 terabits per second, which was more than double the peak of the first quarter of 2019.

We’re very pleased that the capacity we added to the platform last year has enabled us to help our customers, when they need us most. We’re also making a big difference when it comes to helping the major carriers handle the explosion in demand. That’s because we’ve deployed our infrastructure deep into carrier networks and close to end users, thereby offloading an enormous amount of traffic that would otherwise congest core backbones and routers.

Of course, performance is also critical as businesses move the majority of their operations online. Although some other companies have experienced cases of performance degradation and even extended outages in recent months, I’m very happy to report that Akamai’s performance has remained consistent and strong over the past quarter. In fact, our measurements indicate that the page download times provided by our industry leading Ion service has significantly improved over the past year. This is in spite of the large increase in traffic, and is a direct result of our relentless efforts to improve the performance of our services. Akamai is also helping to protect many of the world’s major enterprises as more employees work from home and as IT departments increase their focus on business continuity. We believe that Akamai’s market leading security services are needed now more than ever, as attackers take advantage of the pandemic to ramp up their exploits on enterprises across all verticals.

In Q1, our cloud-based security portfolio generated $240 million in revenue, up 28% year-over-year in constant currency. Sales continue to be led by our flagship services for DDoS prevention, application-layer firewall and bot management. We also saw a strong surge in bookings for our next-gen Zero Trust enterprise security solutions.

The strong demand we saw in Q1 for our security and media services more than offset the reduced revenue we received from companies that have been hit hardest by the pandemic, especially in the travel and hospitality vertical. Where appropriate, we are modifying the terms of these customers’ contracts to provide them some relief and flexibility, often in return for extended contract line. We value our customers and want them to think of Akamai as a supportive and reliable partner for the long run. We are fortunate that our financial strength enables us to provide assistance to customers in need, which we believe will benefit our shareholders and the global economy over the long term.

We’ve also played an important role in helping to support websites and applications associated with response to the pandemic. And the Akamai Foundation is providing sustainable financial assistance for numerous relief efforts around the world.

Most of all today, I want to recognize and thank our nearly 7,800 employees for working so hard to serve the thousands of organizations and billions of internet users who rely on us during these very-challenging times. I couldn’t be proud of the way that our people have stepped up and of what they’re managing to accomplish, despite their own personal challenges and dealing with a pandemic. Their spirit and leadership during a time of crisis is a key part of what makes Akamai such a unique and strong company.

Lastly, I want to offer a warm welcome to our Board’s newest member, Marianne Brown. Marianne joined Akamai’s Board last month and brings with her extensive financial and operational expertise, as well as valuable leadership experience with global technology-driven companies.

I’ll now turn the call over to Ed for more details on our Q1 performance and our outlook for Q2. Ed?

Ed McGowan

Thank you, Tom.

Before I begin, I would also like to thank our fellow employees for their amazing work and dedication. And I would like to acknowledge our customers and partners, especially those who have been hardest hit by the global pandemic.

Today, I plan to review our Q1 results, discuss the impact the pandemic is having on our business and provide Q2 guidance and an update on the full year.

As Tom mentioned, we delivered a very strong quarter on both the top and bottom line. Q1 revenue was $764 million, up 8% year-over-year or 9% in constant currency, driven by a significant increase of global traffic, as well as continued strong growth across our security portfolio.

Revenue from our Media and Carrier division was $358 million, up 8% year-over-year and 9% in constant currency. The outperformance in media was primarily due to the surge in traffic from OTT video, gaming, social media and news and information sites as more and more people around the world began to shelter in place.

Revenue from our internet platform customers was $45 million, in line with our expectations. Revenue from our Web division was $406 million, up 8% year-over-year and 10% in constant currency. Revenue growth for this group of customers was again driven by our security business.

Moving on to revenue by geography. International revenue was $335 million, up 16% year-over-year or 19% in constant currency. We continue to see very strong international growth, especially in APJ.

Foreign exchange fluctuations had a negative $3 million impact to revenue on a sequential basis and had a negative $7 million impact on a year-over-year basis. Sales in our international markets represented 44% of total revenue in Q1, up 3 points from Q1 2019 and up 2 points from Q4 level. Revenue from our U.S. markets was $429 million, up 3% year-over-year.

Moving on to costs. Cash gross margin was 77%, consistent with our expectations. GAAP gross margins, which includes both depreciation and stock-based compensation, was 65%, down a point from Q1 of last year.

Non-GAAP cash operating expenses were $260 million, in line with expectations. Adjusted EBITDA was $327 million, up $8 million from Q4 and up 9% in the same period in 2019. Our adjusted EBITDA margin was 43%, up 2 points from Q4 and up 1 point from Q1 of 2019.

Non-GAAP operating income was $230 million, up $8 million from Q4 levels and up $20 million or 9% from the same period last year. Non-GAAP operating margin was 30%, up 1 point from Q4 levels and consistent with Q1 of last year.

Capital expenditures in Q1, excluding equity compensation and capitalized interest expense were $136 million. This was lower than our guidance range, given some pandemic-related supply chain disruptions and travel restrictions that delayed some planned network buildup. However, thanks in part to the capacity work we undertook in 2019, we are very pleased that we’ve been able to maintain network resiliency during this virus outbreak.

Moving on to earnings. GAAP net income for the first quarter was $123 million or $0.75 cents of earnings per diluted share. This included a restructuring charge of about $11 million associated with the prior actions I mentioned on our last quarterly call. We did not take any new restructuring actions during Q1.

Non-GAAP net income was $196 million or $1.20 of earnings per diluted share, up 9% year-over-year, up 11% in constant currency, and $0.02 above the high end of our guidance range, due to higher than expected revenue in the quarter.

Taxes included in our non-GAAP earnings were $35 million based on a Q1 effective tax rate of 15%. This was slightly better than we expected, due to stronger than expected growth outside the U.S.

Now, I will turn to some balance sheet items. We believe that our balance sheet is strong. We anticipate that we can maintain this position in the face of the current economic uncertainty. As of March 31st, our cash, cash equivalents and marketable securities totaled $2.2 billion. Our total debt at the end of Q1 remained unchanged at $2.3 billion. As a reminder, our debt is comprised of two convertible notes with par values of $1.15 billion each and maturity in 2025 and 2027, respectively.

Now, I will review our use of capital. During the first quarter, we spent $81 million to repurchase shares, buying back approximately 900,000 shares. We have approximately $750 million remaining on our previously announced share repurchase authorization. We plan to continue to leverage our share buyback program to offset dilution, resulting from equity compensation over time and subject to global financial conditions. In summary, we are very pleased with our Q1 results.

Given these uncertain times and with the increased volatility we are seeing in global markets, I thought it would be helpful to provide some additional context on the impact that the recent elevated traffic levels may have on our media division and the negative impact the pandemic may have on some key verticals in our Web division.

First, as Tom mentioned, with many countries around the world issuing shelter-in-place orders, we have seen a dramatic increase in media traffic across our platform. We expect this elevated traffic to continue to have a positive impact on our Q2 results. However, we anticipate that traffic levels may start to moderate if life begins return to normal, and as the warmer summer months get underway in our larger markets.

As an aside, some of you may be wondering about live sports. As a reminder, no individual live event has a significant impact on our results. And to-date, the stronger traffic from shelter-in-place orders has more than offset the impact of live sports cancellations and postponements.

Moving now to our Web division. There are two verticals notably impacted by the global pandemic, travel and hospitality, and commerce and retail. Travel and hospitality vertical accounted for roughly 4% of total Akamai revenue in Q1. This vertical is comprised of over 200 customers globally, including some of the largest airlines, hotels, cruise lines and travel-related sites. Most of these customers have seen sharp declines in demand. The trend is expected to continue throughout 2020.

Our commerce and retail vertical is an area we have highlighted for some time as being under financial pressure. This vertical includes more than 900 customers globally and represents approximately 16% of Akamai’s total revenue. So, while we have seen a recent traffic uptick with some customers, other customers are struggling, especially those that rely heavily on brick and mortar operations. We believe they could become increasingly challenged, the longer the shelter-in-place orders continue.

As Tom mentioned, we have already begun to work with many of our customers whose businesses have been impacted by the pandemic. Q1 was negatively impacted by approximately $5 million due to a combination of contract restructurings and elevated bad debt reserves. Although it is difficult for us to project the total impact, we do expect to incur additional charges in the coming quarters, if the economy continues to suffer.

I’d now like to provide our outlook for the second quarter. We are projecting Q2 revenue in the range of $752 million to $778 million, or up 6% to 12% in constant currency over Q2 2019. Given the COVID-related impacts on the business I just discussed, we expect to see continued sequential growth in our media division and a slight decline sequentially on our Web division is Q2.

At current spot rates, foreign exchange is expected to have a negative $7 million impact on Q2 revenue compared to Q1 levels and have a negative $11 million impact on a year-over-year basis. At these revenue levels, we expect cash gross margins of approximately 76%. Q2 non-GAAP operating expenses are projected to be $252 million to $260 million. Factoring in the cash gross margin and operating expense expectations I just provided, we anticipate Q2 EBITDA margins of approximately 43%.

Moving now to depreciation. We expect non-GAAP depreciation expense to be between $98 million to $101 million. We expect non-GAAP operating margins of approximately 30% for Q2.

Moving on to CapEx. We expect to spend approximately $186 million to $206 million, excluding equity compensation in the second quarter. This assumes there’s not a significant change in the overall economic environment and that we will catch up on our CapEx spend for the first half of 2020 in Q2. With the overall revenue and spend configuration I just outlined, we expect Q2 non-GAAP EPS in the range of $1.18 to $1.24, or up 14% to 20% in constant currency. This EPS guidance assumes taxes of approximately $34 million to $36 million, based on an estimated quarterly non-GAAP tax rate of approximately 15%. It also reflects a fully diluted share count of proximately 164 million shares.

As our Q1 results and Q2 guidance demonstrate, we are optimistic about the continued strength of our business, even in the light of the pandemic. As you’re seeing from other companies reporting, however, it has become much more challenging to predict economic conditions, resulting customer impacts in the second half of the year. As a result of this uncertainty, especially as it relates to the holiday shopping season in Q4, we are withdrawing full year 2020 guidance at this time. We plan to reassess providing annual guidance next quarter as we gain additional insights into the direction of the global economy.

We’re very thankful for the resiliency of our employees, the diversification of our revenue, the strength of our customer relationships and our strong balance sheet. We believe we are well-positioned to continue to help our customers during this very difficult time by providing them with the best and most secure digital experiences around the world.

Thank you. Tom and I would be happy to take your questions. Operator?

Question-and-Answer Session

Operator

Thank you. [Operator Instructions] Our first question comes from the line of Will Power with Baird.

Will Power

Great. Okay. Thank you for taking the question. Well, I guess first, I hope everyone in Akamai team is staying as a healthy and safe as possible. Maybe two quick questions, if I can. First, would love to get more granularity if possible on the sources of strength in media? Maybe just trying to understand, the strength in OTT video versus gaming, if there’s any way to kind of rank order what you’re seeing there?

Then, the second question is on security, given the uncertain climate and questions on IT budgets. Maybe just talk about how you’re thinking about security growth going forward and what you’re seeing in terms of potential lengthened sales cycles versus the need for work-at-home capabilities.

Ed McGowan

Yes, sure. I’ll take the first one, Tom, and maybe you take the second one. So, the strength in media really came, like I mentioned in the earlier remarks, we really saw strength across several different sub verticals in media, probably the largest would be in OTT video. It also was a very, very strong gaming quarter, especially in March. And really, we saw a significant uptake in traffic over the last couple of weeks of March. And as the shelter-in-place orders came around the world as we got to places like Europe, India, and the U.S., we really saw a dramatic increase. So, there’s pretty much strength across the board and really across the globe as well.

Tom Leighton

Yes. And first, thanks for the concern about Akamai employees. And I’m happy to report that by and large, we’re all doing well. In terms of the question on security growth, it’s looking very strong. And partly, that’s because the attackers aren’t held back by the pandemic or working remotely. In fact, we’ve seen a substantial increase in attack activity. And, perhaps — that perhaps they’re doing that because they know IT managers have a lot of other things that they got to worry about in terms of supporting their workforce remotely that increases vulnerabilities. And so, it’s really a perfect storm for the attackers to run their exploits. And we have products that are really well-designed to help major enterprises deal with that, both for securing their websites and apps and also for securing access for their employees who are now remote, all of a sudden. And so, we’ve seen a very strong uptick in bookings for enterprise security products. And I guess, the last point there is, our customer base is the world’s major enterprises. And they’re going to fare better than most through the pandemic. And we have very good relationships. And so, we’re in a better position to provide them with the new security capabilities or the increased capacity that they’re going to need for the security products.

So, on balance, I think the security business is looking very strong. And of course, we’re all hoping that the global recession doesn’t really deepen or persist for a long time.

Will Power

Great, thank you.

Operator

Thank you. And our next question comes from line of Keith Weiss with Morgan Stanley.

Keith Weiss

Thank you, guys, for taking the question and very nice quarter. So, two questions, one on — as we think about Q2, any quantification you could give us in terms of kind of the puts and takes, and particularly on sort of the drags of having to reprice some of those contracts — or I’m assuming reprice, having to amend some of those contracts on the performance side of the equation? Any sense you could give us and just like what kind of impact that has on Q2? And then, on the flip side of the equation, is it possible to quantify kind of the — your expectation for how well this sort of up traffic is going sustain into Q2, like how much of that did you actually put into the guide on a go forward basis?

Ed McGowan

Sure. Hey, Keith. It’s Ed. So, let’s start with the Web division. Obviously, what I tried to do was call on a couple of verticals that our customers are experiencing some significant challenges. So, we’re dealing with those on a case by case basis. And in the prepared remarks, I talked a little bit about how we expect to see a slight — sequential decline in the web business. And really what that’s all about is a couple of things that we have to take into consideration.

In some cases, the customers will come direct to us and ask us if there’s anything we can do to help them during this period of time where there’s a lot of uncertainty. In some cases, we’ll amend contracts and we’ll get something in exchange for that. In other cases, we have to assess the ability of the customer to pay us. And so, there’s some customers in particular in certain geographic areas of the country that we’re more concerned about. And if you don’t have — if you have any concern about the customers’ ability to pay, you have to reserve that revenue. So, the combination of that is going on.

I am encouraged to see that the capital markets have been open. And we’ve seen a number of customers that have been able to secure funding. There’s obviously availability with certain government bailout programs and things like that. But, it is an area that we’re keeping a close eye on. And then, obviously, bankruptcies are another possibility.

So, what we did is, we did — ran a number of different scenarios. And we assumed that we would continue to see additional pressure in the web business and we would see a slight decline. Obviously, this is out of control — out of our control, in terms of what’s going to happen with this pandemic and also out of the control of our customers in many ways.

So, then, on the media side, we assume that this continued strong traffic growth that we saw in March to continue throughout most of the quarter. We made an assumption that in June that we may see a slight decline in the traffic as things hopefully start to get back to normal and the warmer months start to hit. We’ve seen a pretty strong traffic growth here in April.

Keith Weiss

Got it. And just in terms of the nature of the contract negotiations, is it more on billing terms, or does actual pricing change? Give us some color on to what you’re willing to give to your customers and is there anything kind of out of bounds in what you’re not willing to do in terms of contract amendments?

Ed McGowan

Yes, sure. I mean, you take it case by case, we always take the long term view a lot of these customers have been with us for 15 or 20 years. And they certainly take the travel and hospitality vertical. That was a vertical that I never worried about. It’s a — made up of fantastic, amazing companies. They have been always pay on time. They’re usually folks that are early adopters of our new solutions, et cetera. But obviously, they just saw demand evaporate here in the second quarter — excuse me, in the first quarter. So, we work with them. Sometimes it could be you enter into a zero overage contract. A lot of customers are asking for extended terms and payments. So, we have to take that into consideration. Sometimes it’s some credit relief, but we do it case-by-case. So, far the customers have been pretty reasonable in terms of their RASK. There haven’t been things that have been completely outrageous so far.

Operator

And our next question comes from the line of James Fish with Piper Sandler.

James Fish

I just want to double click on Will’s question. What are you guys seeing thus far with the security solutions with work-from-home, specifically more about that new cloud, web gateway or security solution and the EAA product?

Tom Leighton

Yes. So, strong bookings there. Now, the secure web gateway is just now available in beta and as part of our Enterprise Threat Protector solution, version 3.0. And I think that really increases the strength of the offer. Where we’re seeing a lot of the bookings now is an Enterprise Application Access. And you think of that as the VPN replacement, think of that as a thing that lets all your employees who used to just log in, in a physical building now have to do it from home and you need to secure them and you need to scale that overnight. And so, I think that’s why we’re seeing a real uptake there. And in general, I think, these are the solutions of the future for enterprise security. They enable the zero trust model, they are much more secure within the traditional solutions that enterprises have been using now for decades and can put a big dent in enterprise data breaches in the future.

James Fish

And then, on the media side, I mean, one of your peers and in that space get the share loss of some of the streaming services. Were you guys able to capture some of that share, given the Akamai network size or did you see any specific media share gains with some of newer OTT services?

Ed McGowan

Yes. So, that’s a great question. We did — one of the things that has been a bit of a challenge in the industry is that there’s been a surge of demand, so capacity becomes a bigger component of the equation. And along with that comes performance. So, in some cases, we’ve seen pretty nice share gains across the board. So, we’ve been very happy with that in Q1.

Operator

Thank you. And our next question comes from the line of Sterling Auty with JP Morgan.

Sterling Auty

You mentioned in your prepared remarks that no single live sporting event is a meaningful part of revenue. But, I think you’ve talked in the past that things like the Olympics and World Cup that span a couple of weeks are more meaningful. So, I’m wondering how you quantified or how you gauged the potential for a fade off in traffic in June, versus the loss of the Olympics this year, within the guide and what we should be thinking as we go into the back half of the year?

Ed McGowan

So, I’ll get into a little bit of detail on this one, just to try to help you guys out. So, we did talk about there’s no individual events is material. Take the Olympics for example. When you think about the Olympics, there’s obviously the direct right holders, there’s the web traffic that can sometimes go along with an event of that size, the travel and news, and things like that. And then there’s also live television. We’ve got several folks that show live television. And then obviously, the duration of the streaming is what really matters. We do web delivery, we do services, we do security, et cetera. But it’s really the length of the streaming. An event like that could be, let’s call it, the $3 million to $5 million range, maybe a few million on a really good year. If I think about live sports in general, it’s probably a little over 1% of our total revenue throughout the year. So, right now, you see in Q1, we certainly more than offset the lack of live sports, and we expect that to happen in Q2.

So, in terms of what we’ve built into our guides, we’re assuming that live sports is not fully back up and running and that what we’re seeing from the OTT and other gaming and other sub verticals will more than offset that in Q2.

Sterling Auty

That’s great transparency. Thank you for that. And then, on the security side, can you give us a sense of where the strength is coming from, from this aspect? How much of that strength in spending is new customers coming onto the platform versus existing customers, either taking more product, or existing customers just paying more because of either some sort of volume commitment on any of this or just help peel back the onion a bit on the contributions from the growth in security?

Ed McGowan

Yes, sure. Good question, Sterling. So, first of all, I’ll take it from a couple of lenses. I’ll start off with the product side. So, we saw great strength with strength with Bot Man, KSD services, and EAA and ETP, albeit a bit smaller, good uptake of multiple solutions. And I’ve provided this metric before in terms of the number of customers that have purchased a security product for up to 57% now, up from 55% last quarter. So, we’re seeing good uptake in the installed base and growing there. And also, customers taking on more than one product, customer buying two or more, up to about 29%, that’s up 1 point from last quarter as well. So, doing well with the installed base.

In terms of bookings, we’re seeing new customer bookings, again being led by security. And, again, so you see this stuff in your installed base. And we’re also very excited about page integrity. We came up with our limited availability page integrity. We signed a number of customers this quarter and expect to continue to do that throughout the year. Tom mentioned secure web gateway, which is up in beta now and then obviously enterprise has got a long way to go there.

Operator

Thank you. And our next question comes from the line of Heather Bellini with Goldman Sachs.

Caroline Liu

Hi. This is Caroline on for Heather. First off, I do want to echo the comments that my colleagues on the line have already made. I do hope that you and your families are staying safe and healthy. First off, I wanted to dive a little bit more into the comments that you made about OTT. I’m curious, how has the OTT demand environment trended relative to your expectations, or I guess, put another way, how much of the OTT strength would you characterize as due to the new launches, the share gains versus the general increase in user traffic that was driven by the shelter-in-place orders?

Ed McGowan

Yes. Good question. And this is one that I challenged my team to come up with a number. And it’s a little difficult. Times like this tend to self-accelerate trends you see in the market and OTT growth being one and obviously cord-cutting being another. And in March is when we really saw a big uptick in traffic. So, there’s no doubt that the shelter-in-place really drove a lot of traffic. But we also had a major customer launch a new service over in EMEA. And we had our own models about what we expected. And I would say, we did a little bit better, could be because of the shelter-in-place. But, I’d say, it’s kind of a combination of both the shelter-in-place, but also, we had — we took some share in some places as well, like I talked about earlier, we have capacity in a lot of places where it really matters, we’re able to outperform some of our competitors in certain areas. So, it’s sort of a combination of everything, but I would say that, shelter-in-place certainly did help accelerate the trend that we’re seeing in the market.

Caroline Liu

Got it. And can you talk through what the demand was like, sort of in the last two weeks of March? And what are you seeing now, especially in areas like APJ where some of the countries have sort of relaxed the shelter-in-place orders and people are starting to return back to their workplaces?

Tom Leighton

Yes. The demand increased steadily through March and total traffic increasing from March to April. And you can see, as countries went into shelter-in-place, you see the traffic increased. And I think most of the world is, at least the traffic wise is still in that condition of being high. And as we look forward, we may see more normal growth from here, depending, as Ed said, on live events and OTT launches and so forth. So, APJ, I would say also very strong. And as you know, a lot of our — got a lot of strong growth there.

Caroline Liu

Got it. Thank you so much.

Operator

Thank you. And our next question comes from the line of James Breen with William Blair.

James Breen

Thanks for taking the questions. Just on the CapEx side, you talked about a little bit delay and sort of the expansion that you had, you were prepared for just because some of the build out you did at the end of last year. Is there any concern about those delays continuing and the ability to sort of meet demand from a customer side, as we go forward here?

Tom Leighton

Yes. We think we’re past the delays. We did have about 90 days of delay on delivery of a bunch of servers, but we’ve had plenty of capacity. And as you can tell by hitting a peak, which is really what the CapEx governs of doubling year-over-year. And at this point, we think we’re in very good shape, with the supply lines and getting the full capacity we want for the rest of the year.

We have the tax in all the cities where we need to do that. We do the installation. And we have the approvals from pretty much all the major governments that our folks can move around, even where it’s a very strict lockdown, just because we’re such a critical resource in countries around the world. So, we’re optimistic, as Ed said, on being able to continue to deploy capacity and to stay ahead of the demand.

James Breen

Great. Thank you.

Operator

Thank you. And our next question comes from the line of Michael Turits with Raymond James.

Michael Turits

With you guys withdrawing guidance, as I think through your different segments, I’d like to just try to focus on which are the ones that provide that uncertainty. Because it sounds like CDN is strong now. And really, it worst, at least on the media side at worst, come back to the level it was at. Security, it doesn’t sound like you think there’s some uncertainty that’s macro related, but perhaps there isn’t. And you can tell me if you think there is. So, we’re left with ecommerce and around travel and retail. So, am I right, Ed that that’s really the reason why we have an uncertainty that caused you to pull guidance in that segment?

Ed McGowan

Yes. I mean, obviously, we hated to do that, as we ran our scenarios, there is so much that’s out of our control and really impacts our customers. For example, if you run into a second flare-up against in the fall and get into another round of shelter-in-place, how does that impact our customers business, especially in the Web division? Obviously we would be bullish for the media division because we’d see those elevated traffic levels. But on the website, it could be considerable. And what’s the consumer going to do, how is the consumer going to behave? And with Q4 being a very strong seasonal quarter for us, you can imagine, as you run through a number of scenarios, your range just gets really wide. And we just didn’t think it would be helpful. And that’s why we provided some additional color, so, you guys can run your models by giving you some size, relative size and number of customers, et cetera. That’s really what’s driving, Michael, is just the uncertainty around those Web division customers and more, in particular to what’s happening with the virus. There’s just so much that’s out of all of our controls, and including capital markets. Who knows in the second round right now, it’s good to see some of our customers getting funding, but that may close down at the second round happens, and elevated bankruptcies, consumers may not be spending, may not be travelling. So, it’s not something that we’re experts in and we wanted to give it more time to get some more color rather than providing something we thought was unhelpful.

Michael Turits

And then, if I think about CDN as a division, obviously the only thing you’ve guided to is 2Q. But, CDN is made up of both the media side as well as the website. So, do you think that it is enough in traffic to give you an offset to both, live sports and to web that you can see growth in the CDN business year-over-year next quarter?

Ed McGowan

So, in Q2, yes, I would say right now there’s a good chance that we could see the strength medium, no more than offset live sports and potentially the impact on Web. Right now, we have 60 days to go. And you never know what’s going to happen here in the last 60 days, whether it gives you a larger than normal range, but it is possible and I wouldn’t be surprised if we saw CDN growth here in Q2.

Operator

Thank you. And your next question comes from the line of Tim Horan with Oppenheimer.

Tim Horan

Tom, could you maybe step back a second and I can talk about what you kind of expect for a secular shifts in internet usage and trends and maybe how COVID here might change what you guys are doing, your strategy, if at all or, maybe other areas that you might want to invest in as a result of all this? And then, just a quick follow up on security. On the bookings, can you give us maybe just some comparisons of past quarter? Is it like well — 10 points and above trend that you’ve seen the last few years or any kind of color around that would be great? Thanks.

Tom Leighton

Yes. In terms of the secular shift, I think there’s a reasonable prospect that there will be much more use of the internet coming out of this permanently than there was going in. And in many areas, you look at ecommerce and traditionally that was — the penetration of ecommerce and commerce as a whole has grown about 2% of the year and low to mid teens and pretty much now the large majority of commerce is online. And after people get used to doing that for an extended period, a lot of that share gain may become permanent. That’s really good for Akamai.

If you look at media, and movie releases being done online, a lot of consumption now moving online. And that may become permanent, a lot of that as well. You look at work from home, there wasn’t a lot of that before. But now there’s just a ton of it. And after you’ve done it for a while, I think you may see a lot of that become permanent. And so, just across the board, it’s not so much new users of the internet that weren’t done a little bit before. But now they’re being done at massive scale. And there’s a prospect that the scale will be very large coming out. And so, when we look at the secular tailwinds here, obviously, we’re worried about a global recession, as Ed talked about. We just have no idea how long or deep that will be. We’re hoping we get out of this pandemic situation by the end of the year and things are looking better. That’s beyond our control. But once we do emerge, it does seem like there’s a lot of strong tailwinds for Akamai. Because the things I described are all the things that we’re really good at and the market leaders at.

And so, I would say long term view, very bullish about Akamai. It’s not a major product shift for us. Obviously, go to market now. We’re changing how we do that, because we’re not traveling. So, the go-to-market motions are all virtual and digital now. And we’ve gotten off to a great start there and how many of you came to our virtual edge live event but tremendous attendance there and really good feedback. And so, how we approach customers, how we talk to them physically is changing. And that’s fine. We’re in good shape there.

In terms of the security bookings, yes, for the enterprise security products, very substantial increase year-over-year in Q1.And that seems to be continuing into Q2. So, that is good news. Now, it takes a while for that to turn into revenue, of course. But, that’s a very positive development. And I do think that again in the long term, with more employees working from home, and already the need to stop data breaches and protect enterprise applications and data that there is a bright future for our Zero Trust enterprise security products.

Tim Horan

Thank you.

Operator

Thank you. Your next question comes from the line of Colby Synesael with Cowen.

Colby Synesael

Great. Thank you. Two questions, if I may. I guess, first I just want to drill a bit further down on bad debt. Wondering if you could provide any more color as it relates to — as a percentage of revenue or what the actual step up was in the quarter. And what should we be looking for that could suggest that you might have to take it up a little bit further potentially in the second quarter. And then just real quickly on pricing. I’m just curious with the incremental volume that you’re seeing tied to the CDN business, whether it’s just the broader OTT trend or CD-19 related, if we’re seeing any significant material shift in pricing trends. Thank you.

Ed McGowan

Sure. I’ll take those. Bad debt was up a couple of million this quarter. There’s a new accounting standard that we adopted at the beginning of January ASC 326, which basically in the past used to look at — sorry to get wonky here, but in fact, you had to look at the historic and anything that happens within a quarter. Now you have to look at potential future credit losses. So, think of it almost like you’re a bank where you’re evaluating your trade receivables and having to put up a reserve for potential future credit losses. And I mentioned earlier, we’ll be extending out, in some cases, some payment terms to folks. In some cases, as they are just asking for some time. In other cases, like in places like India, they physically can’t get into the office and are not set up to do electronic payments. So, we’ll be evaluating that as every company that adopts this standard will be doing the same. So, I do expect that debt expenses will go higher, and we did plan for that in our guidance. So, you’ll see in G&A line that that will start to tick up a bit.

On the pricing side, pricing in the CDN market, I didn’t see anything this quarter that was out of the ordinary. I will say, though, that we are seeing, as I talked about capacity, the push for capacity reservation fees, which essentially is just getting a little on top of what you’d normally get for the cost of this delivery. Capacity is at a premium at this point. So, we are seeing a little bit of a benefit there. But, in terms of the normal pricing environment, it’s still volume-based and I don’t see a lot of difference in the market at this point.

Colby Synesael

Thank you very much.

Operator

Thank you. And our next question comes from the line of Jane Lee [ph] with RBC Capital Markets.

UnidentifiedAnalyst

Hi. Thank you. This is Jane for Mark Mahaney. Thanks for taking the question. So, maybe just a couple of points, one on the guidance. You mentioned the vertical weaknesses in your hospitality, travel, commerce. Can you give perhaps ballpark the magnitude of the impact? And maybe just like, do you bake in a similar impact in Q2, or do you expect that in your Q2 guide — or do you expect that to kind of be a worsening scenario, just given how much of that has just happened in the last month of the quarter? And then, I have a follow-up. Thank you.

Ed McGowan

Yes, sure. So, in the guide, we did expect that we see additional pressure in those verticals and in my prepared remarks I talked about how we expected the Web division to decline slightly. It’s not usually a division that grows very steadily obviously with the exception of a seasonally strong Q4 going to Q1. So, we are anticipating that. So, I did bake in some of that and then included in the range as a various set of scenarios in terms of good, better, best in terms of how we will land. So far in the first 30 days — or the 28 days of the quarter, I would say, we’re trending about what I would have expected, but see how things go here in the next 60 days as we finish up the quarter. Hopefully as some of these countries and states start to come back out of shelter-in-place, we don’t see a panic back to things getting worse. And there’s more consumer confidence, we don’t see as much pressure. But that’s how we thought about it.

Unidentified Analyst

Got it. And another question just on security, maybe pre and post COVID. Maybe parsing out the COVID impact before that really hit and you see a surge in booking. How the growth has been trending versus your expectations and what’s kind of the cadence of transition to Zero Trust? And maybe after the COVID impact, you mentioned a few new launches and it has obviously page integrity being one, SWG as well that will be a more material revenue driver in the out years. Now, do you see any of these new product launches actually becoming more meaningful revenue drivers in perhaps this year or next year, sooner than projected?

Tom Leighton

Yes. Good question. I would say, the security growth remains very strong. It’s been in the high 20s for some time, and we saw that in Q1 as well, and that’s going into COVID. I think, the pandemic as we talked about, the rate of attacks is increased as bad as that is, during the pandemic, as the attackers try to take advantage of it, I would say. Now ,the new services like page integrity and secure web gateway and enterprise security and the increased bookings around enterprise, security, those are things that will drive revenue in the future. So, there’s some time between bookings and growth. I would say that the pandemic and the stuff that’s happening there helps Zero Trust because in our enterprise security, because there is even more need for it. And in some cases, it’s an urgent need. Whereas before there was — I think it was early days of a trend towards moving to Zero Trust. So, there’s an accelerant because of the pandemic. I don’t think the pandemic yet you’ve seen any change in revenue because of it, the same way you would for traffic. Traffic, you monetize that immediately, as soon as you’re delivering more, you get the revenue for it. With security products, that more is the bookings and the recurring revenue that’s generated as customers find new services or increase the services they have. And so, there — I think there is benefit, in the future, but we haven’t experienced that yet in the same way we have the traffic.

Operator

Thank you. And our next question comes from the line of Rishi Jaluria with D.A. Davidson.

Rishi Jaluria

First, I wanted to go back to retail and commerce as a vertical. Look at — I know it’s been under pressure, even pre-COVID. It feels like certain parts of that vertical though might be doing better than others in this environment, right, especially those like a Walmart that are selling essential goods and services, and we’re seeing pockets of ecommerce. So, I wanted to get a sense for what are you seeing within that vertical. And if you think you’re withdrawing of guidance and one of the factors being uncertainty around the holiday shopping season. Is that a function of the impact from the fact that we’re in a recession, it might take time for recovery. So, discretionary spending might be down or maybe some more detail around that? And then, the second question I wanted to ask, you talked a little bit about the payment terms and restructuring your deals. One of your competitors or peers talked about some customers deferring minimum traffic commitments in this environment. Just wanted to get a sense, is that something that you are seeing as well. Thanks.

Ed McGowan

All right. So, I’ll start with the second one. So, in terms of deferring minimum traffic commitments, we haven’t got into that. As a matter of fact, traffic is up significantly. So, it hasn’t been an issue for us. There are some customers in the Web division that have opted for the zero overage, but that’s been a normal sales motion. So, I wouldn’t say — I wouldn’t really call of anything there.

On your question about retail and what we’re worried about there. You’re correct. There’s winners and losers. Some folks have done very well and we’ve seen traffic go higher, and their underlying businesses are doing well. But there’s an awful lot of them that are stressed. And I talked about the size of the vertical, 16% of revenue over 900 customers. That’s global. So, the really the big thing that we’re concerned with and I think you hit it on the head with this, the depth of this reception and how do consumers behave, are they going to go out and spend, are they going to go back into stores, what’s the ability of our customers to be able to raise enough capital to get through this issue.

In some cases, we’re going to see unfortunately some customers go bankrupt. I hate to see it, it does happen. Some liquidate, some come out on the other side. But whenever that happens, it’s a disruption for us. We have to stop taking revenue, write-off revenue in the quarter, take a bad debt hit for some of the older receivables. So, it just becomes very disruptive. And it’s hard for us to really call out what’s going to happen, because I think what’s going to drive the depth of this reception is going to be what happens with the virus and do people feel comfortable coming out, as we’ve never dealt with this before. So, it’s really hard for us to make the call. And, just given the size of that vertical, it can swing around quite a bit. So, that’s what our — that’s why we decided to withdraw our guidance.

Rishi Jaluria

That’s helpful. Thank you.

Operator

Thank you. And our next question comes from the line of Lee Krowl with B. Riley.

Lee Krowl

Great. Thanks for taking my questions. And congrats on a solid quarter, all things considered. I wanted to focus first on the security business. I think, last call, you guys kind of highlighted 20% growth as the baseline for the year. Obviously Q1 is tracking kind of ahead of that, and you’re speaking to some momentum with bookings. Is it reasonable to say that that 20% or possibly higher is still reasonable?

And then, second question, I just wanted to focus on international. Maybe could you parse out contribution of security versus media delivery, especially with the context of new launches on the OTT side? Thanks for taking my questions.

Ed McGowan

Sure. So, I’ll start with the security question. Obviously, we’re off to a great start here. 28%, constant currency growth. Feeling pretty good about Q2. Obviously, Q1’s bookings were strong. We signed one of our largest security deals in our in our history with one of our large media companies. So, good to see that and we see the benefit of that in Q2. So, I think Q2, we’ll see really strong growth. And we did call out 20%. It’s possible we could do better than that. Obviously, the verticals we call out that are challenged, do have big security customers. So, to the extent that there’s bankruptcies and things like that can bump you around a little bit. But, feeling pretty good here in the first half., certainly that will be growing greater than 20%. And it’s possible for the year, really just depends on how things go, some of the comments I made earlier.

And your second question on international in terms of the strength, I’d say, there it’s similar to what we see in the U.S. probably a bit more security adoption, quite more greenfield internationally, especially in places like Latin America, pretty low penetration there, which is good. That’s part of the reason we did the exceeded transaction that gives us a good basis to grow the security business there. We are seeing similar trends that we saw in the U.S. there where you see security and verticals like financial services and commerce and travel first and then you’re seeing media start to catch up. We’ve done some pretty good deals on the media side as well. So, I’d say there’s probably more greenfield in outside the U.S., but we are seeing very similar trends.

Lee Krowl

Got it. Thanks for taking my questions, guys.

Operator

Thank you. And our next question comes from the line of Jeff Van Rhee with Craig-Hallum.

Jeff Van Rhee

Great, thanks. I think most might have been answered. Just one remaining. I think as you look at the enterprise sales effort, and this is a little outside of sort of the COVID environment currently, but I know long term, tremendous growth opportunity. When you look at the sales process and where you are at this point, can you just talk to your satisfaction with win rates, with process, with just the overall execution effort in sales within enterprise and things that are yet to be done to really get that running where you wanted, it if it isn’t.

Tom Leighton

Yes. We’re pretty happy with where that is now, with pretty much everything you mentioned, the people, the process, the execution. As you could imagine, this is a difficult time to go out and get bookings. You can’t physically meet with your accounts, the buyers out there, the IT folks are just swamped with adjusting to the new reality. And yet, we had a great bookings quarter, better than expectation on our enterprise security products, much — big improvement over last year, and that’s — we’re starting off the second quarter very well. So, I think that’s an area where we’re very happy. You don’t see that in generating revenue today. But that will certainly help us going forward.

Jeff Van Rhee

Got it. Great. Thank you.

Operator

Thank you. And our next question comes from the line of Brandon Nispel with KeyBanc Capital Markets.

Brandon Nispel

Okay, great. Thanks for taking the question. I’m wondering if – one for Ed — maybe both for Ed. Can you give us a sense of — again, we’ve talked about some customers doing well in e-commerce, some not. Can you give us a sense of, as you look at your customer base, what could be a worst case scenario if we’re going into the global recession throughout 2020? What percentage of revenue would be at risk? Second, I’m curious, with customers hitting increased traffic during the quarter, how does the pricing change? Is it dynamic during the quarter, where they hit sort of a new threshold for traffic and they reprice to a lower level? I’m just curious how that works. Thanks.

Tom Leighton

Yes. I’ll take the first and Ed will probably take the second. As Ed talked about, I think, barring some kind of deep and long lasting recession that wipes out major customers and a lot of them or just totally wipes out consumer buying, which of course hurts the commerce vertical, I think we’re in good position. We have a really diverse customer base. Our largest vertical is media which is cranking and actually benefiting in many ways from the new reality of what the pandemic has caused.

Our customer base tends to be the biggest names in the business. And generally speaking, they’re the ones that are going to thrive the best, even if the global recession deepens and is lengthy. And it’s just that I think no one really knows what the future holds through the global recession. And if it really is deep at the end of the year, and it’s going persist into 2021, that could put our commerce customers and companies pretty much everywhere under pressure. And it’s hard to really know what the impact of that could be. And that impacts the potential downside of any guidance we can give.

And on the other side, we’ve got, as you know, substantial upsides in the media business and in security above where we were thinking. And as Ed talked about, just we want to be careful that we don’t know for sure that just persists and grows from there all year long. And as Ed talked about, in June, he even — we put in a dampening there in June on that. And so, that’s really what’s going on in our thinking that there’s the potential for large upside and the potential for downsides that are hard for us to really quantify. And it’s beyond our control at this point. I would say at a high level, business is very strong, as you can tell with the strong Q1 and I think a strong guide, albeit with a wider range in Q2. And Ed, do you want to talk about pricing with increased traffic?

Ed McGowan

Yes, sure. So, obviously, customers know one size fits all for customer pricing. But, what I would say is that typically we do have tiered pricing in most of our contracts, especially the ones with very large volume, so that as you do clip into new tiers, you do get typically a lower rate for that tier. But again, it does vary from customer-to-customer, but we do in most cases have some kind of a tiered pricing structure.

Brandon Nispel

And I guess, just as a follow-up, you guys gave the travel hospitality exposure and sort of talked about live events, but could you give us what percentage of revenue is coming from what you would call SMB? Thanks.

Ed McGowan

Oh, it’s very small. Yes, we do very little with SMB. We have a couple of partners that work with SMB. Like, for example our carriers will sell some security offerings to small, medium business. It’s such a small part of our business. We have a few OVP partners and other partners. But, it’s not a significant part of our business at all.

Tom Barth

Okay. Well, thank you, everyone. In closing, we will be presenting at several virtual investor conferences and events throughout the rest of the second quarter. Details of these can be found in the Investor Relations section of akamai.com. I want to thank you for joining us. And all of us at Akamai wish you continued health, and I wish you a very nice evening. So, thank you.

Operator

Ladies and gentlemen, this concludes today’s conference call. Thank you for participating. You may now disconnect.

Source